	_id	name	date	lineages
68	2021.04.02.438288	An emerging SARS-CoV-2 mutant evading cellular immunity and increasing viral infectivity	2021-04-05 00:00:00	b.1.427
68	2021.04.02.438288	An emerging SARS-CoV-2 mutant evading cellular immunity and increasing viral infectivity	2021-04-05 00:00:00	b.1.2
73	pmid33788923	Estimation of secondary household attack rates for emergent spike L452R SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco.	2021-03-31 00:00:00	b.1.427
73	pmid33788923	Estimation of secondary household attack rates for emergent spike L452R SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco.	2021-03-31 00:00:00	b.1.429
85	pmid33580111	SARS-CoV-2 genomic surveillance in Rondônia, Brazilian Western Amazon.	2021-02-17 00:00:00	b.1
85	pmid33580111	SARS-CoV-2 genomic surveillance in Rondônia, Brazilian Western Amazon.	2021-02-17 00:00:00	b.1.1
63	pmid33147321	An unconventional view of COVID-19 T cell immunity.	2020-11-09 00:00:00	m.2
97	pmid32576424	Stress, Anxiety, and Depression in People Aged Over 60 in the COVID-19 Outbreak in a Sample Collected in Northern Spain.	2020-05-16 00:00:00	v.2
29	2020.12.23.20248598	Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil	2020-12-26 00:00:00	b.1.1
99	pmid33881861	Fast Prediction of Binding Affinities of the SARS-CoV-2 Spike Protein Mutant N501Y (UK Variant) with ACE2 and Miniprotein Drug Candidates.	2021-04-21 00:00:00	lineage b.1.1.7
99	pmid33881861	Fast Prediction of Binding Affinities of the SARS-CoV-2 Spike Protein Mutant N501Y (UK Variant) with ACE2 and Miniprotein Drug Candidates.	2021-04-21 00:00:00	uk variant
57	pmid33759812	Clozapine treatment: Ensuring ongoing monitoring during the COVID-19 pandemic.	2021-03-24 00:00:00	a.1
57	pmid33759812	Clozapine treatment: Ensuring ongoing monitoring during the COVID-19 pandemic.	2021-03-24 00:00:00	s.1
57	pmid33759812	Clozapine treatment: Ensuring ongoing monitoring during the COVID-19 pandemic.	2021-03-24 00:00:00	l.3
23	2021.04.23.441186	Binding mechanism of neutralizing Nanobodies targeting SARS-CoV-2 Spike Glycoprotein	2021-04-26 00:00:00	501.v2 variant
50	2021.04.03.438330	Driving potent neutralization of a SARS-CoV-2 Variant of Concern with a heterotypic boost	2021-04-05 00:00:00	b.1.35
30	pmid33917138	The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus.	2021-04-04 00:00:00	lineage b.1.351
30	pmid33917138	The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus.	2021-04-04 00:00:00	b.1.351 lineage
68	2021.02.18.431484	A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine	2021-02-18 00:00:00	b.1.351
68	2021.02.18.431484	A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine	2021-02-18 00:00:00	p.1 variant
6	pmid33007020	Impact of the COVID-19 epidemic on patterns of pregnant women's perception of threat and its relationship to mental state: A latent class analysis.	2020-12-18 00:00:00	cluster 5
52	pmid33618008	Characterizing SARS-CoV-2 genome diversity circulating in South American countries: signatures of potentially emergent lineages?	2021-02-15 00:00:00	b.1.1.7
52	pmid33618008	Characterizing SARS-CoV-2 genome diversity circulating in South American countries: signatures of potentially emergent lineages?	2021-02-15 00:00:00	b.1.351
52	pmid33618008	Characterizing SARS-CoV-2 genome diversity circulating in South American countries: signatures of potentially emergent lineages?	2021-02-15 00:00:00	p.1
52	pmid33618008	Characterizing SARS-CoV-2 genome diversity circulating in South American countries: signatures of potentially emergent lineages?	2021-02-15 00:00:00	brazilian variant
52	pmid33618008	Characterizing SARS-CoV-2 genome diversity circulating in South American countries: signatures of potentially emergent lineages?	2021-02-15 00:00:00	uk variant
86	pmid33140444	Public Libraries as health literate multi-purpose workspaces for improving health literacy.	2020-11-03 00:00:00	s.1
87	pmid33737631	Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19.	2021-03-19 00:00:00	s.1
44	pmid33883984	Mutations in the SARS-CoV-2 spike protein modulate the virus affinity to the human ACE2 receptor, an in silico analysis.	2021-04-24 00:00:00	b.1.1.7
74	pmid33072339	Knowledge, attitude, practice and psychological response toward COVID-19 among nurses during the COVID-19 outbreak in northern Ethiopia, 2020.	2020-10-11 00:00:00	v.2
2	pmid33888419	"Letter of concern re: ""Immunochromatographic test for the detection of SARS-CoV-2 in saliva. J Infect Chemother. 2021 Feb;27(2):384-386. doi: 10.1016/j.jiac.2020.11.016."""	2021-03-15 00:00:00	c.2
23	pmid33581228	"Editorial: Learning From the Pandemic: ""Building Back Better"" Through Research on Risk and Resilience With Diverse Populations."	2021-03-15 00:00:00	s.1
35	2021.03.09.21253165	Evaluating the impacts of tiered restrictions introduced in England, during October and December 2020 on COVID-19 cases: A synthetic control study.	2021-03-12 00:00:00	b.1.1.7
69	pmid33602859	Dynamics of SARS-CoV-2 shedding in the respiratory depends on the severity of disease in COVID-19 patients.	2021-02-19 00:00:00	a.4
78	pmid33680365	Severe COVID-19 Pneumonia is Associated with Increased Plasma Immunoglobulin G Agonist Autoantibodies Targeting the 5-Hydroxytryptamine 2A Receptor.	2021-03-08 00:00:00	n.1
20	pmid32253143	COVID 19 in INDIA: Strategies to combat from combination threat of life and livelihood.	2020-03-23 00:00:00	y.1
50	2021.03.03.21252815	Economic Benefits of COVID-19 Screening Tests with a Vaccine Rollout	2021-03-05 00:00:00	b.1.1
93	pmid33610239	Clinical, epidemiological, laboratory, and radiological characteristics of novel Coronavirus (2019-nCoV) in retrospective studies: A systemic review and meta-analysis.	2021-02-21 00:00:00	v.1
23	2021.03.23.21254171	SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a widely used commercial multiplex PCR assay	2021-03-26 00:00:00	b.1.1.7 lineage
23	2021.03.23.21254171	SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a widely used commercial multiplex PCR assay	2021-03-26 00:00:00	b.1.1.7
48	pmid33824139	The new UK SARS-CoV-2 variant and lockdown - causes and consequences.	2021-04-07 00:00:00	b.1.1.7
25	pmid33706862	Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021.	2021-03-16 00:00:00	lineage b.1.1.7
25	pmid33706862	Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021.	2021-03-16 00:00:00	b.1.1.7 lineage
25	pmid33706862	Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021.	2021-03-16 00:00:00	b.1.1.7
23	pmid33679622	Evolutionary Dynamics and Dissemination Pattern of the SARS-CoV-2 Lineage B.1.1.33 During the Early Pandemic Phase in Brazil.	2021-03-10 00:00:00	b.1.1
2	2021.04.05.438465	The Up state of the SARS-COV-2 Spike homotrimer favors an increased virulence for new variants	2021-04-06 00:00:00	south african variant
2	2021.04.05.438465	The Up state of the SARS-COV-2 Spike homotrimer favors an increased virulence for new variants	2021-04-06 00:00:00	b.1.35
3	pmid32869339	Cutaneous Symptoms of Patients Diagnosed with Covid-19 in One Province: A Cross-Sectional Survey.	2020-09-01 00:00:00	d.2
14	2021.03.17.435802	Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV2 variants	2021-03-17 00:00:00	b.1.1.7
14	2021.03.17.435802	Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV2 variants	2021-03-17 00:00:00	b.1.351
15	pmid33203639	Characteristics of online medical care consultation for pregnant women during the COVID-19 outbreak: cross-sectional study.	2020-11-21 00:00:00	v.2
88	2021.01.29.21250798	Identification of B.1.346 lineage of SARS-CoV-2 in Japan: Genomic evidence of re-entry of Clade 20C	2021-02-01 00:00:00	b.1.346
88	2021.01.29.21250798	Identification of B.1.346 lineage of SARS-CoV-2 in Japan: Genomic evidence of re-entry of Clade 20C	2021-02-01 00:00:00	b.1.1.284
88	2021.01.29.21250798	Identification of B.1.346 lineage of SARS-CoV-2 in Japan: Genomic evidence of re-entry of Clade 20C	2021-02-01 00:00:00	b.1.1
86	pmid33822064	The stability of an isolate of the SARS-CoV-2 B.1.1.7 lineage in aerosols is similar to three earlier isolates.	2021-04-06 00:00:00	b.1.1.7 lineage
86	pmid33822064	The stability of an isolate of the SARS-CoV-2 B.1.1.7 lineage in aerosols is similar to three earlier isolates.	2021-04-06 00:00:00	b.1.1.7
48	pmid33723631	Transmission of SARS-CoV-2 in northern Ghana: insights from whole-genome sequencing.	2021-03-18 00:00:00	b.1
26	2021.02.11.21251585	CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants	2021-02-15 00:00:00	b.1.351
22	2021.03.09.21253184	Increased mortality among individuals hospitalised with COVID-19 during the second wave in South Africa	2021-03-10 00:00:00	b.1.1.7
72	pmid32576982	COVID-19 Government Response Event Dataset (CoronaNet v.1.0).	2020-08-13 00:00:00	v.1
4	pmid32513231	Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial.	2020-06-30 00:00:00	n.2
81	2021.04.29.441933	Possible link between higher transmissibility of B.1.617 and B.1.1.7 variants of SARS-CoV-2 and increased structural stability of its spike protein and hACE2 affinity	2021-04-29 00:00:00	b.1.6
81	2021.04.29.441933	Possible link between higher transmissibility of B.1.617 and B.1.1.7 variants of SARS-CoV-2 and increased structural stability of its spike protein and hACE2 affinity	2021-04-29 00:00:00	b.1.1.7
81	2021.04.29.441933	Possible link between higher transmissibility of B.1.617 and B.1.1.7 variants of SARS-CoV-2 and increased structural stability of its spike protein and hACE2 affinity	2021-04-29 00:00:00	b.1.617 variant
11	pmid33690910	COVID-19 Test Reporting for Deceased Donors: Emergent Policies, Logistical Challenges and Future Directions.	2021-03-10 00:00:00	s.1
91	pmid33906636	Construction of a demand and capacity model for intensive care and hospital ward beds, and mortality from COVID-19.	2021-05-02 00:00:00	b.1.1.7
17	pmid33724560	COVID-19 pandemic and autoimmune bullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid Foundation.	2021-03-16 00:00:00	ak.1
66	2021.01.27.428516	SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines	2021-01-28 00:00:00	b.1.1.7
80	pmid33526412	Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant.	2021-02-02 00:00:00	uk variant
80	pmid33526412	Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant.	2021-02-02 00:00:00	south african variant
18	2021.02.03.21251057	Field performance evaluation of the PanBio rapid SARS-CoV-2 antigen assay in an epidemic driven by 501Y.v2 (lineage B.1.351) in the Eastern Cape, South Africa	2021-02-05 00:00:00	lineage b.1.351
45	pmid33362877	Importance of the treatment of patients with lip and palate cleft, especially during the COVID-19 pandemic.	2020-12-28 00:00:00	n.1
89	pmid32223697	Response to Wen and Li, Anesthesia Procedure of Emergency Operation for Patients with Suspected or Confirmed COVID-19 (DOI: 10.1089/sur.2020.040).	2020-05-07 00:00:00	r.2
42	2021.03.29.21254563	Improved performance of saliva for the detection of the B.1.351 variant in South Africa	2021-03-31 00:00:00	b.1.351 variant
42	2021.03.29.21254563	Improved performance of saliva for the detection of the B.1.351 variant in South Africa	2021-03-31 00:00:00	b.1.351
71	2021.04.27.21255987	Rapid and simultaneous identification of three mutations by the NovaplexTM SARS-CoV-2 Variants I Assay kit	2021-04-27 00:00:00	b.1.1.7
71	2021.04.27.21255987	Rapid and simultaneous identification of three mutations by the NovaplexTM SARS-CoV-2 Variants I Assay kit	2021-04-27 00:00:00	b.1.351
71	2021.04.27.21255987	Rapid and simultaneous identification of three mutations by the NovaplexTM SARS-CoV-2 Variants I Assay kit	2021-04-27 00:00:00	p.1
71	2021.04.27.21255987	Rapid and simultaneous identification of three mutations by the NovaplexTM SARS-CoV-2 Variants I Assay kit	2021-04-27 00:00:00	r.1
30	pmid33581054	Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people.	2021-02-13 00:00:00	b.1.1.7
89	pmid32367319	Artificial intelligence to codify lung CT in Covid-19 patients.	2020-12-18 00:00:00	l.2
9	pmid32304737	Maintaining the Quality Standards of Care for Inflammatory Bowel Disease Patients During the COVID-19 Pandemic.	2021-01-10 00:00:00	n.1
9	pmid32304737	Maintaining the Quality Standards of Care for Inflammatory Bowel Disease Patients During the COVID-19 Pandemic.	2021-01-10 00:00:00	n.2
22	2021.03.15.435528	Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines	2021-03-16 00:00:00	b.1.1.7
22	2021.03.15.435528	Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines	2021-03-16 00:00:00	b.1.351 variant
59	pmid33914720	COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program - Kentucky, March 2021.	2021-05-03 00:00:00	r.1
72	pmid33489643	Retraction: Racial Disparity Amongst Stroke Patients During the Coronavirus Disease 2019 Pandemic.	2021-01-25 00:00:00	s.1
88	2021.03.26.21254367	Emergence of a SARS-CoV-2 E484K variant of interest in Arizona	2021-03-28 00:00:00	b.1.2
9	2021.04.23.441209	Insertions in SARS-CoV-2 genome caused by template switch and duplications give rise to new variants of potential concern	2021-04-26 00:00:00	b.1.351
9	2021.04.23.441209	Insertions in SARS-CoV-2 genome caused by template switch and duplications give rise to new variants of potential concern	2021-04-26 00:00:00	b.1.1.1
32	pmid33840632	Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study.	2021-03-11 00:00:00	b.6
96	pmid33705729	SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines.	2021-02-19 00:00:00	b.1.1.7
17	pmid32993467	Cardiovascular clinical trials in the era of a pandemic.	2020-10-28 00:00:00	s.1
45	2021.01.24.427939	In silico investigation of the new UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 variants with a focus at the ACE2-Spike RBD interface	2021-01-24 00:00:00	b.1.1.7
10	pmid33671631	Genomic Epidemiology of SARS-CoV-2 in Madrid, Spain, during the First Wave of the Pandemic: Fast Spread and Early Dominance by D614G Variants.	2021-02-17 00:00:00	b.1
85	pmid32299752	Cardiac Surgery in Canada During the COVID-19 Pandemic: A Guidance Statement From the Canadian Society of Cardiac Surgeons.	2020-04-01 00:00:00	c.1
85	pmid32299752	Cardiac Surgery in Canada During the COVID-19 Pandemic: A Guidance Statement From the Canadian Society of Cardiac Surgeons.	2020-04-01 00:00:00	s.1
16	pmid33666916	Bench Building during COVID-19: Creating Capabilities and Training Teams.	2021-03-08 00:00:00	s.1
47	2021.02.06.21251159	Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States	2021-02-07 00:00:00	b.1.1.7
47	pmid33919314	A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil.	2021-04-01 00:00:00	b.1.1
47	pmid33919314	A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil.	2021-04-01 00:00:00	p.1
47	pmid33919314	A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil.	2021-04-01 00:00:00	p.2
47	pmid33919314	A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil.	2021-04-01 00:00:00	lineage b.1.1.28
47	pmid33919314	A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil.	2021-04-01 00:00:00	lineage p.1
47	pmid33919314	A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil.	2021-04-01 00:00:00	n.9
15	pmid33567246	Imported SARS-COV-2 Variant P.1 Detected in Traveler Returning from Brazil to Italy.	2021-02-10 00:00:00	variant p.1
55	pmid33866307	Characterization of an open access medical news platform readership during the COVID-19 pandemic.	2021-04-18 00:00:00	w.2
63	2020.04.05.20054429	Feasibility of Controlling COVID-19 Outbreaks in the UK by Rolling Interventions	2020-04-07 00:00:00	d.3
24	2021.04.17.21255656	Rapid detection of SARS CoV-2 N501Y mutation in clinical samples	2021-04-20 00:00:00	brazilian variant
45	pmid33842902	Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016.	2021-03-22 00:00:00	b.1.351
45	pmid33842902	Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016.	2021-03-22 00:00:00	p.1
45	pmid33842902	Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016.	2021-03-22 00:00:00	b.1.429
68	figshare12952238	The Exclusion of Patients with CKD in Prospectively Registered Interventional Trials for COVID-19-a Rapid Review of International Registry Data.	2020-09-29 00:00:00	s.1
83	2020.04.09.20059204	Myocyte Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2 mediated myocarditis	2020-04-14 00:00:00	r.1
27	2021.02.24.21251989	Virological and serological characterization of critically ill patient with COVID-19 in the UK: a special focus on variant detection	2021-03-05 00:00:00	b.1.1.7
51	pmid33728680	Molecular Mechanism of the N501Y Mutation for Enhanced Binding between SARS-CoV-2's Spike Protein and Human ACE2 Receptor.	2021-03-09 00:00:00	b.1.1.7
3	pmid33506951	Emergence of SARS-CoV-2 Variant: A Wake-Up Call for Pakistan's overburdened Healthcare System.	2021-01-28 00:00:00	vui-202012/01
3	pmid33506951	Emergence of SARS-CoV-2 Variant: A Wake-Up Call for Pakistan's overburdened Healthcare System.	2021-01-28 00:00:00	voc-202012/01
50	2020.05.06.20090340	The German COVID-19 Survey on Mental Health: Primary Results	2020-05-12 00:00:00	a.1
62	pmid33111978	Occupational dermatoses during the Covid-19 pandemic: a multicentre audit in the UK and Ireland.	2020-10-28 00:00:00	s.1
68	pmid33062414	Computational perspectives revealed prospective vaccine candidates from five structural proteins of novel SARS corona virus 2019 (SARS-CoV-2).	2020-10-22 00:00:00	v.2
98	2020.12.21.20248673	CovidSIMVL -- Transmission Trees, Superspreaders and Contact Tracing in Agent Based Models of Covid-19	2020-12-22 00:00:00	m.2
93	2021.01.12.426373	Phylogenetic analyses of SARS-CoV-2 B.1.1.7 lineage suggest a single origin followed by multiple exportation events versus convergent evolution	2021-01-13 00:00:00	b.1.1.7 lineage
93	2021.01.12.426373	Phylogenetic analyses of SARS-CoV-2 B.1.1.7 lineage suggest a single origin followed by multiple exportation events versus convergent evolution	2021-01-13 00:00:00	b.1.1.7
50	2021.02.07.21251287	Modelling the impact of reopening schools in early 2021 in the presence of the new SARS-CoV-2 variant and with roll-out of vaccination against COVID-19	2021-02-09 00:00:00	b.1.1.7
71	figshare12682135	Reviewer_2_v.2 – Supplemental material for Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study	2020-07-21 00:00:00	v.2
77	pmid33202092	Genetic insight into COVID-19 related liver injury: a note on MBOAT7.	2020-11-17 00:00:00	al.1
56	pmid33047029	Displacement ventilation: a viable ventilation strategy for makeshift hospitals and public buildings to contain COVID-19 and other airborne diseases.	2020-10-16 00:00:00	d.4
56	pmid33047029	Displacement ventilation: a viable ventilation strategy for makeshift hospitals and public buildings to contain COVID-19 and other airborne diseases.	2020-10-16 00:00:00	s.1
95	pmid33930563	Assessment of basic reproduction number (R	2021-04-22 00:00:00	b.1
95	pmid33930563	Assessment of basic reproduction number (R	2021-04-22 00:00:00	b.1.1
95	pmid33930563	Assessment of basic reproduction number (R	2021-04-22 00:00:00	b.1.36
98	2021.03.02.21252704	RT-RC-PCR: a novel and highly scalable next-generation sequencing method for simultaneous detection of SARS-COV-2 and typing variants of concern	2021-03-05 00:00:00	uk variant
98	2021.03.02.21252704	RT-RC-PCR: a novel and highly scalable next-generation sequencing method for simultaneous detection of SARS-COV-2 and typing variants of concern	2021-03-05 00:00:00	b.1.1.7
1	2020.09.15.20194712	Genomic epidemiology of the Los Angeles COVID-19 outbreak	2020-09-18 00:00:00	b.1
33	pmid32600378	Therapeutic pulmonary telerehabilitation protocol for patients affected by COVID-19, confined to their homes: study protocol for a randomized controlled trial.	2020-12-18 00:00:00	v.2
6	2021.01.20.427043	Design of Specific Primer Sets for the Detection of B.1.1.7, B.1.351 and P.1 SARS-CoV-2 Variants using Deep Learning	2021-01-21 00:00:00	b.1.1.7
6	2021.01.20.427043	Design of Specific Primer Sets for the Detection of B.1.1.7, B.1.351 and P.1 SARS-CoV-2 Variants using Deep Learning	2021-01-21 00:00:00	b.1.351
6	2021.01.20.427043	Design of Specific Primer Sets for the Detection of B.1.1.7, B.1.351 and P.1 SARS-CoV-2 Variants using Deep Learning	2021-01-21 00:00:00	p.1
6	2021.01.20.427043	Design of Specific Primer Sets for the Detection of B.1.1.7, B.1.351 and P.1 SARS-CoV-2 Variants using Deep Learning	2021-01-21 00:00:00	b.1.1.7 lineage
24	2020.06.11.20125799	The arrival and spread of SARS-CoV2 in Colombia	2020-06-12 00:00:00	b.1
71	pmid32480009	Rates of Symptomatic SARS-CoV-2 Infection in Patients With Autoimmune Liver Diseases in Northern Italy: A Telemedicine Study.	2020-05-23 00:00:00	s.1
46	2020.03.26.20041426	Clinical features and outcomes of 197 adult discharged patients with COIVD-19 in Yichang, Hubei	2020-03-30 00:00:00	s.1
55	2021.03.09.21253204	Detection of SARS-CoV-2 lineage P.1 in patients from a region with exponentially increasing hospitalization rates in February 2021, Rio Grande do Sul, Southern Brazil	2021-03-12 00:00:00	lineage p.1
55	2021.03.09.21253204	Detection of SARS-CoV-2 lineage P.1 in patients from a region with exponentially increasing hospitalization rates in February 2021, Rio Grande do Sul, Southern Brazil	2021-03-12 00:00:00	p.1
17	pmid33095922	Comment on: Bilò MB, Pravettoni V, Mauro M, Bonadonna P. Treating venom allergy during COVID-19 pandemic. Allergy. 2020 Jul 16. doi: 10.1111/all.14473: Management of venom allergen immunotherapy during the COVID-19 outbreak in Spain.	2020-08-17 00:00:00	l.1
64	pmid33500262	Covid-19: New UK variant may be linked to increased death rate, early data indicate.	2021-01-27 00:00:00	uk variant
95	pmid32790932	Kidney transplantation during the COVID-19 pandemic: Potential long-term consequences of an early post-transplant infection.	2020-08-20 00:00:00	al.1
75	2021.02.26.433062	Comparative infectivity and pathogenesis of emerging SARS-CoV-2 variants in Syrian hamsters	2021-02-26 00:00:00	b.1.1.7
75	2021.02.26.433062	Comparative infectivity and pathogenesis of emerging SARS-CoV-2 variants in Syrian hamsters	2021-02-26 00:00:00	b.1.35
75	2021.02.26.433062	Comparative infectivity and pathogenesis of emerging SARS-CoV-2 variants in Syrian hamsters	2021-02-26 00:00:00	b.1.1
75	2021.02.26.433062	Comparative infectivity and pathogenesis of emerging SARS-CoV-2 variants in Syrian hamsters	2021-02-26 00:00:00	b.1.351 lineage
0	pmid32378737	The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19.	2020-12-18 00:00:00	al.1
47	pmid33208205	Wound care during the COVID-19 emergency in Padua Hospital (Italy).	2020-11-19 00:00:00	s.1
51	pmid33131098	COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data.	2020-11-01 00:00:00	al.1
64	pmid33519019	"[Correction in article by Rodríguez et al. ""Exercising in times of COVID-19: what do experts recommend doing within four walls?"", Rev Esp Cardiol. 2020;73:527-529]."	2021-02-01 00:00:00	p.2
56	2021.03.09.434607	The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2	2021-03-10 00:00:00	b.1.1.7
56	2021.03.09.434607	The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2	2021-03-10 00:00:00	b.1.351
56	2021.03.09.434607	The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2	2021-03-10 00:00:00	p.1 variant
11	2020.08.03.233866	SARS-CoV-2 genome sequences from late April in Stockholm, Sweden reveal a novel mutation in the spike protein	2020-08-03 00:00:00	b.1
47	2021.02.12.430472	Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies	2021-02-12 00:00:00	b.1.1.7
47	2021.02.12.430472	Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies	2021-02-12 00:00:00	b.1.351 variant
47	2021.02.12.430472	Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies	2021-02-12 00:00:00	b.1.351
71	pmid33840038	The first familial cluster of the B.1.1.7 variant of SARS-CoV-2 in the northeast of Italy.	2021-04-11 00:00:00	b.1.1.7
47	pmid33066910	Malignant Cerebral Ischemia in A COVID-19 Infected Patient: Case Review and Histopathological Findings.	2020-07-30 00:00:00	s.1
11	pmid33777966	Corrigendum: Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused.	2021-03-29 00:00:00	d.2
19	pmid33666930	Deployment of the 1st Area Medical Laboratory to South Korea in Response to the COVID-19 Pandemic.	2021-03-08 00:00:00	a.1
27	2021.04.22.21255574	Mutation-specific SARS-CoV-2 PCR Screen: Rapid and Accurate Detection of Variants of Concern and the Identification of a Newly Emerging Variant with Spike L452R Mutation	2021-04-22 00:00:00	b.1.1.7
27	2021.04.22.21255574	Mutation-specific SARS-CoV-2 PCR Screen: Rapid and Accurate Detection of Variants of Concern and the Identification of a Newly Emerging Variant with Spike L452R Mutation	2021-04-22 00:00:00	p.1
27	2021.04.22.21255574	Mutation-specific SARS-CoV-2 PCR Screen: Rapid and Accurate Detection of Variants of Concern and the Identification of a Newly Emerging Variant with Spike L452R Mutation	2021-04-22 00:00:00	b.1.427
27	2021.04.22.21255574	Mutation-specific SARS-CoV-2 PCR Screen: Rapid and Accurate Detection of Variants of Concern and the Identification of a Newly Emerging Variant with Spike L452R Mutation	2021-04-22 00:00:00	b.1.526
36	2020.12.24.20248822	Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England	2020-12-26 00:00:00	variant of concern 202012/01
36	2020.12.24.20248822	Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England	2020-12-26 00:00:00	lineage b.1.1.7
99	2021.02.23.21252277	Impact of the Tier system on SARS-CoV-2 transmission in the UK between the first and second national lockdowns	2021-02-24 00:00:00	b.1.1.7
37	pmid33889106	Prolonged COVID 19 Outbreak and Psychological Response of Nurses in Italian Healthcare System: Cross-Sectional Study.	2021-04-24 00:00:00	n.6
18	pmid33372194	A meta-analysis of accuracy and sensitivity of chest CT and RT-PCR in COVID-19 diagnosis.	2021-01-01 00:00:00	v.1
21	2021.04.13.439681	Epitope classification and RBD binding properties of neutralizing antibodies against SARS-CoV-2 variants of concern	2021-04-13 00:00:00	p.1
21	2021.04.13.439681	Epitope classification and RBD binding properties of neutralizing antibodies against SARS-CoV-2 variants of concern	2021-04-13 00:00:00	b.1.427
21	2021.04.13.439681	Epitope classification and RBD binding properties of neutralizing antibodies against SARS-CoV-2 variants of concern	2021-04-13 00:00:00	b.1.429
91	2021.03.27.21254107	Detection of SARS-CoV-2 N501Y mutation by RT-PCR to identify the UK and the South African strains in the population of South Indian state of Telangana	2021-03-28 00:00:00	b.1.1.7
97	pmid33763697	Epidemiological, clinical and genomic snapshot of the first 100 B.1.1.7 SARS-CoV-2 cases in Madrid.	2021-03-25 00:00:00	b.1.1.7
54	2021.03.09.21253218	An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status	2021-03-12 00:00:00	b.1.1.7
39	2021.04.14.21255503	Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland	2021-04-20 00:00:00	b.1.1.7
69	pmid33797392	Linked transmission chains of imported SARS-CoV-2 variant B.1.351 across mainland France, January 2021.	2021-04-07 00:00:00	b.1.351
69	pmid33797392	Linked transmission chains of imported SARS-CoV-2 variant B.1.351 across mainland France, January 2021.	2021-04-07 00:00:00	b.1.351 variant
69	pmid33797392	Linked transmission chains of imported SARS-CoV-2 variant B.1.351 across mainland France, January 2021.	2021-04-07 00:00:00	south african variant
80	2021.03.10.21253291	Monitoring the propagation of SARS CoV2 variants by tracking identified mutation in wastewater using specific RT-qPCR	2021-03-20 00:00:00	brazilian variant
81	2020.12.21.423779	Cetylpyridinium chloride-containing mouthwashes reduce in vitro SARS-CoV-2 infectivity	2020-12-21 00:00:00	b.1.1.7
10	pmid33810168	Multiple Early Introductions of SARS-CoV-2 to Cape Town, South Africa.	2021-03-10 00:00:00	b.1
10	pmid33810168	Multiple Early Introductions of SARS-CoV-2 to Cape Town, South Africa.	2021-03-10 00:00:00	b.1.1.1
10	pmid33810168	Multiple Early Introductions of SARS-CoV-2 to Cape Town, South Africa.	2021-03-10 00:00:00	b.1.1.29
10	pmid33810168	Multiple Early Introductions of SARS-CoV-2 to Cape Town, South Africa.	2021-03-10 00:00:00	b.1.8
10	pmid33810168	Multiple Early Introductions of SARS-CoV-2 to Cape Town, South Africa.	2021-03-10 00:00:00	b.3
10	pmid33810168	Multiple Early Introductions of SARS-CoV-2 to Cape Town, South Africa.	2021-03-10 00:00:00	b.4
12	2021.01.21.21249764	Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil	2021-01-26 00:00:00	b.1.1
12	2021.01.21.21249764	Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil	2021-01-26 00:00:00	b.1.1.248
12	2021.01.21.21249764	Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil	2021-01-26 00:00:00	b.1.9
53	pmid33201914	Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics of COVID-19 patients in Hanoi, Vietnam.	2020-11-20 00:00:00	b.1.1
43	pmid33551470	Mental Health from Medical School to Medical Practice: Finding a Path Forward.	2021-02-10 00:00:00	y.1
94	pmid33899031	BNT162b2 Vaccination Effectively Prevents the Rapid Rise of SARS-CoV-2 Variant B.1.1.7 in high risk populations in Israel.	2021-03-16 00:00:00	b.1.1.7
99	2021.03.05.21252541	Early estimates of SARS-CoV-2 B.1.1.7 variant emergence in a university setting	2021-03-09 00:00:00	b.1.1.7
10	pmid33857454	Monitoring differences between the SARS-CoV-2 B.1.1.7 variant and other lineages.	2021-04-17 00:00:00	b.1.1.7
46	2021.01.07.21249353	Inherent random fluctuations in COVID-19 outbreaks may explain rapid growth of new mutated virus variants	2021-01-08 00:00:00	b.1.1.7
88	pmid33211586	Congressional Budget Responses to the Pandemic: Fund Health Care, Not Warfare.	2020-11-19 00:00:00	al.1
95	pmid33888505	Report of SARS-CoV-2 B1.1.7 Lineage in Morocco.	2021-04-23 00:00:00	b.1.1.7 lineage
73	2021.03.04.433768	Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variants	2021-03-04 00:00:00	b.1.1.7
73	2021.03.04.433768	Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variants	2021-03-04 00:00:00	b.1.35
73	2021.03.04.433768	Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variants	2021-03-04 00:00:00	b.1.526
89	2021.01.12.426407	Distinct Patterns of Emergence of SARS-CoV-2 Spike Variants including N501Y in Clinical Samples in Columbus Ohio	2021-01-15 00:00:00	b.1.1.7
16	2021.01.27.428353	Spike mutations decrease SARS-CoV-2 sensitivity to neutralizing antibodies but not ACE2-Ig in vitro	2021-01-28 00:00:00	b.1.1.7
16	2021.01.27.428353	Spike mutations decrease SARS-CoV-2 sensitivity to neutralizing antibodies but not ACE2-Ig in vitro	2021-01-28 00:00:00	b.1.351
16	2021.01.27.428353	Spike mutations decrease SARS-CoV-2 sensitivity to neutralizing antibodies but not ACE2-Ig in vitro	2021-01-28 00:00:00	p.1
45	2021.03.03.21252812	Genome sequencing and analysis of an emergent SARS-CoV-2 variant characterized by multiple spike protein mutations detected from the Central Visayas Region of the Philippines	2021-03-05 00:00:00	b.1.1.7
45	2021.03.03.21252812	Genome sequencing and analysis of an emergent SARS-CoV-2 variant characterized by multiple spike protein mutations detected from the Central Visayas Region of the Philippines	2021-03-05 00:00:00	b.1.351
45	2021.03.03.21252812	Genome sequencing and analysis of an emergent SARS-CoV-2 variant characterized by multiple spike protein mutations detected from the Central Visayas Region of the Philippines	2021-03-05 00:00:00	p.1
51	2021.03.31.21254687	SARS-CoV-2 infectivity by viral load, S gene variants and demographic factors and the utility of lateral flow devices to prevent transmission	2021-04-05 00:00:00	b.1.1.7
32	pmid33873199	Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.	2021-04-19 00:00:00	b.1.1.7
32	pmid33873199	Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.	2021-04-19 00:00:00	b.1.351 variant
32	pmid33873199	Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.	2021-04-19 00:00:00	b.1.351
38	2020.06.09.20125690	Proteomic Profiling in Biracial Cohorts Implicates DC-SIGN as a Mediator of Genetic Risk in COVID-19	2020-06-11 00:00:00	r.1
66	2021.03.11.21253231	Emergence of the E484K Mutation in SARS-CoV-2 Lineage B.1.1.220 in Upstate New York	2021-03-23 00:00:00	b.1.1
48	pmid33310764	Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag CARD.	2020-12-14 00:00:00	a.1
3	pmid33896413	Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications.	2021-04-26 00:00:00	b.1
3	pmid33896413	Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications.	2021-04-26 00:00:00	b.1.1.7
3	pmid33896413	Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications.	2021-04-26 00:00:00	b.1.429
65	pmid33527635	Virtual Grand Rounds in COVID-19: a financial analysis.	2021-02-02 00:00:00	s.1
75	pmid32513289	The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.	2020-12-10 00:00:00	l.3
12	pmid33016958	Erratum: Patients' Attitudes to Unproven Therapies in Treating COVID-19 Merit Evaluation.	2020-11-04 00:00:00	n.2
21	pmid33769251	Detection of SARS-CoV-2 lineage P.1 in patients from a region with exponentially increasing hospitalisation rate, February 2021, Rio Grande do Sul, Southern Brazil.	2021-03-26 00:00:00	lineage p.1
21	pmid33769251	Detection of SARS-CoV-2 lineage P.1 in patients from a region with exponentially increasing hospitalisation rate, February 2021, Rio Grande do Sul, Southern Brazil.	2021-03-26 00:00:00	p.1
54	zenodo.3988139	Anticovidian v.2 COVID-19: Hypothesis of the Lab Origin Versus a Zoonotic Event which can also be of a Lab Origin	2020-08-10 00:00:00	v.2
91	pmid33705368	Travel from the United Kingdom to the United States by a Symptomatic Patient Infected with the SARS-CoV-2 B.1.1.7 Variant - Texas, January 2021.	2021-03-12 00:00:00	b.1.1.7
37	2021.04.30.442029	Evolutionary insights into a non-coding deletion of SARS-CoV-2 B.1.1.7	2021-05-01 00:00:00	b.1.1.7
89	2020.09.05.284604	Genomic analysis reveals local transmission of SARS-CoV-2 in early pandemic phase in Peru	2020-09-06 00:00:00	b.1.1.1
51	pmid33630488	Practical protocols for managing patients with SARS-CoV-2 infection (COVID-19) in the emergency department.	2021-02-25 00:00:00	s.1
19	2021.03.28.21254404	Quantitative detection of SARS-CoV-2 B.1.1.7 variant in wastewater by allele-specific RT-qPCR	2021-03-29 00:00:00	b.1.1.7
29	2021.03.11.435000	ChAdOx1 nCoV-19 (AZD1222) protects against SARS-CoV-2 B.1.351 and B.1.1.7	2021-03-11 00:00:00	b.1.351
29	2021.03.11.435000	ChAdOx1 nCoV-19 (AZD1222) protects against SARS-CoV-2 B.1.351 and B.1.1.7	2021-03-11 00:00:00	b.1.1.7
84	pmid33856889	The Importance of Federal Waivers and Technology in Ensuring Access to WIC During COVID-19.	2021-04-15 00:00:00	am.2
84	pmid33856889	The Importance of Federal Waivers and Technology in Ensuring Access to WIC During COVID-19.	2021-04-15 00:00:00	s.1
21	2021.04.27.21256187	Estimating the early impact of immunization against COVID-19 on deaths among elderly people in Brazil: analyses of secondary data on vaccine coverage and mortality.	2021-04-30 00:00:00	p.1 variant
55	figshare12900259	Additional file 4 of ANDC: an early warning score to predict mortality risk for patients with Coronavirus Disease 2019	2020-09-01 00:00:00	a.1
62	2020.06.02.20117499	Emergency calls are early indicators of ICU bed requirement during the COVID-19 epidemic	2020-06-05 00:00:00	w.2
16	2021.01.07.425307	Stable Interaction Of The UK B.1.1.7 lineage SARS-CoV-2 S1 Spike N501Y Mutant With ACE2 Revealed By Molecular Dynamics Simulation	2021-01-07 00:00:00	b.1.1.7 lineage
19	pmid33410583	Regulatory action to protect access to hydroxychloroquine for approved rheumatologic indications during COVID-19 in New Zealand.	2021-01-07 00:00:00	n.1
37	2021.03.30.21254648	A time series forecasting of the proportion of SARS-CoV-2 N501Y lineage in North America	2021-03-31 00:00:00	b.1.35
37	2021.03.30.21254648	A time series forecasting of the proportion of SARS-CoV-2 N501Y lineage in North America	2021-03-31 00:00:00	b.1.1.7
37	2021.03.30.21254648	A time series forecasting of the proportion of SARS-CoV-2 N501Y lineage in North America	2021-03-31 00:00:00	p.1
37	2021.03.30.21254648	A time series forecasting of the proportion of SARS-CoV-2 N501Y lineage in North America	2021-03-31 00:00:00	p.1 variant
37	2021.03.30.21254648	A time series forecasting of the proportion of SARS-CoV-2 N501Y lineage in North America	2021-03-31 00:00:00	b.1.351
53	2021.04.27.441707	Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant	2021-04-28 00:00:00	south african variant
53	2021.04.27.441707	Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant	2021-04-28 00:00:00	b.1.351
53	2021.04.27.441707	Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant	2021-04-28 00:00:00	b.1.1.7
53	2021.04.27.441707	Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant	2021-04-28 00:00:00	b.1.351 variant
86	pmid33647767	Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males.	2021-01-24 00:00:00	n.1
93	pmid33258149	Identifying public concerns and reactions during the COVID-19 pandemic on Twitter: A text-mining analysis.	2020-11-05 00:00:00	v.1
30	2021.01.18.21249786	Emergence of a novel SARS-CoV-2 strain in Southern California, USA	2021-01-20 00:00:00	b.1.1.7
30	2021.01.18.21249786	Emergence of a novel SARS-CoV-2 strain in Southern California, USA	2021-01-20 00:00:00	cal.20c
48	pmid33498225	Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein.	2021-01-15 00:00:00	b.1.1.7
64	2021.04.15.21255389	Emergence of the SARS-CoV-2 B.1.1.7 lineage and its characteristics at an outpatient testing site in Berlin, Germany, January-March 2021	2021-04-20 00:00:00	b.1.1.7 lineage
64	2021.04.15.21255389	Emergence of the SARS-CoV-2 B.1.1.7 lineage and its characteristics at an outpatient testing site in Berlin, Germany, January-March 2021	2021-04-20 00:00:00	b.1.1.7
24	pmid32838331	WITHDRAWN:A Case Series of Stent Thrombosis During the COVID-19 Pandemic.	2020-05-19 00:00:00	as.2
70	pmid33268477	Palliative care in critically ill COVID-19 patients: the early New York City experience.	2020-10-09 00:00:00	v.1
1	2021.04.13.439709	Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants	2021-04-14 00:00:00	b.1.1.7
1	2021.04.13.439709	Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants	2021-04-14 00:00:00	b.1.351 variant
27	2021.02.04.21251111	SARS-CoV-2 Worldwide Replication Drives Rapid Rise and Selection of Mutations across the Viral Genome: A Time-Course StudyPotential Challenge for Vaccines and Therapies	2021-02-06 00:00:00	b.1.1.7
27	2021.02.04.21251111	SARS-CoV-2 Worldwide Replication Drives Rapid Rise and Selection of Mutations across the Viral Genome: A Time-Course StudyPotential Challenge for Vaccines and Therapies	2021-02-06 00:00:00	b.1.35
27	2021.02.04.21251111	SARS-CoV-2 Worldwide Replication Drives Rapid Rise and Selection of Mutations across the Viral Genome: A Time-Course StudyPotential Challenge for Vaccines and Therapies	2021-02-06 00:00:00	p.1
27	2021.02.04.21251111	SARS-CoV-2 Worldwide Replication Drives Rapid Rise and Selection of Mutations across the Viral Genome: A Time-Course StudyPotential Challenge for Vaccines and Therapies	2021-02-06 00:00:00	p.2
28	pmid33567580	In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface.	2021-02-03 00:00:00	b.1.1.7
7	pmid32838330	WITHDRAWN: Complete Heart Block, Severe Ventricular Dysfunction and Myocardial Inflammation in a Child with COVID-19 Infection.	2020-05-14 00:00:00	as.2
24	2021.04.27.21256156	Affordable and time-effective high throughput screening of SARS-CoV-2 variants using Denaturing High-Performance Liquid Chromatography analysis	2021-04-29 00:00:00	p.1
24	2021.04.27.21256156	Affordable and time-effective high throughput screening of SARS-CoV-2 variants using Denaturing High-Performance Liquid Chromatography analysis	2021-04-29 00:00:00	b.1.585
31	2021.04.16.440141	Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2	2021-04-16 00:00:00	b.1.1.7
8	2021.02.24.21252406	Impact of a new SARS-CoV-2 variant on the population: A mathematical modeling approach	2021-03-01 00:00:00	voc-202012/01
8	2021.02.24.21252406	Impact of a new SARS-CoV-2 variant on the population: A mathematical modeling approach	2021-03-01 00:00:00	lineage b.1.1.7
20	2020.07.24.20161604	CCOFEE-GI Study: Colombian COVID19 First Experience in Gastroentrology. Characterization of digestive manifestations in patients diagnosed with COVID-19 at a highly complex institution in Bogota D.C., Colombia	2020-07-24 00:00:00	v.1
9	2020.10.28.20221143	Major new lineages of SARS-CoV-2 emerge and spread in South Africa during lockdown.	2020-10-30 00:00:00	c.1
9	2020.10.28.20221143	Major new lineages of SARS-CoV-2 emerge and spread in South Africa during lockdown.	2020-10-30 00:00:00	b.1.1
95	figshare13109720	Vitamin D Deficiency and ARDS after SARS-CoV-2 Infection	2020-11-26 00:00:00	a.3
20	2020.04.02.20050740	Comparison of transmissibility of coronavirus between symptomatic and asymptomatic patients: Reanalysis of the Ningbo Covid-19 data	2020-04-07 00:00:00	al.1
92	2021.04.02.438186	SARS-CoV-2 B.1.1.7 infection of Syrian hamster does not cause more severe disease and is protected by naturally acquired immunity	2021-04-02 00:00:00	b.1.1.7
92	2021.04.02.438186	SARS-CoV-2 B.1.1.7 infection of Syrian hamster does not cause more severe disease and is protected by naturally acquired immunity	2021-04-02 00:00:00	lineage b.1.1.7
92	2021.04.02.438186	SARS-CoV-2 B.1.1.7 infection of Syrian hamster does not cause more severe disease and is protected by naturally acquired immunity	2021-04-02 00:00:00	b.1
50	pmid33748790	A dual antibody test for accurate surveillance of SARS-CoV-2 exposure rates.	2021-03-23 00:00:00	al.1
78	2021.02.09.21251168	A novel, multiplexed RT-qPCR assay to distinguish lineage B.1.1.7 from the remaining SARS-CoV-2 lineages	2021-03-03 00:00:00	lineage b.1.1.7
78	2021.02.09.21251168	A novel, multiplexed RT-qPCR assay to distinguish lineage B.1.1.7 from the remaining SARS-CoV-2 lineages	2021-03-03 00:00:00	b.1.1.7 lineage
78	2021.02.09.21251168	A novel, multiplexed RT-qPCR assay to distinguish lineage B.1.1.7 from the remaining SARS-CoV-2 lineages	2021-03-03 00:00:00	b.1.1.7
4	pmid32618358	ACC.20: Impact of social media at the virtual scientific sessions during the COVID-19 pandemic.	2020-12-18 00:00:00	c.2
4	pmid32618358	ACC.20: Impact of social media at the virtual scientific sessions during the COVID-19 pandemic.	2020-12-18 00:00:00	c.19
51	2021.03.27.21252266	A rapid, cost efficient and simple method to identify current SARS-CoV-2 variants of concern by Sanger sequencing part of the spike protein gene	2021-03-29 00:00:00	b.1.1.7
51	2021.03.27.21252266	A rapid, cost efficient and simple method to identify current SARS-CoV-2 variants of concern by Sanger sequencing part of the spike protein gene	2021-03-29 00:00:00	b.1.351
51	2021.03.27.21252266	A rapid, cost efficient and simple method to identify current SARS-CoV-2 variants of concern by Sanger sequencing part of the spike protein gene	2021-03-29 00:00:00	p.1
88	2021.01.21.21249906	Genomic Epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil	2021-01-26 00:00:00	lineage b.1.351
88	2021.01.21.21249906	Genomic Epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil	2021-01-26 00:00:00	b.1.1
88	2021.01.21.21249906	Genomic Epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil	2021-01-26 00:00:00	b.1.1.248
57	pmid33909009	Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.	2021-02-25 00:00:00	b.1.351 lineage
57	pmid33909009	Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.	2021-02-25 00:00:00	b.1.1.7 lineage
98	pmid33914735	Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.	2021-04-29 00:00:00	b.1.1.7
33	2020.11.30.20241265	Detection of the Novel SARS-CoV-2 European Lineage B.1.177 in Ontario, Canada	2020-12-02 00:00:00	b.1.177
36	pmid33666924	Alternative Immunization Clinics to Improve Vaccination Access during the COVID-19 Pandemic.	2021-03-08 00:00:00	s.1
45	2021.02.07.21251262	L18F substrain of SARS-CoV-2 VOC-202012/01 is rapidly spreading in England	2021-02-09 00:00:00	voc-202012/01
45	2021.02.07.21251262	L18F substrain of SARS-CoV-2 VOC-202012/01 is rapidly spreading in England	2021-02-09 00:00:00	b.1.1.7
1	pmid33163356	"Corrigendum to ""Rapid review protocol: Zinc for the prevention or treatment of COVID-19 and other coronavirus-related respiratory tract infections"" [Integr. Med. Res. 9 (2020) 100457]."	2020-11-09 00:00:00	r.2
26	2021.03.24.436850	Factors Associated with Emerging and Re-emerging of SARS-CoV-2 Variants	2021-03-24 00:00:00	b.1.1.7
26	2021.03.24.436850	Factors Associated with Emerging and Re-emerging of SARS-CoV-2 Variants	2021-03-24 00:00:00	b.1.351
26	2021.03.24.436850	Factors Associated with Emerging and Re-emerging of SARS-CoV-2 Variants	2021-03-24 00:00:00	p.1
26	2021.03.24.436850	Factors Associated with Emerging and Re-emerging of SARS-CoV-2 Variants	2021-03-24 00:00:00	cal.20c
39	2020.08.13.20173807	Validation of Saliva and Self-Administered Nasal Swabs for COVID-19 Testing	2020-08-14 00:00:00	b.6
63	2021.01.22.427749	Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies	2021-01-22 00:00:00	b.1.1.7 lineage
63	2021.01.22.427749	Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies	2021-01-22 00:00:00	voc-202012/01
63	2021.01.22.427749	Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies	2021-01-22 00:00:00	b.1.35
99	2021.03.26.21254391	Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of Long-Term Care Facilities (VIVALDI study)	2021-03-26 00:00:00	b.1.1.7
62	pmid33932449	Observations of SARS-CoV-2 variant of concern B.1.1.7 at the UK's largest hospital Trust.	2021-05-01 00:00:00	b.1.1.7
71	figshare12902089	Reviewer_1_v.1 – Supplemental material for Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia	2020-09-01 00:00:00	v.1
19	2021.04.01.437942	Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants	2021-04-01 00:00:00	b.1.1.7
19	2021.04.01.437942	Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants	2021-04-01 00:00:00	b.1.351
24	2021.02.01.21250959	Increased hazard of death in community-tested cases of SARS-CoV-2 Variant of Concern 202012/01	2021-02-03 00:00:00	variant of concern 202012/01
24	2021.02.01.21250959	Increased hazard of death in community-tested cases of SARS-CoV-2 Variant of Concern 202012/01	2021-02-03 00:00:00	lineage b.1.1.7
24	2021.02.01.21250959	Increased hazard of death in community-tested cases of SARS-CoV-2 Variant of Concern 202012/01	2021-02-03 00:00:00	b.1.1.7
65	pmid33666922	Conducting Virtual Global Health Engagement (GHE) activities in the Midst of the Global COVID-19 Pandemic: Considerations for the Department of Defense GHE Enterprise.	2021-03-08 00:00:00	s.1
52	2021.04.07.21255081	Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study	2021-04-07 00:00:00	p.1 variant
52	2021.04.07.21255081	Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study	2021-04-07 00:00:00	p.1
76	pmid33462906	Long-term recovery from COVID-19 anosmia: promising findings and unanswered questions.	2021-01-19 00:00:00	a.1
60	pmid33766711	SARS-CoV-2 variants lacking ORF8 occurred in farmed mink and pangolin.	2021-03-26 00:00:00	variant of concern 202012/01
60	pmid33766711	SARS-CoV-2 variants lacking ORF8 occurred in farmed mink and pangolin.	2021-03-26 00:00:00	voc-202012/01
46	2021.04.16.21255459	Increased Transmissibility of SARS-CoV-2 Lineage B.1.1.7 by Age and Viral Load: Evidence from Danish Households	2021-04-19 00:00:00	lineage b.1.1.7
46	2021.04.16.21255459	Increased Transmissibility of SARS-CoV-2 Lineage B.1.1.7 by Age and Viral Load: Evidence from Danish Households	2021-04-19 00:00:00	b.1.1.7
31	pmid33804556	SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations.	2021-02-19 00:00:00	variant of concern 202012/01
31	pmid33804556	SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations.	2021-02-19 00:00:00	b.1.1.7
52	pmid33526352	Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01.	2021-02-06 00:00:00	vui-202012/01
52	pmid33526352	Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01.	2021-02-06 00:00:00	b.1.1.7
31	2021.04.09.21255206	High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.525 lineage in Oyo State, Nigeria	2021-04-17 00:00:00	b.1.1.7
31	2021.04.09.21255206	High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.525 lineage in Oyo State, Nigeria	2021-04-17 00:00:00	b.1.525
6	pmid33607034	Investigating the risks of removing wild meat from global food systems.	2020-11-26 00:00:00	y.1
97	2021.02.16.430500	Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants	2021-02-17 00:00:00	b.1.35
97	2021.02.16.430500	Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants	2021-02-17 00:00:00	b.1.1
25	pmid33120515	Impact of household quarantine on SARS-Cov-2 infection in mainland China: A mean-field modelling approach.	2020-11-16 00:00:00	b.6
38	2021.01.14.21249386	Epidemiological Investigation of New SARS-CoV-2 Variant of Concern 202012/01 in England	2021-01-15 00:00:00	variant of concern 202012/01
81	2021.01.06.20249091	Epidemiological and Clinical Characteristics, and Virologic Features of COVID-19 Patients in Kazakhstan: a Nation-Wide, Retrospective, Cohort Study.	2021-01-08 00:00:00	b.4.1
81	2021.01.06.20249091	Epidemiological and Clinical Characteristics, and Virologic Features of COVID-19 Patients in Kazakhstan: a Nation-Wide, Retrospective, Cohort Study.	2021-01-08 00:00:00	a.2
81	2021.01.06.20249091	Epidemiological and Clinical Characteristics, and Virologic Features of COVID-19 Patients in Kazakhstan: a Nation-Wide, Retrospective, Cohort Study.	2021-01-08 00:00:00	b.1.1
81	2021.01.06.20249091	Epidemiological and Clinical Characteristics, and Virologic Features of COVID-19 Patients in Kazakhstan: a Nation-Wide, Retrospective, Cohort Study.	2021-01-08 00:00:00	b.1
81	2021.01.06.20249091	Epidemiological and Clinical Characteristics, and Virologic Features of COVID-19 Patients in Kazakhstan: a Nation-Wide, Retrospective, Cohort Study.	2021-01-08 00:00:00	b.1.2
81	2021.01.06.20249091	Epidemiological and Clinical Characteristics, and Virologic Features of COVID-19 Patients in Kazakhstan: a Nation-Wide, Retrospective, Cohort Study.	2021-01-08 00:00:00	b.1.3
81	2021.01.06.20249091	Epidemiological and Clinical Characteristics, and Virologic Features of COVID-19 Patients in Kazakhstan: a Nation-Wide, Retrospective, Cohort Study.	2021-01-08 00:00:00	b.1.1.10
75	pmid32503657	The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial.	2020-12-10 00:00:00	d.3
67	2020.05.25.20113092	Finding Tentative Causes for the reduced impact of Covid-19 on the Health Systems of poorer and developing nations: An ecological study of the effect of demographic, climatological and health-related factors on the global spread of Covid-19	2020-05-26 00:00:00	l.3
60	2021.04.05.21251104	Detection of two CAL.20C SARS-CoV-2 variants in Monterrey metropolitan area in Northeast Mexico	2021-04-07 00:00:00	cal.20c
2	2021.02.05.429982	Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation	2021-02-05 00:00:00	b.1.1.7
30	pmid33333160	Black Children and the Pressing Need for Antiracism in Child Psychiatry.	2020-10-17 00:00:00	y.1
0	pmid33294366	"Corrigendum to ""Choose your shortcuts wisely: COVID-19 rapid reviews of traditional, complementary and integrative medicine"" [Integr Med Res 2020; 9: 100484]."	2020-12-09 00:00:00	r.2
51	pmid33704818	Immunoinformatic Analysis of Structural and Epitope Variations in Spike and Orf8 Proteins of SARS-CoV-2/B.1.1.7.	2021-03-11 00:00:00	b.1.1.7
51	pmid33704818	Immunoinformatic Analysis of Structural and Epitope Variations in Spike and Orf8 Proteins of SARS-CoV-2/B.1.1.7.	2021-03-11 00:00:00	b.1.1.7 lineage
10	figshare13221387	Reviewer_1_v.1 – Supplemental material for The use of nebulized pharmacotherapies during the COVID-19 pandemic	2020-11-11 00:00:00	v.1
97	2021.04.22.21255913	Impact of vaccination on SARS-CoV-2 cases in the community: a population-based study using the UK COVID-19 Infection Survey	2021-04-23 00:00:00	b.1.1.7
7	pmid33631434	Impact of COVID-19 on quality of life in people with epilepsy, and a multinational comparison of clinical and psychological impacts.	2021-02-02 00:00:00	s.1
35	pmid33157300	SARS-CoV-2 spread across the Colombian-Venezuelan border.	2020-10-20 00:00:00	b.1.13
43	2021.04.09.21255194	Antibody and T-cell responses to a single dose of the AZD1222/Covishield vaccine in previously SARS-CoV-2 infected and naive health care workers in Sri Lanka	2021-04-13 00:00:00	b.1.1.7
43	2021.04.09.21255194	Antibody and T-cell responses to a single dose of the AZD1222/Covishield vaccine in previously SARS-CoV-2 infected and naive health care workers in Sri Lanka	2021-04-13 00:00:00	b.1.351
74	pmid33289787	COVID-19 stokes inflammasomes.	2020-12-09 00:00:00	m.2
5	pmid33317760	Role of pharmacist during the COVID-19 pandemic: A scoping review.	2020-12-17 00:00:00	v.2
59	2021.04.14.439719	INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants	2021-04-14 00:00:00	b.1.351
5	pmid33169044	"[Correction in article by Bonanad et al. ""Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology"", 
                    Rev Esp Cardiol
                 . 2020;73:569-576]."	2020-11-10 00:00:00	p.2
22	pmid33713390	Oral Candidiasis of COVID-19 Patients: Case Report and Review of Evidence.	2021-03-13 00:00:00	n.1
75	2021.03.08.434499	The N501Y spike substitution enhances SARS-CoV-2 transmission	2021-03-09 00:00:00	b.1.1.7
75	2021.03.08.434499	The N501Y spike substitution enhances SARS-CoV-2 transmission	2021-03-09 00:00:00	uk variant
29	2021.01.10.426143	Impact of South African 501.V2 Variant on SARS-CoV-2 Spike Infectivity and Neutralization: A Structure-based Computational Assessment	2021-01-11 00:00:00	501.v2 variant
29	2021.01.10.426143	Impact of South African 501.V2 Variant on SARS-CoV-2 Spike Infectivity and Neutralization: A Structure-based Computational Assessment	2021-01-11 00:00:00	501.v2
29	2021.01.10.426143	Impact of South African 501.V2 Variant on SARS-CoV-2 Spike Infectivity and Neutralization: A Structure-based Computational Assessment	2021-01-11 00:00:00	b.1.1.7
29	2021.01.10.426143	Impact of South African 501.V2 Variant on SARS-CoV-2 Spike Infectivity and Neutralization: A Structure-based Computational Assessment	2021-01-11 00:00:00	south african variant
84	pmid32665969	A dataset for emotional reactions and family resilience during COVID-19 isolation period among Indonesian families.	2020-06-23 00:00:00	v.2
46	2021.01.26.426986	Neutralization of UK-variant VUI-202012/01 with COVAXIN vaccinated human serum	2021-01-26 00:00:00	vui-202012/01
6	pmid33041375	Erratum: The Transaction Costs of Government Responses to the COVID-19 Emergency in Latin America.	2020-10-13 00:00:00	r.1
41	2021.03.19.21253997	The Impact of Early or Late Lockdowns on the Spread of COVID-19 in US Counties	2021-03-22 00:00:00	al.1
41	2021.03.19.21253997	The Impact of Early or Late Lockdowns on the Spread of COVID-19 in US Counties	2021-03-22 00:00:00	l.2
39	2021.02.25.21252490	Early genomic detection of SARS-CoV-2 P.1 variant in Northeast Brazil	2021-03-01 00:00:00	p.1 variant
47	2021.04.24.21256045	Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests	2021-04-26 00:00:00	b.1.1.7
47	2021.04.24.21256045	Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests	2021-04-26 00:00:00	b.1.351
47	2021.04.24.21256045	Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests	2021-04-26 00:00:00	p.1 variant
47	2021.04.24.21256045	Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests	2021-04-26 00:00:00	p.1
74	2021.01.05.21249196	Genomic and mobility data reveal mass population movement as a driver of SARS-CoV-2 dissemination and diversity in Bangladesh	2021-01-13 00:00:00	b.1.36
74	2021.01.05.21249196	Genomic and mobility data reveal mass population movement as a driver of SARS-CoV-2 dissemination and diversity in Bangladesh	2021-01-13 00:00:00	b.1.1
7	pmid33755190	Higher infectivity of the SARS-CoV-2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data.	2021-03-01 00:00:00	uk variant
50	pmid33883059	Severe Acute Respiratory Syndrome Coronavirus 2 P.2 Lineage Associated with Reinfection Case, Brazil, June-October 2020.	2021-04-22 00:00:00	p.2
50	pmid33883059	Severe Acute Respiratory Syndrome Coronavirus 2 P.2 Lineage Associated with Reinfection Case, Brazil, June-October 2020.	2021-04-22 00:00:00	b.1.1
7	pmid33316947	Multiple Introductions Followed by Ongoing Community Spread of SARS-CoV-2 at One of the Largest Metropolitan Areas of Northeast Brazil.	2020-11-16 00:00:00	b.1.1
11	2021.03.13.435222	BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection but recognition of mutant viruses is up to 10-fold reduced	2021-03-15 00:00:00	b.1.351
11	2021.03.13.435222	BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection but recognition of mutant viruses is up to 10-fold reduced	2021-03-15 00:00:00	p.1
33	pmid33676232	SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring.	2021-03-09 00:00:00	variant of concern 202012/01
33	pmid33676232	SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring.	2021-03-09 00:00:00	voc-202012/01
19	pmid32557597	SARS-CoV-2 infection: the same virus can cause different cutaneous manifestations: reply from the authors.	2020-06-19 00:00:00	s.1
40	pmid32947203	"Letter of concern re: ""Analysis of Covid-19 and non-Covid-19 viruses, including influenza viruses, to determine the influence of intensive preventive measures in Japan. J. Clin. Virol. 2020; 129: 104543. doi:10.1016/j.jcv.2020.104543""."	2020-11-12 00:00:00	v.2
46	pmid33421056	Confirmed Reinfection with SARS-CoV-2 Variant VOC-202012/01.	2021-01-09 00:00:00	voc-202012/01
25	pmid33857406	Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.	2021-03-05 00:00:00	b.1.1.7 lineage
25	pmid33857406	Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.	2021-03-05 00:00:00	b.1.1.7
74	2021.04.06.21254882	Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals	2021-04-09 00:00:00	b.1.1.7
74	2021.04.06.21254882	Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals	2021-04-09 00:00:00	b.1.351
4	pmid32575956	Spatial statistical analysis of Coronavirus Disease 2019 (Covid-19) in China.	2020-09-23 00:00:00	v.1
47	pmid33632091	Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia.	2021-02-26 00:00:00	s.1
8	2021.03.11.434758	Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications	2021-03-11 00:00:00	b.1
8	2021.03.11.434758	Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications	2021-03-11 00:00:00	b.1.1.7
8	2021.03.11.434758	Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications	2021-03-11 00:00:00	b.1.429
77	2021.01.28.21250486	PCR assay to enhance global surveillance for SARS-CoV-2 variants of concern	2021-02-01 00:00:00	b.1.1.7
77	2021.01.28.21250486	PCR assay to enhance global surveillance for SARS-CoV-2 variants of concern	2021-02-01 00:00:00	b.1.351
77	2021.01.28.21250486	PCR assay to enhance global surveillance for SARS-CoV-2 variants of concern	2021-02-01 00:00:00	p.1
23	pmid32884212	"Comments on ""An insertion unique to SARS-CoV-2 exhibits super antigenic character strengthened by recent mutations"" by Cheng MH et al.2020."	2020-09-28 00:00:00	l.2
57	pmid33772244	Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.	2021-03-27 00:00:00	b.1.1.7
57	pmid33772244	Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.	2021-03-27 00:00:00	b.1.351 variant
57	pmid33772244	Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.	2021-03-27 00:00:00	b.1.351
23	pmid32932848	What Features and Functions Are Desired in Telemedical Services Targeted at Polish Older Adults Delivered by Wearable Medical Devices?-Pre-COVID-19 Flashback.	2020-08-31 00:00:00	c.1
23	pmid32932848	What Features and Functions Are Desired in Telemedical Services Targeted at Polish Older Adults Delivered by Wearable Medical Devices?-Pre-COVID-19 Flashback.	2020-08-31 00:00:00	c.2
30	2020.07.09.20149849	Severe SAR-CoV-2 infection in humans is defined by a shift in the serum lipidome resulting indysregulation of eicosanoid immune mediators	2020-07-10 00:00:00	y.1
81	2021.02.14.431043	SARS-CoV-2 lineage B.1.526 emerging in the New York region detected by software utility created to query the spike mutational landscape	2021-02-15 00:00:00	lineage b.1.526
81	2021.02.14.431043	SARS-CoV-2 lineage B.1.526 emerging in the New York region detected by software utility created to query the spike mutational landscape	2021-02-15 00:00:00	b.1.526
89	pmid32823907	Molecular Epidemiology Analysis of SARS-CoV-2 Strains Circulating in Romania during the First Months of the Pandemic.	2020-08-10 00:00:00	b.1
89	pmid32823907	Molecular Epidemiology Analysis of SARS-CoV-2 Strains Circulating in Romania during the First Months of the Pandemic.	2020-08-10 00:00:00	b.1.1
16	pmid33914975	Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of Dermatology.	2021-04-29 00:00:00	s.1
14	2021.01.25.428137	Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization	2021-01-26 00:00:00	b.1.351
14	2021.01.25.428137	Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization	2021-01-26 00:00:00	b.1.1.7
14	2021.01.01.425028	Structure-function investigation of a new VUI-202012/01 SARS-CoV-2 variant	2021-01-04 00:00:00	vui-202012/01
92	pmid33526979	Impact on physical and mental health among medical personnel in Wuhan during COVID-19 outbreak: a cluster analysis.	2021-02-05 00:00:00	cluster 5
75	2021.03.29.21254122	Increased transmissibility of the B.1.1.7 SARS-CoV-2 variant: Evidence from contact tracing data in Oslo, January to February 2021	2021-03-30 00:00:00	b.1.1.7
75	2021.03.29.21254122	Increased transmissibility of the B.1.1.7 SARS-CoV-2 variant: Evidence from contact tracing data in Oslo, January to February 2021	2021-03-30 00:00:00	b.1.1.7 lineage
79	2020.05.27.20115071	Clinical population genetic analysis of variants in the SARS-CoV-2 receptor ACE2	2020-05-29 00:00:00	c.2
22	pmid33658326	Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.	2021-03-04 00:00:00	lineage b.1.1.7
54	2021.03.18.436013	The B1.351 and P.1 variants extend SARS-CoV-2 host range to mice	2021-03-18 00:00:00	p.1 variant
91	2021.05.02.442052	Preliminary Immunogenicity of a Pan-COVID-19 T Cell Vaccine in HLA-A*02:01 Mice	2021-05-03 00:00:00	b.1.351
91	2021.05.02.442052	Preliminary Immunogenicity of a Pan-COVID-19 T Cell Vaccine in HLA-A*02:01 Mice	2021-05-03 00:00:00	p.1
20	pmid33596239	High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next-generation sequencing.	2021-02-22 00:00:00	b.1.1
20	pmid33596239	High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next-generation sequencing.	2021-02-22 00:00:00	b.1.9
5	pmid33123626	Delivering a work-integrated learning postgraduate course during COVID-19: Experiences, challenges and strategies.	2020-10-31 00:00:00	l.1
28	pmid33666925	Using Real-Time Google Search Interest as a Predictive Tool for COVID-19 Cases in the United States.	2021-03-08 00:00:00	s.1
41	pmid33370503	Persistence of SARS-CoV-2 antibodies in kidney transplant recipients.	2020-12-28 00:00:00	al.1
81	2021.04.16.440083	Antibody Cocktail Exhibits Broad Neutralization against SARS-CoV-2 and SARS-CoV-2 variants	2021-04-17 00:00:00	b.1.1.7
81	2021.04.16.440083	Antibody Cocktail Exhibits Broad Neutralization against SARS-CoV-2 and SARS-CoV-2 variants	2021-04-17 00:00:00	b.1.351
60	pmid33687922	Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study.	2021-03-15 00:00:00	voc-202012/01
57	2021.02.05.21251182	Antibodies elicited by SARS-CoV-2 infection and boosted by vaccination neutralize an emerging variant and SARS-CoV-1	2021-02-08 00:00:00	b.1.351 variant
57	2021.02.05.21251182	Antibodies elicited by SARS-CoV-2 infection and boosted by vaccination neutralize an emerging variant and SARS-CoV-1	2021-02-08 00:00:00	b.1.351
49	2020.03.09.20033068	Retrospective Analysis of Clinical Features in 101 Death Cases with COVID-19	2020-03-12 00:00:00	l.4
49	2020.03.09.20033068	Retrospective Analysis of Clinical Features in 101 Death Cases with COVID-19	2020-03-12 00:00:00	n.5
54	2021.03.31.437907	A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in VeroE6 cells	2021-03-31 00:00:00	b.1.1.7
54	2021.03.31.437907	A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in VeroE6 cells	2021-03-31 00:00:00	b.1
70	2021.05.03.442455	SARS -CoV-2 T-cell immunity to variants of concern following vaccination	2021-05-03 00:00:00	b.1.1.7
70	2021.05.03.442455	SARS -CoV-2 T-cell immunity to variants of concern following vaccination	2021-05-03 00:00:00	b.1.351
70	2021.05.03.442455	SARS -CoV-2 T-cell immunity to variants of concern following vaccination	2021-05-03 00:00:00	b.1.1.248
19	2021.03.11.21253399	Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape	2021-03-12 00:00:00	b.1.351
19	2021.03.11.21253399	Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape	2021-03-12 00:00:00	p.1
60	figshare12902095	Reviewer_2_v.2 – Supplemental material for Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia	2020-09-01 00:00:00	v.2
4	pmid33766552	Discovery of a SARS-CoV-2 variant 1 from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan.	2021-03-14 00:00:00	p.1
65	pmid33196736	Revisiting Handwashing - As It Is Absolutely Essential.	2020-11-23 00:00:00	d.2
23	pmid33301352	Building Trust in COVID-19 Vaccines and Beyond Through Authentic Community Investment.	2020-12-10 00:00:00	y.1
32	2021.03.11.435037	Effect of natural mutations of SARS-CoV-2 on spike structure, conformation and antigenicity	2021-03-12 00:00:00	b.1.1.7
32	2021.03.11.435037	Effect of natural mutations of SARS-CoV-2 on spike structure, conformation and antigenicity	2021-03-12 00:00:00	b.1.1
32	2021.03.11.435037	Effect of natural mutations of SARS-CoV-2 on spike structure, conformation and antigenicity	2021-03-12 00:00:00	b.1.351
24	2021.03.19.435959	Common dandelion (Taraxacum officinale) efficiently blocks the interaction between ACE2 cell surface receptor and SARS-CoV-2 spike protein D614, mutants D614G, N501Y, K417N and E484K in vitro	2021-03-19 00:00:00	b.1.1.7
24	2021.03.19.435959	Common dandelion (Taraxacum officinale) efficiently blocks the interaction between ACE2 cell surface receptor and SARS-CoV-2 spike protein D614, mutants D614G, N501Y, K417N and E484K in vitro	2021-03-19 00:00:00	b.1.35
24	2021.03.19.435959	Common dandelion (Taraxacum officinale) efficiently blocks the interaction between ACE2 cell surface receptor and SARS-CoV-2 spike protein D614, mutants D614G, N501Y, K417N and E484K in vitro	2021-03-19 00:00:00	p.1
49	pmid33580913	Prostate Specific Antigen in COVID-19 patients.	2021-02-13 00:00:00	s.1
96	pmid32480008	Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy.	2020-05-26 00:00:00	n.1
11	2021.02.26.21252562	An upsurge of SARS CoV-2 B.1.1.7 Variant in Pakistan	2021-03-05 00:00:00	b.1.1.7
25	pmid33059041	The Risk of Contracting COVID-19 Is Not Increased in Patients With Celiac Disease.	2020-10-05 00:00:00	s.1
4	pmid33756017	"Response to Letters Re: ""Assessing mandatory stay- at- home and business closure effects on the spread of COVID- 19""."	2021-03-23 00:00:00	ad.1
52	pmid32654921	Severe infection due to the SARS-CoV-2 coronavirus: Experience of a tertiary hospital with COVID-19 patients during the 2020 pandemic.	2020-05-18 00:00:00	s.1
16	pmid33590633	Plasmacytoid dendritic cell and type I interferons as possible explanation for clearance of longstanding warts during COVID-19 in a transplant patient, reply to Erkayman et al.	2021-02-16 00:00:00	al.1
71	pmid33907511	The Genetic Variant of SARS-CoV-2: would It Matter for Controlling the Devastating Pandemic?	2021-04-29 00:00:00	cluster 5
71	pmid33907511	The Genetic Variant of SARS-CoV-2: would It Matter for Controlling the Devastating Pandemic?	2021-04-29 00:00:00	p.1
30	pmid33364329	"Corrigendum to ""Depression, anxiety, and stress mediate the associations between internet gaming disorder, insomnia, and quality of life during the COVID-19 outbreak"" [Addict. Behav. Rep. 12 (2020) 100307]."	2020-12-28 00:00:00	p.2
91	2020.08.27.20183483	Repeat testing for SARS-COV-2: Persistence of viral RNA is common, and clearance is slower in older age groups	2020-09-01 00:00:00	n.3
91	2020.08.27.20183483	Repeat testing for SARS-COV-2: Persistence of viral RNA is common, and clearance is slower in older age groups	2020-09-01 00:00:00	d.3
1	pmid33245817	Novel technique for safe tracheostomy during COVID-19 pandemic using Evone® flow-controlled ventilation system.	2020-11-27 00:00:00	s.1
91	2021.04.05.21254952	mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition	2021-04-07 00:00:00	b.1.1.7
91	2021.04.05.21254952	mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition	2021-04-07 00:00:00	p.1
91	2021.04.05.21254952	mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition	2021-04-07 00:00:00	b.1.351
68	pmid33400409	Leveraging Virtual Boot Camp to Alleviate First Year Dermatology Resident Anxiety.	2021-01-06 00:00:00	s.1
25	pmid32726557	Recommendations for Dermatology Office Reopening in the Era of COVID-19.	2020-08-06 00:00:00	d.2
83	pmid33501730	A deletion in SARS-CoV-2 ORF7 identified in COVID-19 outbreak in Uruguay.	2021-01-27 00:00:00	b.1.1
48	pmid33826819	Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351.	2021-04-07 00:00:00	b.1.429
48	pmid33826819	Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351.	2021-04-07 00:00:00	b.1.351
12	pmid33514508	Covid-19: Sore throat, fatigue, and myalgia are more common with new UK variant.	2021-02-01 00:00:00	uk variant
38	pmid33496249	Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil, December 2020.	2021-02-03 00:00:00	lineage b.1.1.7
38	pmid33496249	Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil, December 2020.	2021-02-03 00:00:00	b.1.1.7 lineage
10	2021.01.25.428190	Computational Investigation of Increased Virulence and Pathogenesis of SARS-CoV-2 Lineage B.1.1.7	2021-01-26 00:00:00	lineage b.1.1.7
10	2021.01.25.428190	Computational Investigation of Increased Virulence and Pathogenesis of SARS-CoV-2 Lineage B.1.1.7	2021-01-26 00:00:00	b.1.1.7
57	2020.05.23.20111443	COVID-19 in Latin America: Contrasting phylodynamic inference with epidemiological surveillance.	2020-05-26 00:00:00	b.1
57	2020.05.23.20111443	COVID-19 in Latin America: Contrasting phylodynamic inference with epidemiological surveillance.	2020-05-26 00:00:00	b.1.1
17	figshare12497222	Reviewer_2_v.1 – Supplemental material for Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications	2020-06-17 00:00:00	v.1
94	2021.04.07.438849	Synthetic repertoires derived from convalescent COVID-19 patients enable discovery of SARS-CoV-2 neutralizing antibodies and a novel quaternary binding modality	2021-04-08 00:00:00	uk variant
94	2021.04.07.438849	Synthetic repertoires derived from convalescent COVID-19 patients enable discovery of SARS-CoV-2 neutralizing antibodies and a novel quaternary binding modality	2021-04-08 00:00:00	b.1.1.7
78	pmid32706371	Presence of Genetic Variants Among Young Men With Severe COVID-19.	2020-07-29 00:00:00	c.21
78	pmid32706371	Presence of Genetic Variants Among Young Men With Severe COVID-19.	2020-07-29 00:00:00	c.2
53	2021.01.26.21250543	The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.	2021-01-29 00:00:00	b.1.351
53	2021.01.26.21250543	The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.	2021-01-29 00:00:00	p.1
10	2021.03.26.437153	Comparison of SARS-CoV-2 VOC 202012/01 (UK variant) and D614G variant transmission by different routes in Syrian hamsters	2021-03-26 00:00:00	uk variant
27	pmid33531709	Sixteen novel lineages of SARS-CoV-2 in South Africa.	2021-02-03 00:00:00	b.1.1.5
27	pmid33531709	Sixteen novel lineages of SARS-CoV-2 in South Africa.	2021-02-03 00:00:00	c.1
27	pmid33531709	Sixteen novel lineages of SARS-CoV-2 in South Africa.	2021-02-03 00:00:00	b.1.1
74	pmid33724631	Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.	2021-01-29 00:00:00	b.1.1.7
74	pmid33724631	Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.	2021-01-29 00:00:00	b.1.35
74	pmid33724631	Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.	2021-01-29 00:00:00	p.1
98	pmid33783431	[Public Health commitment to the protection of health at the time of the pandemic].	2021-04-01 00:00:00	a.3
35	pmid32722343	Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic.	2020-07-17 00:00:00	b.1
29	2020.02.20.20025536	Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing，China	2020-02-23 00:00:00	n.4
38	pmid32711898	On Answering the Call to Action for COVID-19: Continuing a Bold Legacy of Health Advocacy.	2020-09-14 00:00:00	s.1
63	2020.12.29.424715	Design of Specific Primer Set for Detection of B.1.1.7 SARS-CoV-2 Variant using Deep Learning	2020-12-29 00:00:00	b.1.1.7
63	2020.12.29.424715	Design of Specific Primer Set for Detection of B.1.1.7 SARS-CoV-2 Variant using Deep Learning	2020-12-29 00:00:00	b.1.1.7 lineage
37	2021.04.02.21254832	Higher Relative Viral Load Excretion Determined by Normalised Threshold Crossing Value in Acute Cases infected with the B.1.1.7 Lineage VOC 202012/01 (Using S gene target failure as a Proxy) When Compared to other Circulating Lineages in Wales	2021-04-07 00:00:00	b.1.1.7 lineage
37	2021.04.02.21254832	Higher Relative Viral Load Excretion Determined by Normalised Threshold Crossing Value in Acute Cases infected with the B.1.1.7 Lineage VOC 202012/01 (Using S gene target failure as a Proxy) When Compared to other Circulating Lineages in Wales	2021-04-07 00:00:00	b.1.1.7
64	pmid33871106	Covid-19-triggered sarcoidal granulomas mimicking scar sarcoidosis.	2021-04-19 00:00:00	s.1
95	2021.02.23.21252259	A Novel SARS-CoV-2 Variant of Concern, B.1.526, Identified in New York	2021-02-25 00:00:00	b.1.526
95	2021.02.23.21252259	A Novel SARS-CoV-2 Variant of Concern, B.1.526, Identified in New York	2021-02-25 00:00:00	b.1.1.7 lineage
95	2021.02.23.21252259	A Novel SARS-CoV-2 Variant of Concern, B.1.526, Identified in New York	2021-02-25 00:00:00	lineage b.1.526
95	2021.02.23.21252259	A Novel SARS-CoV-2 Variant of Concern, B.1.526, Identified in New York	2021-02-25 00:00:00	b.15
95	2021.02.23.21252259	A Novel SARS-CoV-2 Variant of Concern, B.1.526, Identified in New York	2021-02-25 00:00:00	b.1.1.7
7	pmid33837580	COVID-19 and melanoma surgery in a dermo-oncology center in Italy.	2021-04-10 00:00:00	c.1
58	2020.12.15.20248130	Determinants of SARS-CoV-2 transmission to guide vaccination strategy in a city	2020-12-17 00:00:00	b.1
95	2021.03.06.21252994	Meta-Analysis of the Dynamics of the Emergence of Mutations and Variants of SARS-CoV-2	2021-03-08 00:00:00	b.1.1.7
95	2021.03.06.21252994	Meta-Analysis of the Dynamics of the Emergence of Mutations and Variants of SARS-CoV-2	2021-03-08 00:00:00	b.1.351
95	2021.03.06.21252994	Meta-Analysis of the Dynamics of the Emergence of Mutations and Variants of SARS-CoV-2	2021-03-08 00:00:00	p.1
95	2021.03.06.21252994	Meta-Analysis of the Dynamics of the Emergence of Mutations and Variants of SARS-CoV-2	2021-03-08 00:00:00	p.1 variant
15	2020.10.18.344622	An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants	2020-10-19 00:00:00	b.1.1.7
77	pmid32149769	Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model.	2021-01-25 00:00:00	s.1
78	2020.03.26.20044057	Clinical and Paraclinical Characteristics of COVID-19 patients: A systematic review and meta-analysis	2020-03-30 00:00:00	v.1
1	2021.03.28.437363	SARS-CoV-2 variant B.1.1.7 caused HLA-A2+ CD8+ T cell epitope mutations for impaired cellular immune response	2021-03-29 00:00:00	b.1.1.7
28	2020.08.10.242677	High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next generation sequencing	2020-08-10 00:00:00	b.1.1
28	2020.08.10.242677	High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next generation sequencing	2020-08-10 00:00:00	b.1.9
75	2021.03.05.433800	Previous SARS-CoV-2 infection increases B.1.1.7 cross-neutralization by vaccinated individuals.	2021-03-05 00:00:00	b.1.1.7
34	pmid33506970	Will the emergent SARS-CoV2 B.1.1.7 lineage affect molecular diagnosis of COVID19?	2021-01-28 00:00:00	b.1.1.7 lineage
68	2020.09.11.293183	Molecular Characterization, Phylogenetic and Variation Analyzes of SARS-CoV-2 strains in Turkey	2020-09-11 00:00:00	b.1
68	2020.09.11.293183	Molecular Characterization, Phylogenetic and Variation Analyzes of SARS-CoV-2 strains in Turkey	2020-09-11 00:00:00	b.1.1
68	2020.09.11.293183	Molecular Characterization, Phylogenetic and Variation Analyzes of SARS-CoV-2 strains in Turkey	2020-09-11 00:00:00	b.1.9
43	2021.03.17.21253782	B.1.1.7 became the dominant variant in Lebanon.	2021-03-17 00:00:00	b.1.1.7
43	2021.03.17.21253782	B.1.1.7 became the dominant variant in Lebanon.	2021-03-17 00:00:00	b.1.1.7 lineage
28	2021.01.21.21250264	Abrupt increase in the UK coronavirus death-case ratio in December 2020	2021-01-22 00:00:00	b.1.1.7
53	pmid32616134	[Comparison of Recovery Phase CT Features between Mild/moderate and Severe/critical Coronavirus Disease 2019 Patients].	2020-07-07 00:00:00	s.1
69	2021.04.19.440414	Low dose inocula of SARS-CoV-2 B.1.1.7 variant initiate more robust infections in the upper respiratory tract of hamsters than earlier D614G variants	2021-04-19 00:00:00	b.1.1.7
5	2021.03.19.21253946	The ongoing evolution of variants of concern and interest of SARS-CoV-2 in Brazil revealed by convergent indels in the amino (N)-terminal domain of the Spike protein	2021-03-20 00:00:00	p.1
5	2021.03.19.21253946	The ongoing evolution of variants of concern and interest of SARS-CoV-2 in Brazil revealed by convergent indels in the amino (N)-terminal domain of the Spike protein	2021-03-20 00:00:00	n.10
5	2021.03.19.21253946	The ongoing evolution of variants of concern and interest of SARS-CoV-2 in Brazil revealed by convergent indels in the amino (N)-terminal domain of the Spike protein	2021-03-20 00:00:00	b.1.1
79	2020.07.11.20149344	Placental SARS-CoV-2 in a patient with mild COVID-19 disease	2020-07-14 00:00:00	n.2
9	2021.01.04.425316	Molecular Mechanism of the N501Y Mutation for Enhanced Binding between SARS-CoV-2's Spike Protein and Human ACE2 Receptor	2021-01-05 00:00:00	b.1.1.7
88	2021.03.07.21252647	Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation	2021-03-09 00:00:00	b.1.427
88	2021.03.07.21252647	Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation	2021-03-09 00:00:00	b.1.429
88	2021.03.07.21252647	Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation	2021-03-09 00:00:00	b.1.1.7
88	2021.03.07.21252647	Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation	2021-03-09 00:00:00	b.1.351
88	2021.03.07.21252647	Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation	2021-03-09 00:00:00	p.1 variant
1	2021.03.30.21254323	A novel variant of interest of SARS-CoV-2 with multiple spike mutations is identified from travel surveillance in Africa	2021-04-04 00:00:00	lineage b.1.351
89	pmid33120400	Infusion of Convalescent Plasma is associated with Clinical Improvement in Critically Ill Patients With Covid-19: A Comment.	2020-10-29 00:00:00	al.1
45	pmid33915216	One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages.	2021-04-17 00:00:00	b.1.1.7
45	pmid33915216	One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages.	2021-04-17 00:00:00	b.1.35
45	pmid33915216	One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages.	2021-04-17 00:00:00	p.1
17	pmid33818952	The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.	2021-04-08 00:00:00	n.2
82	2021.02.16.21251819	The rise of SARS-CoV-2 variant B.1.1.7 in Israel intensifies the role of surveillance and vaccination in elderly	2021-02-19 00:00:00	b.1.1.7
82	2020.05.20.20108357	Liver Function in Novel Coronavirus Disease (COVID-19): A Systematic Review and Meta-Analysis	2020-05-23 00:00:00	v.1
75	pmid33483330	COVID-19 Vaccination: An Overview and Education Tool for Nuclear Medical Technologists.	2021-01-23 00:00:00	d.3
86	pmid33509993	Genome Sequences of 10 SARS-CoV-2 Viral Strains Obtained by Nanopore Sequencing of Nasopharyngeal Swabs in Malta.	2021-01-29 00:00:00	b.1
58	pmid33145338	Erratum to the effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension.	2020-11-05 00:00:00	m.2
31	2021.04.30.441559	Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of BBV152 vaccine	2021-04-30 00:00:00	b.1.1
57	pmid33905892	SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation.	2021-04-15 00:00:00	b.1
57	pmid33905892	SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation.	2021-04-15 00:00:00	b.1.1
57	pmid33905892	SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation.	2021-04-15 00:00:00	b.1.2
10	2021.04.08.21255135	Early evidence of COVID-19 vaccine effectiveness within the general population of California	2021-04-10 00:00:00	b.1.1.7
10	2021.04.08.21255135	Early evidence of COVID-19 vaccine effectiveness within the general population of California	2021-04-10 00:00:00	b.1.427
10	2021.04.08.21255135	Early evidence of COVID-19 vaccine effectiveness within the general population of California	2021-04-10 00:00:00	b.1.429
80	pmid32486557	[Clinical features and high resolution CT imaging evolution of coronavirus disease 2019].	2020-06-04 00:00:00	s.1
95	pmid33870493	SARS-CoV-2 antibodies: comparison of three high-throughput immunoassays versus the neutralization test.	2021-04-19 00:00:00	c.1
65	2021.01.13.21249721	Increased infections, but not viral burden, with a new SARS-CoV-2 variant	2021-01-15 00:00:00	b.1.1.7
75	2021.04.07.438820	Comparable environmental stability and disinfection profiles of the currently circulating SARS-CoV-2 variants of concern B.1.1.7 and B.1.351	2021-04-08 00:00:00	b.1.1.7
75	2021.04.07.438820	Comparable environmental stability and disinfection profiles of the currently circulating SARS-CoV-2 variants of concern B.1.1.7 and B.1.351	2021-04-08 00:00:00	b.1.351
75	2021.04.07.438820	Comparable environmental stability and disinfection profiles of the currently circulating SARS-CoV-2 variants of concern B.1.1.7 and B.1.351	2021-04-08 00:00:00	b.1.351 variant
26	2020.06.20.20099010	Compassionate Use of Opaganib For Patients with Severe COVID-19	2020-06-23 00:00:00	s.1
88	pmid32665352	Effects of respiratory rehabilitation on patients with novel coronavirus (COVID-19) pneumonia in the rehabilitation phase: protocol for a systematic review and meta-analysis.	2020-12-18 00:00:00	v.1
47	pmid32721580	Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.	2020-07-22 00:00:00	n.1
47	pmid32721580	Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.	2020-07-22 00:00:00	d.4
64	2020.06.30.20143859	Role of pharmacist during the COVID-19 pandemic: a scoping review	2020-07-02 00:00:00	v.2
74	2021.03.08.21253075	Evolutionary and phenotypic characterization of spike mutations in a new SARS-CoV-2 Lineage reveals two Variants of Interest	2021-03-12 00:00:00	b.1.177.6
95	pmid33450112	Zero healthcare-associated respiratory viral infections amongst solid-organ-transplant (SOT) recipients: infection prevention outcomes during COVID-19 pandemic.	2021-01-15 00:00:00	s.1
20	2021.03.25.21254356	Molecular beacons allow specific RT-LAMP detection of B.1.1.7 variant SARS-CoV-2	2021-03-26 00:00:00	b.1.1.7
36	2021.04.14.21255431	Post-vaccination SARS-CoV-2 infections and incidence of the B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center	2021-04-22 00:00:00	b.1.427
36	2021.04.14.21255431	Post-vaccination SARS-CoV-2 infections and incidence of the B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center	2021-04-22 00:00:00	b.1.429
45	pmid33651424	Association Between COVID-19 and Chilblains: A Case-Control Study.	2021-03-02 00:00:00	s.1
28	2021.02.03.21251054	Age-related heterogeneity in Neutralising antibody responses to SARS-CoV-2 following BNT162b2 vaccination	2021-02-05 00:00:00	b.1.1.7
95	2021.04.01.438087	Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites	2021-04-01 00:00:00	b.1.1.7
95	2021.04.01.438087	Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites	2021-04-01 00:00:00	p.1
18	pmid32691722	[Reply to a Comment Published on Acta Med Port 2020; May 25; doi:10.20344/amp.14155 about the Article Published on Acta Med Port 2020; Apr 27; doi:10.20344/amp.13928].	2020-11-18 00:00:00	p.1
74	pmid33905481	Vaccinated and convalescent donor-derived SARS-CoV-2-specific T cells as adoptive immunotherapy for high-risk COVID-19 patients.	2021-04-27 00:00:00	b.1.1.7
57	pmid33000462	SARS-CoV-2 Has Not Been Detected Directly by Electron Microscopy in the Endothelium of Chilblain Lesions.	2020-10-01 00:00:00	c.1
94	2020.12.21.423850	SARS-CoV-2 Genomic Surveillance in Costa Rica: Evidence of a Divergent Population and an Increased Detection of a Spike T1117I Mutation	2020-12-22 00:00:00	b.1
94	2020.12.21.423850	SARS-CoV-2 Genomic Surveillance in Costa Rica: Evidence of a Divergent Population and an Increased Detection of a Spike T1117I Mutation	2020-12-22 00:00:00	b.1.1
94	2020.12.21.423850	SARS-CoV-2 Genomic Surveillance in Costa Rica: Evidence of a Divergent Population and an Increased Detection of a Spike T1117I Mutation	2020-12-22 00:00:00	b.1.2
98	2021.04.06.438731	Functional evaluation of proteolytic activation for the SARS-CoV-2 variant B.1.1.7: role of the P681H mutation	2021-04-08 00:00:00	b.1.1.7
13	2020.12.16.423118	Modelling conformational state dynamics and its role on infection for SARS-CoV-2 Spike protein variants	2020-12-17 00:00:00	b.1.1.7
13	2020.12.16.423118	Modelling conformational state dynamics and its role on infection for SARS-CoV-2 Spike protein variants	2020-12-17 00:00:00	501.v2
53	pmid32735722	Response to comment on 10.1002/bjs.11679.	2021-02-12 00:00:00	s.1
88	pmid33121072	Testing the Accuracy of the ARIMA Models in Forecasting the Spreading of COVID-19 and the Associated Mortality Rate.	2020-10-21 00:00:00	v.1
88	pmid33121072	Testing the Accuracy of the ARIMA Models in Forecasting the Spreading of COVID-19 and the Associated Mortality Rate.	2020-10-21 00:00:00	v.2
13	2020.10.05.20206730	Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya	2020-10-07 00:00:00	b.1
13	2020.10.05.20206730	Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya	2020-10-07 00:00:00	b.4
37	2021.03.03.21252867	Rapid increase of SARS-CoV-2 variant B.1.1.7 detected in sewage samples from England between October 2020 and January 2021	2021-03-07 00:00:00	b.1.1.7
37	2021.03.03.21252867	Rapid increase of SARS-CoV-2 variant B.1.1.7 detected in sewage samples from England between October 2020 and January 2021	2021-03-07 00:00:00	lineage b.1.1.7
37	2021.03.03.21252867	Rapid increase of SARS-CoV-2 variant B.1.1.7 detected in sewage samples from England between October 2020 and January 2021	2021-03-07 00:00:00	b.1.351
37	2021.03.03.21252867	Rapid increase of SARS-CoV-2 variant B.1.1.7 detected in sewage samples from England between October 2020 and January 2021	2021-03-07 00:00:00	p.1
37	2021.03.21.436311	Structural and energetic profiling of SARS-CoV-2 antibody recognition and the impact of circulating variants	2021-03-21 00:00:00	b.1.1.7
37	2021.03.21.436311	Structural and energetic profiling of SARS-CoV-2 antibody recognition and the impact of circulating variants	2021-03-21 00:00:00	b.1.351
17	pmid33346250	"Corrigendum: Exercise: A Protective Measure or an ""Open Window"" for COVID-19? A Mini Review."	2020-12-22 00:00:00	r.2
64	2021.03.19.436183	Reduced neutralization of SARS-CoV-2 variants by convalescent plasma and hyperimmune intravenous immunoglobulins for treatment of COVID-19	2021-03-19 00:00:00	b.1.351
64	2021.03.19.436183	Reduced neutralization of SARS-CoV-2 variants by convalescent plasma and hyperimmune intravenous immunoglobulins for treatment of COVID-19	2021-03-19 00:00:00	p.1
64	2021.03.19.436183	Reduced neutralization of SARS-CoV-2 variants by convalescent plasma and hyperimmune intravenous immunoglobulins for treatment of COVID-19	2021-03-19 00:00:00	b.1.1
64	2021.03.19.436183	Reduced neutralization of SARS-CoV-2 variants by convalescent plasma and hyperimmune intravenous immunoglobulins for treatment of COVID-19	2021-03-19 00:00:00	b.1.429
12	2021.03.18.21253931	A convergence based assessment of relative differences in age-stratified susceptibility and infectiousness for SARS-CoV-2 variants of B.1.1.7 lineage	2021-03-20 00:00:00	b.1.1.7 lineage
12	2021.03.18.21253931	A convergence based assessment of relative differences in age-stratified susceptibility and infectiousness for SARS-CoV-2 variants of B.1.1.7 lineage	2021-03-20 00:00:00	b.1.1.7
36	2021.01.14.426475	N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2	2021-01-14 00:00:00	b.1.1.7 lineage
40	2021.04.29.442010	The natural stilbenoid (-)-hopeaphenol inhibits cellular entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7 and B.1.351 variants	2021-04-29 00:00:00	b.1.1.7
40	2021.04.29.442010	The natural stilbenoid (-)-hopeaphenol inhibits cellular entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7 and B.1.351 variants	2021-04-29 00:00:00	b.1.351 variant
40	2021.04.29.442010	The natural stilbenoid (-)-hopeaphenol inhibits cellular entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7 and B.1.351 variants	2021-04-29 00:00:00	b.1.35
40	2021.04.29.442010	The natural stilbenoid (-)-hopeaphenol inhibits cellular entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7 and B.1.351 variants	2021-04-29 00:00:00	b.1.351
91	2021.03.09.21252450	Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the Spike protein	2021-03-12 00:00:00	20j/501y.v3
91	2021.03.09.21252450	Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the Spike protein	2021-03-12 00:00:00	cal.20c
91	2021.03.09.21252450	Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the Spike protein	2021-03-12 00:00:00	b.1.1.29
91	2021.03.09.21252450	Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the Spike protein	2021-03-12 00:00:00	brazilian variant
1	pmid33180061	"[Erratum to ""Acute renal failure during COVID-19 epidemic"" [Prat. Anesth. Reanim. 24 (2020) 207-11]]."	2020-11-12 00:00:00	n.2
72	2021.03.14.21252289	Genetic screening for TLR7 variants in young and previously healthy men with severe COVID-19: a case series	2021-03-25 00:00:00	c.6
72	2021.03.14.21252289	Genetic screening for TLR7 variants in young and previously healthy men with severe COVID-19: a case series	2021-03-25 00:00:00	c.27
61	pmid32779356	Withdrawn: How perceived threat of Covid-19 causes turnover intention among Pakistani nurses: A moderation and mediation analysis.	2020-07-16 00:00:00	m.1
59	2021.04.13.21254841	A very simple model to account for the rapid rise of the British variant of SARS-CoV-2 in several countries and the world	2021-04-16 00:00:00	british variant
59	2021.04.13.21254841	A very simple model to account for the rapid rise of the British variant of SARS-CoV-2 in several countries and the world	2021-04-16 00:00:00	b.1.1.7
16	2021.03.01.433110	Ultrapotent miniproteins targeting the receptor-binding domain protect against SARS-CoV-2 infection and disease in mice	2021-03-01 00:00:00	b.1.1.7
45	pmid33727176	Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travelers from South Africa and Tanzania to India.	2021-03-08 00:00:00	b.1.35
15	pmid33631222	Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil.	2021-02-12 00:00:00	b.1.1
15	pmid33631222	Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil.	2021-02-12 00:00:00	b.1.1.248
15	pmid33631222	Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil.	2021-02-12 00:00:00	b.1.9
54	pmid32702365	Comparison of serologic and molecular SARS-CoV 2 results in a large cohort in Southern Tuscany demonstrates a role for serologic testing to increase diagnostic sensitivity.	2020-07-13 00:00:00	n.2
58	pmid33740028	SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event.	2021-03-19 00:00:00	b.1
58	pmid33740028	SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event.	2021-03-19 00:00:00	b.1.1
31	2021.01.06.20248960	Impact of B.1.1.7 variant mutations on antibody recognition of linear SARS-CoV-2 epitopes	2021-01-08 00:00:00	b.1.1.7
33	2020.03.20.20039891	COVID-19 outbreak in Algeria: A mathematical model to predict the incidence	2020-03-23 00:00:00	g.1
61	pmid33910569	Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes.	2021-04-30 00:00:00	b.1.1.7 lineage
61	pmid33910569	Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes.	2021-04-30 00:00:00	b.1.1.7
49	2021.03.21.21253418	Genomic surveillance of SARS-CoV-2 tracks early interstate transmission of P.1 lineage and diversification within P.2 clade in Brazil	2021-03-25 00:00:00	p.1
49	2021.03.21.21253418	Genomic surveillance of SARS-CoV-2 tracks early interstate transmission of P.1 lineage and diversification within P.2 clade in Brazil	2021-03-25 00:00:00	p.2
49	2021.03.21.21253418	Genomic surveillance of SARS-CoV-2 tracks early interstate transmission of P.1 lineage and diversification within P.2 clade in Brazil	2021-03-25 00:00:00	b.1.1
65	2020.08.27.269738	SARS-CoV-2 lineage B.6 is the major contributor to transmission in Malaysia	2020-08-27 00:00:00	b.6
65	2020.08.27.269738	SARS-CoV-2 lineage B.6 is the major contributor to transmission in Malaysia	2020-08-27 00:00:00	b.1
65	2020.08.27.269738	SARS-CoV-2 lineage B.6 is the major contributor to transmission in Malaysia	2020-08-27 00:00:00	b.1.1
65	2020.08.27.269738	SARS-CoV-2 lineage B.6 is the major contributor to transmission in Malaysia	2020-08-27 00:00:00	b.1.1.1
65	2020.08.27.269738	SARS-CoV-2 lineage B.6 is the major contributor to transmission in Malaysia	2020-08-27 00:00:00	b.1.36
65	2020.08.27.269738	SARS-CoV-2 lineage B.6 is the major contributor to transmission in Malaysia	2020-08-27 00:00:00	b.3
68	2020.12.28.20248906	SARS-CoV-2 Variant Under Investigation 202012/01 has more than twofold replicative advantage	2021-01-04 00:00:00	b.1.1.7
37	pmid32737100	Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials.	2020-08-11 00:00:00	v.2
35	2020.11.04.20225680	Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in males.	2020-11-05 00:00:00	n.1
19	2020.07.25.20162198	Changes in Cause-of-Death Attribution During the Covid-19 Pandemic: Association with Hospital Quality Metrics and Implications for Future Research	2020-07-28 00:00:00	s.1
19	2020.07.25.20162198	Changes in Cause-of-Death Attribution During the Covid-19 Pandemic: Association with Hospital Quality Metrics and Implications for Future Research	2020-07-28 00:00:00	g.1
19	2020.07.25.20162198	Changes in Cause-of-Death Attribution During the Covid-19 Pandemic: Association with Hospital Quality Metrics and Implications for Future Research	2020-07-28 00:00:00	d.2
19	2020.07.25.20162198	Changes in Cause-of-Death Attribution During the Covid-19 Pandemic: Association with Hospital Quality Metrics and Implications for Future Research	2020-07-28 00:00:00	n.2
19	2020.07.25.20162198	Changes in Cause-of-Death Attribution During the Covid-19 Pandemic: Association with Hospital Quality Metrics and Implications for Future Research	2020-07-28 00:00:00	a.28
19	2020.07.25.20162198	Changes in Cause-of-Death Attribution During the Covid-19 Pandemic: Association with Hospital Quality Metrics and Implications for Future Research	2020-07-28 00:00:00	d.3
19	2020.07.25.20162198	Changes in Cause-of-Death Attribution During the Covid-19 Pandemic: Association with Hospital Quality Metrics and Implications for Future Research	2020-07-28 00:00:00	n.3
19	2020.07.25.20162198	Changes in Cause-of-Death Attribution During the Covid-19 Pandemic: Association with Hospital Quality Metrics and Implications for Future Research	2020-07-28 00:00:00	m.3
12	2020.08.10.241414	SARS-CoV-2 Quasispecies Mediate Rapid Virus Evolution and Adaptation	2020-08-10 00:00:00	b.1.351
12	2020.08.10.241414	SARS-CoV-2 Quasispecies Mediate Rapid Virus Evolution and Adaptation	2020-08-10 00:00:00	b.1.1.248
54	pmid33725359	Response to: COVID-19 re-infection. Vaccinated individuals as a potential source of transmission.	2021-03-16 00:00:00	b.1.1.7
54	pmid33725359	Response to: COVID-19 re-infection. Vaccinated individuals as a potential source of transmission.	2021-03-16 00:00:00	b.1.35
54	pmid33725359	Response to: COVID-19 re-infection. Vaccinated individuals as a potential source of transmission.	2021-03-16 00:00:00	p.1
62	pmid33725432	Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.	2021-03-16 00:00:00	b.1.351 variant
62	pmid33725432	Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.	2021-03-16 00:00:00	b.1.351
83	pmid33592168	Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies.	2021-01-27 00:00:00	20j/501y.v3
30	2021.03.31.21254660	Qualitatively distinct modes of Sputnik V vaccine-neutralization escape by SARS-CoV-2 Spike variants	2021-04-02 00:00:00	b.1.1.7
30	2021.03.31.21254660	Qualitatively distinct modes of Sputnik V vaccine-neutralization escape by SARS-CoV-2 Spike variants	2021-04-02 00:00:00	b.1.351
46	pmid33545113	Inclusion of pregnant individuals among priority populations for COVID-19 vaccination for all 50 US States.	2021-01-29 00:00:00	s.1
45	2021.03.30.21254591	Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 lineage (20H/501Y.V2) in Brazil	2021-04-04 00:00:00	b.1.351 lineage
45	2021.03.30.21254591	Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 lineage (20H/501Y.V2) in Brazil	2021-04-04 00:00:00	b.1.1
45	2021.03.30.21254591	Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 lineage (20H/501Y.V2) in Brazil	2021-04-04 00:00:00	b.1.1.1
45	2021.03.30.21254591	Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 lineage (20H/501Y.V2) in Brazil	2021-04-04 00:00:00	b.1.1.7
45	2021.03.30.21254591	Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 lineage (20H/501Y.V2) in Brazil	2021-04-04 00:00:00	b.1.566
45	2021.03.30.21254591	Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 lineage (20H/501Y.V2) in Brazil	2021-04-04 00:00:00	p.1
45	2021.03.30.21254591	Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 lineage (20H/501Y.V2) in Brazil	2021-04-04 00:00:00	p.2
45	2021.03.30.21254591	Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 lineage (20H/501Y.V2) in Brazil	2021-04-04 00:00:00	south african variant
45	2021.03.30.21254591	Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 lineage (20H/501Y.V2) in Brazil	2021-04-04 00:00:00	b.1.351
79	2020.05.23.20111310	No evidence for allelic association between Covid-19 and ACE2 genetic variants by direct exome sequencing in 99 SARS-CoV-2 positive patients	2020-05-26 00:00:00	c.4
79	2020.05.23.20111310	No evidence for allelic association between Covid-19 and ACE2 genetic variants by direct exome sequencing in 99 SARS-CoV-2 positive patients	2020-05-26 00:00:00	c.21
79	2020.05.23.20111310	No evidence for allelic association between Covid-19 and ACE2 genetic variants by direct exome sequencing in 99 SARS-CoV-2 positive patients	2020-05-26 00:00:00	c.18
12	pmid33833618	Whole-Transcriptome RNA Sequencing Reveals Significant Differentially Expressed mRNAs, miRNAs, and lncRNAs and Related Regulating Biological Pathways in the Peripheral Blood of COVID-19 Patients.	2021-02-20 00:00:00	g.1
60	pmid33253226	SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia.	2020-11-30 00:00:00	b.6
60	pmid33253226	SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia.	2020-11-30 00:00:00	b.1
60	pmid33253226	SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia.	2020-11-30 00:00:00	b.1.1
60	pmid33253226	SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia.	2020-11-30 00:00:00	b.1.1.1
60	pmid33253226	SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia.	2020-11-30 00:00:00	b.1.36
60	pmid33253226	SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia.	2020-11-30 00:00:00	b.3
54	pmid32431260	The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Outbreak at King Abdul-Aziz Medical City-Riyadh from Emergency Medical Services Perspective.	2021-01-10 00:00:00	a.1
71	pmid32711328	"The spread of 2019-nCoV in China was primarily driven by population density. Comment on ""Association between short-term exposure to air pollution and COVID-19 infection: Evidence from China"" by Zhu et al."	2020-07-13 00:00:00	v.2
9	2021.04.02.437747	XAV-19, a novel swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike, efficiently neutralizes B.1.1.7 British and B.1.351 South-African variants.	2021-04-05 00:00:00	b.1.1.7
9	2021.04.02.437747	XAV-19, a novel swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike, efficiently neutralizes B.1.1.7 British and B.1.351 South-African variants.	2021-04-05 00:00:00	b.1.351
20	pmid33657646	Cold and COVID: Recurrent Pernio during the COVID-19 Pandemic.	2021-03-03 00:00:00	n.1
20	pmid33657646	Cold and COVID: Recurrent Pernio during the COVID-19 Pandemic.	2021-03-03 00:00:00	s.1
88	2021.02.09.21251402	Whole-genome sequencing of SARS-CoV-2 in the Republic of Ireland during waves 1 and 2 of the pandemic	2021-02-10 00:00:00	b.1.1.1
88	2021.02.09.21251402	Whole-genome sequencing of SARS-CoV-2 in the Republic of Ireland during waves 1 and 2 of the pandemic	2021-02-10 00:00:00	b.1.1.267
88	2021.02.09.21251402	Whole-genome sequencing of SARS-CoV-2 in the Republic of Ireland during waves 1 and 2 of the pandemic	2021-02-10 00:00:00	b.1.1
88	2021.02.09.21251402	Whole-genome sequencing of SARS-CoV-2 in the Republic of Ireland during waves 1 and 2 of the pandemic	2021-02-10 00:00:00	b.1.1.70
88	2021.02.09.21251402	Whole-genome sequencing of SARS-CoV-2 in the Republic of Ireland during waves 1 and 2 of the pandemic	2021-02-10 00:00:00	b.1.177
8	pmid33918332	Surveillance of SARS-CoV-2 in Frankfurt am Main from October to December 2020 Reveals High Viral Diversity Including Spike Mutation N501Y in B.1.1.70 and B.1.1.7.	2021-03-30 00:00:00	b.1.1.70
8	pmid33918332	Surveillance of SARS-CoV-2 in Frankfurt am Main from October to December 2020 Reveals High Viral Diversity Including Spike Mutation N501Y in B.1.1.70 and B.1.1.7.	2021-03-30 00:00:00	b.1.1.7
8	pmid33918332	Surveillance of SARS-CoV-2 in Frankfurt am Main from October to December 2020 Reveals High Viral Diversity Including Spike Mutation N501Y in B.1.1.70 and B.1.1.7.	2021-03-30 00:00:00	lineage b.1.1.7
31	2021.03.10.21253321	Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State	2021-03-12 00:00:00	b.1.1.7 lineage
42	2021.02.14.431117	Mutation N501Y in RBD of Spike Protein Strengthens the Interaction between COVID-19 and its Receptor ACE2	2021-02-15 00:00:00	b.1.1.7
42	2021.02.14.431117	Mutation N501Y in RBD of Spike Protein Strengthens the Interaction between COVID-19 and its Receptor ACE2	2021-02-15 00:00:00	b.1.351
42	2021.02.14.431117	Mutation N501Y in RBD of Spike Protein Strengthens the Interaction between COVID-19 and its Receptor ACE2	2021-02-15 00:00:00	p.1
19	2021.04.20.21255480	Multiplex SARS-CoV-2 Genotyping PCR for Population-Level Variant Screening and Epidemiologic Surveillance	2021-04-23 00:00:00	b.1.1.7
19	2021.04.20.21255480	Multiplex SARS-CoV-2 Genotyping PCR for Population-Level Variant Screening and Epidemiologic Surveillance	2021-04-23 00:00:00	b.1.351
19	2021.04.20.21255480	Multiplex SARS-CoV-2 Genotyping PCR for Population-Level Variant Screening and Epidemiologic Surveillance	2021-04-23 00:00:00	b.1.427
19	2021.04.20.21255480	Multiplex SARS-CoV-2 Genotyping PCR for Population-Level Variant Screening and Epidemiologic Surveillance	2021-04-23 00:00:00	b.1.429
19	2021.04.20.21255480	Multiplex SARS-CoV-2 Genotyping PCR for Population-Level Variant Screening and Epidemiologic Surveillance	2021-04-23 00:00:00	b.1.526
19	2021.04.20.21255480	Multiplex SARS-CoV-2 Genotyping PCR for Population-Level Variant Screening and Epidemiologic Surveillance	2021-04-23 00:00:00	p.2
71	2020.11.10.20228528	Screening of the H69 and V70 deletions in the SARS-CoV-2 spike protein with a RT-PCR diagnosis assay reveals low prevalence in Lyon, France	2020-11-13 00:00:00	variant of concern 202012/01
42	2021.04.27.441655	A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice	2021-04-28 00:00:00	b.1.1.7
42	2021.04.27.441655	A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice	2021-04-28 00:00:00	b.1.429
6	figshare12682126	Reviewer_1_v.1 – Supplemental material for Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study	2020-07-21 00:00:00	v.1
10	2021.03.19.21254000	Evaluating the neutralizing ability of a CpG-adjuvanted S-2P subunit vaccine against SARS-CoV-2 Variants of Concern	2021-03-22 00:00:00	b.1.1.7
10	2021.03.19.21254000	Evaluating the neutralizing ability of a CpG-adjuvanted S-2P subunit vaccine against SARS-CoV-2 Variants of Concern	2021-03-22 00:00:00	b.1.351
10	2021.03.19.21254000	Evaluating the neutralizing ability of a CpG-adjuvanted S-2P subunit vaccine against SARS-CoV-2 Variants of Concern	2021-03-22 00:00:00	b.1.351 variant
66	pmid33592554	Facial paralysis as the only symptom of COVID-19: A prospective study.	2021-02-18 00:00:00	n.1
66	pmid33592554	Facial paralysis as the only symptom of COVID-19: A prospective study.	2021-02-18 00:00:00	n.8
36	2021.03.29.21254233	Estimating the strength of selection for new SARS-CoV-2 variants	2021-04-01 00:00:00	b.1.1.7
8	pmid33741267	Hyperlipasemia in absence of acute pancreatitis is associated with elevated D-dimer and adverse outcomes in COVID 19 disease.	2021-02-20 00:00:00	s.1
35	2020.12.29.424708	The high infectivity of SARS-CoV-2 B.1.1.7 is associated with increased interaction force between Spike-ACE2 caused by the viral N501Y mutation	2021-01-01 00:00:00	b.1.1.7
35	2020.12.29.424708	The high infectivity of SARS-CoV-2 B.1.1.7 is associated with increased interaction force between Spike-ACE2 caused by the viral N501Y mutation	2021-01-01 00:00:00	lineage b.1.1.7
35	2020.12.29.424708	The high infectivity of SARS-CoV-2 B.1.1.7 is associated with increased interaction force between Spike-ACE2 caused by the viral N501Y mutation	2021-01-01 00:00:00	b.1.1.7 lineage
50	pmid33548160	Choppy Waters: The Importance of Accounting for Shifting Drug Utilization During the COVID-19 Pandemic in Future Observational Drug-related Studies.	2021-02-06 00:00:00	s.1
84	2021.01.26.21250492	Trajectories of Hypoxemia & Respiratory System Mechanics of COVID-19 ARDS in the NorthCARDS dataset	2021-01-28 00:00:00	s.1
50	2021.03.09.434584	New SARS-CoV-2 lineages could evade CD8+ T-cells response	2021-03-13 00:00:00	p.2
50	2021.03.09.434584	New SARS-CoV-2 lineages could evade CD8+ T-cells response	2021-03-13 00:00:00	b.1.35
50	2021.03.09.434584	New SARS-CoV-2 lineages could evade CD8+ T-cells response	2021-03-13 00:00:00	20j/501y.v3
50	2021.03.09.434584	New SARS-CoV-2 lineages could evade CD8+ T-cells response	2021-03-13 00:00:00	p.1
76	pmid33931567	Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.	2021-05-01 00:00:00	b.1.1.7
76	pmid33931567	Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.	2021-05-01 00:00:00	b.1.351
87	2021.02.22.21252002	SARS CoV-2 escape variants exhibit differential infectivity and neutralization sensitivity to convalescent or post-vaccination sera	2021-02-24 00:00:00	b.1.1.7
87	2021.02.22.21252002	SARS CoV-2 escape variants exhibit differential infectivity and neutralization sensitivity to convalescent or post-vaccination sera	2021-02-24 00:00:00	b.1.35
42	2021.02.14.21251704	Circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity	2021-02-18 00:00:00	b.1.351 variant
87	2021.02.26.21252554	Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil	2021-03-03 00:00:00	lineage p.1
87	2021.02.26.21252554	Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil	2021-03-03 00:00:00	p.1
66	pmid33670182	VOC 202012/01 Variant Is Effectively Neutralized by Antibodies Produced by Patients Infected before Its Diffusion in Italy.	2021-02-04 00:00:00	b.1.1.7
66	pmid33670182	VOC 202012/01 Variant Is Effectively Neutralized by Antibodies Produced by Patients Infected before Its Diffusion in Italy.	2021-02-04 00:00:00	b.1
66	pmid33670182	VOC 202012/01 Variant Is Effectively Neutralized by Antibodies Produced by Patients Infected before Its Diffusion in Italy.	2021-02-04 00:00:00	lineage b.1.1.7
22	pmid32871864	COVID-19 in hematological malignancy patients: A protocol for a systematic review and meta-analysis.	2021-01-12 00:00:00	v.1
31	2021.03.08.21253152	Mutation hotspots, geographical and temporal distribution of SARS-CoV-2 lineages in Brazil, February 2020 to February 2021: insights and limitations from uneven sequencing efforts	2021-03-12 00:00:00	p.1
31	2021.03.08.21253152	Mutation hotspots, geographical and temporal distribution of SARS-CoV-2 lineages in Brazil, February 2020 to February 2021: insights and limitations from uneven sequencing efforts	2021-03-12 00:00:00	p.2
89	2021.04.13.21255447	Genetic risk prediction of COVID-19 susceptibility and severity in the Indian population	2021-04-20 00:00:00	al.1
86	2021.04.06.438584	Mutations in the B.1.1.7 SARS-CoV-2 spike protein reduce receptor-binding affinity and induce a flexible link to the fusion peptide	2021-04-06 00:00:00	b.1.1.7
8	pmid33185367	Clinical course of COVID-19 disease in immunosuppressed renal transplant patients.	2020-11-13 00:00:00	y.1
13	pmid33831136	Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China.	2021-04-08 00:00:00	u.2
98	2021.03.02.433156	Altered Sub-Genomic RNA Expression in SARS-CoV-2 B.1.1.7 Infections	2021-03-03 00:00:00	b.1.1.7
98	2021.03.02.433156	Altered Sub-Genomic RNA Expression in SARS-CoV-2 B.1.1.7 Infections	2021-03-03 00:00:00	lineage b.1.1.7
98	2021.03.02.433156	Altered Sub-Genomic RNA Expression in SARS-CoV-2 B.1.1.7 Infections	2021-03-03 00:00:00	b.1.177
15	pmid33142304	Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City.	2020-11-03 00:00:00	c.1
88	pmid33544010	Evidence of novel SARS-CoV-2 variants circulation in Romania.	2021-02-05 00:00:00	b.1.1.7
88	pmid33544010	Evidence of novel SARS-CoV-2 variants circulation in Romania.	2021-02-05 00:00:00	b.1.2
96	pmid33759804	The need for holistic, longitudinal and comparable, real-time assessment of the emotional, behavioral and societal impact of the COVID-19 pandemic across nations.	2021-03-24 00:00:00	c.4
27	pmid32629121	Increased Internet Search Interest for GI Symptoms May Predict COVID-19 Cases in US Hotspots.	2020-06-15 00:00:00	a.3
52	pmid33893880	Combined RT-qPCR and pyrosequencing of a Spike glycoprotein polybasic cleavage motif can uncover pediatric SARS-CoV-2 infections associated with heterogeneous presentation.	2021-04-24 00:00:00	b.1.1.7
32	pmid32910735	Validation of a Novel Wearable Electromyography Patch for Monitoring Submental Muscle Activity During Swallowing: A Randomized Crossover Trial.	2020-10-26 00:00:00	a.1
62	pmid33427136	501.V2 and B.1.1.7 variants of COVID-19: a new time-bomb in the making?	2021-01-11 00:00:00	501.v2
62	pmid33427136	501.V2 and B.1.1.7 variants of COVID-19: a new time-bomb in the making?	2021-01-11 00:00:00	b.1.1.7
47	figshare12682132	Reviewer_2_v.1 – Supplemental material for Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study	2020-07-21 00:00:00	v.1
6	2021.04.11.439360	Development of highly potent neutralising nanobodies against multiple SARS-CoV-2 variants including the variant of concern B.1.351	2021-04-12 00:00:00	b.1.351
6	2021.04.11.439360	Development of highly potent neutralising nanobodies against multiple SARS-CoV-2 variants including the variant of concern B.1.351	2021-04-12 00:00:00	b.1.351 variant
22	pmid33036903	Trends in urologic oncology clinical practice and medical education under COVID-19 pandemic: An international survey of senior clinical and academic urologists.	2020-09-15 00:00:00	v.2
84	pmid32519664	Reply to a Comment about the Article Published in Acta Med Port 2020; Apr 27; doi:10.20344/amp.13928.	2020-11-09 00:00:00	p.1
87	2021.02.23.21252268	The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape	2021-03-05 00:00:00	b.1.1.7
87	2021.02.23.21252268	The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape	2021-03-05 00:00:00	b.1.351
87	2021.02.23.21252268	The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape	2021-03-05 00:00:00	p.1
3	figshare12911764	Reviewer_1_v.1 – Supplemental material for Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease	2020-09-03 00:00:00	v.1
62	2021.01.06.425392	SARS-CoV-2 RBD in vitro evolution follows contagious mutation spread, yet generates an able infection inhibitor	2021-01-06 00:00:00	501.v2
92	2021.02.26.21252555	Introductions and evolutions of SARS-CoV-2 strains in Japan	2021-03-02 00:00:00	b.1.1.7
92	2021.02.26.21252555	Introductions and evolutions of SARS-CoV-2 strains in Japan	2021-03-02 00:00:00	b.1.351
92	2021.02.26.21252555	Introductions and evolutions of SARS-CoV-2 strains in Japan	2021-03-02 00:00:00	south african variant
92	2021.02.26.21252555	Introductions and evolutions of SARS-CoV-2 strains in Japan	2021-03-02 00:00:00	p.1
92	2021.02.26.21252555	Introductions and evolutions of SARS-CoV-2 strains in Japan	2021-03-02 00:00:00	r.1
3	2021.04.30.442222	Possible role of accessory proteins in the viral replication for the 20I/501Y.V1 (B.1.1.7) SARS-CoV-2 variant	2021-05-04 00:00:00	b.1.1.7
3	2021.04.30.442222	Possible role of accessory proteins in the viral replication for the 20I/501Y.V1 (B.1.1.7) SARS-CoV-2 variant	2021-05-04 00:00:00	b.1
19	pmid33629980	Corrigendum: COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses.	2021-02-26 00:00:00	r.2
16	pmid33857136	Deciphering the introduction and transmission of SARS-CoV-2 in the Colombian Amazon Basin.	2021-04-15 00:00:00	p.1 variant
16	pmid33857136	Deciphering the introduction and transmission of SARS-CoV-2 in the Colombian Amazon Basin.	2021-04-15 00:00:00	p.1
51	2020.03.24.20042762	A model to estimate bed demand for COVID-19 related hospitalization	2020-03-26 00:00:00	y.1
67	pmid32434963	2019 Novel Coronavirus Outbreak: SOS Alert for Dentists.	2020-05-22 00:00:00	y.1
67	pmid32434963	2019 Novel Coronavirus Outbreak: SOS Alert for Dentists.	2020-05-22 00:00:00	s.1
16	pmid33705367	First Identified Cases of SARS-CoV-2 Variant P.1 in the United States - Minnesota, January 2021.	2021-03-12 00:00:00	variant p.1
16	pmid33705367	First Identified Cases of SARS-CoV-2 Variant P.1 in the United States - Minnesota, January 2021.	2021-03-12 00:00:00	p.1 variant
16	pmid33705367	First Identified Cases of SARS-CoV-2 Variant P.1 in the United States - Minnesota, January 2021.	2021-03-12 00:00:00	p.1
71	2021.04.23.21255515	Transmission characteristics of SARS-CoV-2 variants of concern: Rapid Scoping Review	2021-04-25 00:00:00	b.1.1.7
71	2021.04.23.21255515	Transmission characteristics of SARS-CoV-2 variants of concern: Rapid Scoping Review	2021-04-25 00:00:00	b.1.351
71	2021.04.23.21255515	Transmission characteristics of SARS-CoV-2 variants of concern: Rapid Scoping Review	2021-04-25 00:00:00	p.1
71	2021.04.23.21255515	Transmission characteristics of SARS-CoV-2 variants of concern: Rapid Scoping Review	2021-04-25 00:00:00	b.1.35
10	pmid33835528	Multiple clades of SARS-CoV-2 were introduced to Thailand during the first quarter of 2020.	2021-04-09 00:00:00	b.1
10	pmid33835528	Multiple clades of SARS-CoV-2 were introduced to Thailand during the first quarter of 2020.	2021-04-09 00:00:00	b.1.8
10	pmid33835528	Multiple clades of SARS-CoV-2 were introduced to Thailand during the first quarter of 2020.	2021-04-09 00:00:00	b.58
10	pmid33835528	Multiple clades of SARS-CoV-2 were introduced to Thailand during the first quarter of 2020.	2021-04-09 00:00:00	a.6
16	pmid32639862	Triage of patients with venous and lymphatic diseases during the COVID-19 pandemic - The Venous and Lymphatic Triage and Acuity Scale (VELTAS) : A consensus document of the International Union of Phlebology (UIP), Australasian College of Phlebology (ACP), American Vein and Lymphatic Society (AVLS), American Venous Forum (AVF), European College of Phlebology (ECoP), European Venous Forum (EVF), Interventional Radiology Society of Australasia (IRSA), Latin American Venous Forum, Pan-American Society of Phlebology and Lymphology and the Venous Association of India (VAI) This consensus document has been co-published in Phlebology [DOI: 10.1177/0268355520930884] and Journal of Vascular Surgery: Venous and Lymphatic Disorders [DOI: 10.1016/j.jvsv.2020.05.002]. The publications are identical except for minor stylistic and spelling differences in keeping with each journal's style. The contribution has been published under a Attribution-Non Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0), (https://creativecommons.org/licenses/by-nc-nd/4.0/).	2020-12-18 00:00:00	v.2
44	pmid33247643	Status of Health-care Workers in Relation to COVID-19 Infection: A Retrospective Study in a Level 4 COVID Hospital in Eastern India.	2020-12-01 00:00:00	d.5
54	pmid33499798	Technical supplement - COVID-19 Australia: Epidemiology reporting Last updated 19 January 2021.	2021-02-03 00:00:00	c.1
54	pmid33499798	Technical supplement - COVID-19 Australia: Epidemiology reporting Last updated 19 January 2021.	2021-02-03 00:00:00	n.7
88	pmid33390873	Impact of the COVID-19 pandemic: a perspective from industry.	2021-01-26 00:00:00	y.1
6	pmid32552735	Explaining the experience of prenatal care and investigating the association between psychological factors with self-care in pregnant women during COVID-19 pandemic: a mixed method study protocol.	2020-12-18 00:00:00	c.13
89	pmid33766944	mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.	2021-03-26 00:00:00	b.1.351 variant
89	pmid33766944	mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.	2021-03-26 00:00:00	b.1.351
2	pmid32294285	Liver impairment associated with disease progression in COVID-19 patients.	2020-09-25 00:00:00	v.1
3	pmid33739917	INTRODUCTION OF SARS-COV-2 VARIANT OF CONCERN 20H/501Y.V2 (B.1.351) FROM MALAWI TO ITALY.	2021-03-19 00:00:00	b.1.35
3	pmid33739917	INTRODUCTION OF SARS-COV-2 VARIANT OF CONCERN 20H/501Y.V2 (B.1.351) FROM MALAWI TO ITALY.	2021-03-19 00:00:00	b.1.1
80	2020.05.07.20094912	Facemasks prevent influenza-like illness: implications for COVID-19	2020-05-12 00:00:00	al.1
79	pmid33822770	SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63.	2021-04-06 00:00:00	b.1.1.7
79	pmid33822770	SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63.	2021-04-06 00:00:00	b.1.35
44	pmid32374942	Rapid implementation of an evidence-based remote triaging system for assessment of suspected referrals and patients with head and neck cancer on follow-up after treatment during the COVID-19 pandemic: Model for international collaboration.	2020-12-18 00:00:00	v.2
11	pmid32246783	"Response to Commentary on ""The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients""."	2020-03-30 00:00:00	v.2
77	2020.04.19.20071548	Current Understanding of COVID-19 Clinical Course and Investigational Treatments	2020-04-24 00:00:00	al.1
79	pmid33857453	Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.	2021-03-05 00:00:00	b.1.1.7
12	2021.03.24.21254277	Emergence and spread of SARS-CoV-2 lineages B.1.1.7 and P.1 in Italy	2021-03-28 00:00:00	b.1.1.7
12	2021.03.24.21254277	Emergence and spread of SARS-CoV-2 lineages B.1.1.7 and P.1 in Italy	2021-03-28 00:00:00	p.1
12	2021.03.24.21254277	Emergence and spread of SARS-CoV-2 lineages B.1.1.7 and P.1 in Italy	2021-03-28 00:00:00	b.1.177
12	2021.03.24.21254277	Emergence and spread of SARS-CoV-2 lineages B.1.1.7 and P.1 in Italy	2021-03-28 00:00:00	lineage p.1
74	pmid32769869	Antiplatelet/anticoagulant agents for preventing thrombosis events in patients with severe COVID-19: A protocol for systematic review and meta-analysis.	2021-01-11 00:00:00	v.1
94	pmid33400417	Presentation and Management of Cutaneous Manifestations of COVID-19.	2021-01-06 00:00:00	d.2
15	2021.02.03.429355	Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike	2021-02-03 00:00:00	b.1.1.7
26	2021.04.09.21255179	SARS-CoV-2 UK, South African and Brazilian Variants in Karachi- Pakistan	2021-04-13 00:00:00	brazilian variant
26	2021.04.09.21255179	SARS-CoV-2 UK, South African and Brazilian Variants in Karachi- Pakistan	2021-04-13 00:00:00	b.1.1.7
26	2021.04.09.21255179	SARS-CoV-2 UK, South African and Brazilian Variants in Karachi- Pakistan	2021-04-13 00:00:00	b.13
26	2021.04.09.21255179	SARS-CoV-2 UK, South African and Brazilian Variants in Karachi- Pakistan	2021-04-13 00:00:00	p.1 variant
86	pmid32864332	Efficacy and safety of herbal medicine (Lianhuaqingwen) for treating COVID-19: A systematic review and meta-analysis.	2020-08-10 00:00:00	s.1
11	pmid32528815	Genome-Wide Identification and Characterization of Point Mutations in the SARS-CoV-2 Genome.	2020-09-28 00:00:00	g.1
32	2021.03.30.437704	Sequence analysis of SARS-CoV-2 in nasopharyngeal samples from patients with COVID-19 illustrates population variation and diverse phenotypes, placing the in vitro growth properties of B.1.1.7 and B.1.351 lineage viruses in context.	2021-03-30 00:00:00	b.1.1.7
32	2021.03.30.437704	Sequence analysis of SARS-CoV-2 in nasopharyngeal samples from patients with COVID-19 illustrates population variation and diverse phenotypes, placing the in vitro growth properties of B.1.1.7 and B.1.351 lineage viruses in context.	2021-03-30 00:00:00	b.1.351 lineage
32	2021.03.30.437704	Sequence analysis of SARS-CoV-2 in nasopharyngeal samples from patients with COVID-19 illustrates population variation and diverse phenotypes, placing the in vitro growth properties of B.1.1.7 and B.1.351 lineage viruses in context.	2021-03-30 00:00:00	b.1.351
32	2021.03.30.437704	Sequence analysis of SARS-CoV-2 in nasopharyngeal samples from patients with COVID-19 illustrates population variation and diverse phenotypes, placing the in vitro growth properties of B.1.1.7 and B.1.351 lineage viruses in context.	2021-03-30 00:00:00	south african variant
96	pmid33639005	Dermatologists as COVID-19 stigma recipients.	2021-02-27 00:00:00	al.1
31	2020.06.09.20076646	Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment: a retrospective cohort study	2020-06-10 00:00:00	n.3
80	pmid33880458	Epidemiology, clinical characteristics, and virologic features of COVID-19 patients in Kazakhstan: A nation-wide retrospective cohort study.	2021-04-22 00:00:00	b.4.1
80	pmid33880458	Epidemiology, clinical characteristics, and virologic features of COVID-19 patients in Kazakhstan: A nation-wide retrospective cohort study.	2021-04-22 00:00:00	a.2
80	pmid33880458	Epidemiology, clinical characteristics, and virologic features of COVID-19 patients in Kazakhstan: A nation-wide retrospective cohort study.	2021-04-22 00:00:00	b.1.1
80	pmid33880458	Epidemiology, clinical characteristics, and virologic features of COVID-19 patients in Kazakhstan: A nation-wide retrospective cohort study.	2021-04-22 00:00:00	b.1
80	pmid33880458	Epidemiology, clinical characteristics, and virologic features of COVID-19 patients in Kazakhstan: A nation-wide retrospective cohort study.	2021-04-22 00:00:00	b.1.2
80	pmid33880458	Epidemiology, clinical characteristics, and virologic features of COVID-19 patients in Kazakhstan: A nation-wide retrospective cohort study.	2021-04-22 00:00:00	b.1.3
80	pmid33880458	Epidemiology, clinical characteristics, and virologic features of COVID-19 patients in Kazakhstan: A nation-wide retrospective cohort study.	2021-04-22 00:00:00	b.1.1.10
19	2021.02.27.21252427	Comparative performance of SARS-CoV-2 lateral flow antigen tests demonstrates their utility for high sensitivity detection of infectious virus in clinical specimens	2021-03-02 00:00:00	b.1.1.7
19	2021.02.27.21252427	Comparative performance of SARS-CoV-2 lateral flow antigen tests demonstrates their utility for high sensitivity detection of infectious virus in clinical specimens	2021-03-02 00:00:00	uk variant
30	2021.04.10.439279	Ultrastructural insight into SARS-CoV-2 attachment, entry and budding in human airway epithelium	2021-04-11 00:00:00	b.1.1.7
41	pmid33721001	Erratum: A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China.	2021-03-15 00:00:00	r.2
10	2021.03.14.21253535	Monitoring the rise of the SARS-CoV-2 lineage B.1.1.7 in Tenerife (Spain) since mid-December 2020	2021-03-15 00:00:00	lineage b.1.1.7
10	2021.03.14.21253535	Monitoring the rise of the SARS-CoV-2 lineage B.1.1.7 in Tenerife (Spain) since mid-December 2020	2021-03-15 00:00:00	b.1.1.7
10	2021.03.14.21253535	Monitoring the rise of the SARS-CoV-2 lineage B.1.1.7 in Tenerife (Spain) since mid-December 2020	2021-03-15 00:00:00	b.1.1.7 lineage
52	pmid33685741	First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant.	2021-02-09 00:00:00	b.1.1.7
52	pmid33685741	First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant.	2021-02-09 00:00:00	lineage b.1.1.7
65	2021.02.02.429431	Potential global impact of the N501Y mutation on MHC-II presentation and immune escape	2021-02-03 00:00:00	b.1.1.7
95	pmid33580167	Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques.	2021-02-17 00:00:00	b.1.1.7
76	pmid33794143	SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.	2021-02-26 00:00:00	b.1.351
76	pmid33794143	SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.	2021-02-26 00:00:00	p.1
76	pmid33794143	SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.	2021-02-26 00:00:00	b.1.1.7
76	pmid33794143	SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.	2021-02-26 00:00:00	p.1 variant
94	pmid33914723	Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.	2021-04-29 00:00:00	ad.2
31	pmid33026775	Outcome Disparities Among Men and Women With COVID-19: An Analysis of the New York City Population Cohort.	2020-10-19 00:00:00	d.2
85	pmid33359061	Molecular epidemiology of COVID-19 in Oman: a molecular and surveillance study for the early transmission of COVID-19 in the country.	2020-12-13 00:00:00	b.1.1
56	2021.04.02.21254839	Genomic Sequencing of SARS-COV-2 in Rwanda: evolution and regional dynamics	2021-04-07 00:00:00	a.23
56	2021.04.02.21254839	Genomic Sequencing of SARS-COV-2 in Rwanda: evolution and regional dynamics	2021-04-07 00:00:00	b.1.1.7
56	2021.04.02.21254839	Genomic Sequencing of SARS-COV-2 in Rwanda: evolution and regional dynamics	2021-04-07 00:00:00	b.1.351
79	2021.01.26.428302	40 minutes RT-qPCR Assay for Screening Spike N501Y and HV69-70del Mutations	2021-01-26 00:00:00	voc-202012/01
79	2021.01.26.428302	40 minutes RT-qPCR Assay for Screening Spike N501Y and HV69-70del Mutations	2021-01-26 00:00:00	b.1.351
79	2021.01.26.428302	40 minutes RT-qPCR Assay for Screening Spike N501Y and HV69-70del Mutations	2021-01-26 00:00:00	p.1
34	figshare13221390	Reviewer_2_v.1 – Supplemental material for The use of nebulized pharmacotherapies during the COVID-19 pandemic	2020-11-11 00:00:00	v.1
51	pmid32755508	Retraction of: No Deleterious Effect of Lockdown Due to COVID-19 Pandemic on Glycaemic Control, Measured by Glucose Monitoring, in Adults with Type 1 Diabetes. Beato-Vibora PI. Diabetes Technol Ther 2020; epub DOI: 10.1089/dia.2020.0184.	2020-08-12 00:00:00	a.2
40	2021.01.13.21249779	Evaluating the Long-Term Efficacy of COVID-19 Vaccines	2021-01-21 00:00:00	c.1
86	pmid32306657	[Clinical features and outcome of treatment for novel coronavirus pneumonia: a meta-analysis].	2020-07-31 00:00:00	v.2
83	2021.01.06.20249026	Recurrent dissemination of SARS-CoV-2 through the Uruguayan-Brazilian border	2021-01-08 00:00:00	b.1.1
55	2021.02.05.430003	Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies	2021-02-07 00:00:00	b.1.1.7
55	2021.02.05.430003	Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies	2021-02-07 00:00:00	b.1.351
55	2021.02.05.430003	Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies	2021-02-07 00:00:00	cluster 5
91	pmid33083287	Factors Associated with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis.	2020-10-22 00:00:00	r.1
28	pmid33922613	Semicovariance Coefficient Analysis of Spike Proteins from SARS-CoV-2 and Other Coronaviruses for Viral Evolution and Characteristics Associated with Fatality.	2021-04-14 00:00:00	uk variant
28	pmid33922613	Semicovariance Coefficient Analysis of Spike Proteins from SARS-CoV-2 and Other Coronaviruses for Viral Evolution and Characteristics Associated with Fatality.	2021-04-14 00:00:00	b.1.1.7
69	2021.02.22.21252041	An allele-specific primer extension assay to quantify the proportion of B.1.1.7-specific SARS-CoV-2 RNA in wastewater	2021-02-23 00:00:00	b.1.1.7
69	2021.02.22.21252041	An allele-specific primer extension assay to quantify the proportion of B.1.1.7-specific SARS-CoV-2 RNA in wastewater	2021-02-23 00:00:00	b.1.351
69	2021.02.22.21252041	An allele-specific primer extension assay to quantify the proportion of B.1.1.7-specific SARS-CoV-2 RNA in wastewater	2021-02-23 00:00:00	p.1
15	2021.02.24.432576	Increased transmission of SARS-CoV-2 lineage B.1.1.7 (VOC 2020212/01) is not accounted for by a replicative advantage in primary airway cells or antibody escape	2021-02-24 00:00:00	lineage b.1.1.7
15	2021.02.24.432576	Increased transmission of SARS-CoV-2 lineage B.1.1.7 (VOC 2020212/01) is not accounted for by a replicative advantage in primary airway cells or antibody escape	2021-02-24 00:00:00	b.1.1.7
98	pmid32620220	A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.	2020-12-18 00:00:00	s.1
58	2020.04.17.20069161	Mortality from COVID-19 in 12 countries and 6 states of the United States	2020-04-22 00:00:00	k.1
9	pmid33384393	Impact of the COVID-19 pandemic on mental health and well-being of communities: an exploratory qualitative study protocol.	2021-01-05 00:00:00	v.1
12	pmid33826816	Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351).	2021-04-07 00:00:00	b.1.35
83	2021.02.21.432168	Structural Basis for Accommodation of Emerging B.1.351 and B.1.1.7 Variants by Two Potent SARS-CoV-2 Neutralizing Antibodies	2021-02-22 00:00:00	b.1.351
83	2021.02.21.432168	Structural Basis for Accommodation of Emerging B.1.351 and B.1.1.7 Variants by Two Potent SARS-CoV-2 Neutralizing Antibodies	2021-02-22 00:00:00	b.1.1.7
71	pmid32754311	"Erratum to ""Is the lockdown important to prevent the COVID-19 pandemic? Effects on psychology, environment and economy-perspective"" [Ann. Med. Surg. 56 (2020) 38-42]."	2020-09-28 00:00:00	u.2
73	2021.01.11.426269	Cryo-EM Structure of the N501Y SARS-CoV-2 Spike Protein in Complex with a Potent Neutralizing Antibody	2021-01-12 00:00:00	uk variant
59	pmid33842511	Corrigendum: The Dental Team: An Additional Resource for Delivering Vaccinations.	2021-04-12 00:00:00	d.2
18	2020.04.06.028811	The Potential Use of Unprocessed Sample for RT-qPCR Detection of COVID-19 without an RNA Extraction Step	2020-04-08 00:00:00	n.1
38	pmid33798491	Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant.	2021-03-09 00:00:00	b.1.351
38	pmid33798491	Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant.	2021-03-09 00:00:00	b.1
38	pmid33798491	Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant.	2021-03-09 00:00:00	b.1.351 variant
68	pmid33684923	Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7.	2021-03-08 00:00:00	b.1.351
68	pmid33684923	Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7.	2021-03-08 00:00:00	b.1.1.7
63	pmid33301389	Weiss Response to Sengupta et al. (DOI: 10.1089/scd.2020.0095).	2021-02-04 00:00:00	d.2
71	2021.04.22.21255954	Effects of B.1.1.7 and B.1.351 on COVID-19 dynamics. A campus reopening study	2021-04-27 00:00:00	b.1.1.7
71	2021.04.22.21255954	Effects of B.1.1.7 and B.1.351 on COVID-19 dynamics. A campus reopening study	2021-04-27 00:00:00	b.1.351
71	2021.04.22.21255954	Effects of B.1.1.7 and B.1.351 on COVID-19 dynamics. A campus reopening study	2021-04-27 00:00:00	b.1.351 variant
83	pmid33026745	The Impact of COVID-19 on the Faces of Frontline Healthcare Workers.	2020-10-20 00:00:00	d.2
81	figshare12593696	COVID-19 cumulative mortality rates for frontline healthcare staff in England	2020-07-06 00:00:00	s.1
81	figshare12593696	COVID-19 cumulative mortality rates for frontline healthcare staff in England	2020-07-06 00:00:00	n.5
6	pmid32767018	Complete post-mortem data in a fatal case of COVID-19: clinical, radiological and pathological correlations.	2020-11-03 00:00:00	b.1
30	pmid33663928	Facts and challenges on global deployment of vaccines for the immunotherapy of the evolving SARS Cov-2 variants: What a new year, with a fast spreading South African and the most fearful Brazilian variants, as the unwanted gifts, imposing enormous crises to surmount.	2021-03-08 00:00:00	brazilian variant
40	2020.10.30.20223024	Prognostic factors of chest CT findings for ICU admission and mortality in patients with COVID-19 pneumonia	2020-11-03 00:00:00	v.2
26	figshare12110130	Fever Incidence is Much Lower in the Morning than the Evening: Boston and US National Triage Data	2020-08-05 00:00:00	m.2
30	pmid33330851	Erratum: A Learning-Based Model to Evaluate Hospitalization Priority in COVID-19 Pandemics.	2020-12-17 00:00:00	r.2
35	2021.04.14.21255385	Evolution of case fatality rates in the second wave of coronavirus in England: effects of false positives, a Variant of Concern and vaccination.	2021-04-22 00:00:00	b.1.1.7
87	pmid33230812	Co-infections with SARS-CoV-2 and other respiratory viruses in Southeastern France: a matter of sampling time.	2020-11-24 00:00:00	al.1
20	2021.02.24.21252372	Bamlanivimab does not neutralize two SARS-CoV-2 variants carrying E484K in vitro	2021-02-26 00:00:00	b.1.1.7
20	2021.02.24.21252372	Bamlanivimab does not neutralize two SARS-CoV-2 variants carrying E484K in vitro	2021-02-26 00:00:00	b.1.351
20	2021.02.24.21252372	Bamlanivimab does not neutralize two SARS-CoV-2 variants carrying E484K in vitro	2021-02-26 00:00:00	p.2
20	2021.02.24.21252372	Bamlanivimab does not neutralize two SARS-CoV-2 variants carrying E484K in vitro	2021-02-26 00:00:00	b.1.13
63	pmid33415131	Erratum: Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO).	2021-01-08 00:00:00	m.2
24	pmid33538568	The Impact of the COVID-19 Pandemic on Physician-Pharmaceutical Office-Based Interactions.	2021-02-05 00:00:00	d.2
77	pmid33802899	Detection and Genome Sequencing of SARS-CoV-2 in a Domestic Cat with Respiratory Signs in Switzerland.	2021-03-02 00:00:00	b.1.1
13	2021.02.08.21251393	A SARS-CoV-2 lineage A variant (A.23.1) with altered spike has emerged and is dominating the current Uganda epidemic	2021-02-11 00:00:00	a.23
12	2021.02.19.431311	SARS-CoV-2 variant evolution in the United States: High accumulation of viral mutations over time likely through serial Founder Events and mutational bursts.	2021-02-19 00:00:00	b.1.1.7
9	figshare12593944	Reviewer_2_v.1 – Supplemental material for Targeting the gut–lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection	2020-07-01 00:00:00	v.1
4	2021.01.13.426548	Surveillance of genetic diversity and evolution in locally transmitted SARS-CoV-2 in Pakistan during the first wave of the COVID-19 pandemic	2021-01-14 00:00:00	b.6
4	2021.01.13.426548	Surveillance of genetic diversity and evolution in locally transmitted SARS-CoV-2 in Pakistan during the first wave of the COVID-19 pandemic	2021-01-14 00:00:00	b.1
4	2021.01.13.426548	Surveillance of genetic diversity and evolution in locally transmitted SARS-CoV-2 in Pakistan during the first wave of the COVID-19 pandemic	2021-01-14 00:00:00	b.1.36
4	2021.01.13.426548	Surveillance of genetic diversity and evolution in locally transmitted SARS-CoV-2 in Pakistan during the first wave of the COVID-19 pandemic	2021-01-14 00:00:00	b.1.160
4	2021.01.13.426548	Surveillance of genetic diversity and evolution in locally transmitted SARS-CoV-2 in Pakistan during the first wave of the COVID-19 pandemic	2021-01-14 00:00:00	b.1.2
25	2021.01.19.21250111	SARS-CoV-2 B.1.1.7 lineage-related perceptions and travel worry among healthcare workers	2021-01-21 00:00:00	b.1.1.7 lineage
25	2021.01.19.21250111	SARS-CoV-2 B.1.1.7 lineage-related perceptions and travel worry among healthcare workers	2021-01-21 00:00:00	b.1.1.7
67	2021.02.09.21250937	Increased hazard of mortality in cases compatible with SARS-CoV-2 variant of concern 202012/1 - a matched cohort study	2021-02-19 00:00:00	voc-202012/01
32	2021.01.16.21249946	Immunisation, asymptomatic infection, herd immunity and the new variants of COVID-19	2021-01-20 00:00:00	lineage b.1.1.7
32	2021.01.16.21249946	Immunisation, asymptomatic infection, herd immunity and the new variants of COVID-19	2021-01-20 00:00:00	voc-202012/01
67	2021.04.01.438035	The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against novel viral variants	2021-04-01 00:00:00	b.1.1.7
67	2021.04.01.438035	The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against novel viral variants	2021-04-01 00:00:00	b.1.351 variant
67	2021.04.01.438035	The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against novel viral variants	2021-04-01 00:00:00	b.1.351
76	pmid33891875	Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States.	2021-03-10 00:00:00	b.1.1.7
76	pmid33891875	Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States.	2021-03-10 00:00:00	lineage b.1.1.7
89	pmid32493447	Effect of hydroxychloroquine on prevention of COVID-19 virus infection among healthcare professionals: a structured summary of a study protocol for a randomised controlled trial.	2020-12-18 00:00:00	c.13
35	2021.03.06.434193	SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies	2021-03-06 00:00:00	b.1.35
35	2021.03.06.434193	SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies	2021-03-06 00:00:00	p.1
76	pmid33630820	Detection of B.1.351 SARS-CoV-2 Variant Strain - Zambia, December 2020.	2021-02-26 00:00:00	b.1.351
76	pmid33630820	Detection of B.1.351 SARS-CoV-2 Variant Strain - Zambia, December 2020.	2021-02-26 00:00:00	lineage b.1.351
76	pmid33630820	Detection of B.1.351 SARS-CoV-2 Variant Strain - Zambia, December 2020.	2021-02-26 00:00:00	b.1.351 variant
21	2020.06.29.20140376	Circulating Markers of Angiogenesis and Endotheliopathy in COVID-19	2020-07-01 00:00:00	d.2
85	2021.03.08.21252958	Immune response to SARS-CoV-2 variants of concern in vaccinated individuals	2021-03-10 00:00:00	south african variant
19	pmid33507804	Insuring the Population During National Emergencies Leveraging Both Medicaid and the Marketplace.	2021-01-28 00:00:00	s.1
50	pmid32722950	Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.	2020-10-23 00:00:00	c.2
50	pmid32722950	Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.	2020-10-23 00:00:00	c.19
4	pmid33615040	"Corrigendum to ""mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19"" [Gene Rep. 20 (2020) 100765]."	2021-02-22 00:00:00	p.2
64	2020.02.11.20022095	Primary Care Practitioners' Response to 2019 Novel Coronavirus Outbreak in China	2020-02-12 00:00:00	a.1
64	2020.02.11.20022095	Primary Care Practitioners' Response to 2019 Novel Coronavirus Outbreak in China	2020-02-12 00:00:00	l.2
1	2021.02.12.21251614	Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with build-in screening functionality for DelHV69/70- and N501Y variants such as B.1.1.7	2021-02-18 00:00:00	b.1.1.7
1	2021.02.12.21251614	Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with build-in screening functionality for DelHV69/70- and N501Y variants such as B.1.1.7	2021-02-18 00:00:00	b.1.1.7 lineage
58	2021.01.26.21250584	First detection and report of SARS-CoV-2 Spike protein N501Y mutations in Oklahoma USA	2021-01-29 00:00:00	b.1.1.7
58	2021.01.26.21250584	First detection and report of SARS-CoV-2 Spike protein N501Y mutations in Oklahoma USA	2021-01-29 00:00:00	b.1.1.7 lineage
59	pmid33827042	The first SARS-CoV-2 genetic variants of concern (VOC) in Poland: The concept of a comprehensive approach to monitoring and surveillance of emerging variants.	2021-04-09 00:00:00	lineage b.1.351
59	pmid33827042	The first SARS-CoV-2 genetic variants of concern (VOC) in Poland: The concept of a comprehensive approach to monitoring and surveillance of emerging variants.	2021-04-09 00:00:00	south african variant
59	pmid33827042	The first SARS-CoV-2 genetic variants of concern (VOC) in Poland: The concept of a comprehensive approach to monitoring and surveillance of emerging variants.	2021-04-09 00:00:00	lineage b.1.1.7
59	pmid33827042	The first SARS-CoV-2 genetic variants of concern (VOC) in Poland: The concept of a comprehensive approach to monitoring and surveillance of emerging variants.	2021-04-09 00:00:00	british variant
60	2021.04.30.442182	LY-CoV1404 potently neutralizes SARS-CoV-2 variants	2021-04-30 00:00:00	b.1.1.7
60	2021.04.30.442182	LY-CoV1404 potently neutralizes SARS-CoV-2 variants	2021-04-30 00:00:00	b.1.351
60	2021.04.30.442182	LY-CoV1404 potently neutralizes SARS-CoV-2 variants	2021-04-30 00:00:00	b.1.427
60	2021.04.30.442182	LY-CoV1404 potently neutralizes SARS-CoV-2 variants	2021-04-30 00:00:00	b.1.429
60	2021.04.30.442182	LY-CoV1404 potently neutralizes SARS-CoV-2 variants	2021-04-30 00:00:00	p.1
60	2021.04.30.442182	LY-CoV1404 potently neutralizes SARS-CoV-2 variants	2021-04-30 00:00:00	b.1.526
84	pmid33075424	Effects of work status changes and perceived stress onglycaemiccontrol in individuals with type 1 diabetes during COVID-19 lockdown in Italy.	2020-09-30 00:00:00	s.1
15	2021.03.17.435637	Epigallocatechin Gallate from Green Tea Effectively Blocks Infection of SARS-CoV-2 and New Variants by Inhibiting Spike Binding to ACE2 Receptor	2021-03-17 00:00:00	b.1.1.7
15	2021.03.17.435637	Epigallocatechin Gallate from Green Tea Effectively Blocks Infection of SARS-CoV-2 and New Variants by Inhibiting Spike Binding to ACE2 Receptor	2021-03-17 00:00:00	b.1.35
15	2021.03.17.435637	Epigallocatechin Gallate from Green Tea Effectively Blocks Infection of SARS-CoV-2 and New Variants by Inhibiting Spike Binding to ACE2 Receptor	2021-03-17 00:00:00	b.1.429
33	pmid33887205	Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization.	2021-03-31 00:00:00	variant p.1
33	pmid33887205	Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization.	2021-03-31 00:00:00	b.1.1.7
33	pmid33887205	Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization.	2021-03-31 00:00:00	b.1.351
33	pmid33887205	Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization.	2021-03-31 00:00:00	p.1
33	pmid33887205	Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization.	2021-03-31 00:00:00	p.1 variant
84	pmid32867305	COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells.	2020-08-22 00:00:00	c.8
84	pmid32867305	COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells.	2020-08-22 00:00:00	c.19
84	pmid32867305	COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells.	2020-08-22 00:00:00	c.33
84	pmid32867305	COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells.	2020-08-22 00:00:00	c.2
84	pmid32867305	COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells.	2020-08-22 00:00:00	c.5
48	2021.03.01.433314	Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains	2021-03-01 00:00:00	b.1.1.7
48	2021.03.01.433314	Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains	2021-03-01 00:00:00	b.1.351 variant
26	2021.04.05.438547	Murine monoclonal antibodies against RBD of SARS-CoV-2 neutralize authentic wild type SARS-CoV-2 as well as B.1.1.7 and B.1.351 viruses and protect in vivo in a mouse model in a neutralization dependent manner	2021-04-06 00:00:00	b.1.1.7
26	2021.04.05.438547	Murine monoclonal antibodies against RBD of SARS-CoV-2 neutralize authentic wild type SARS-CoV-2 as well as B.1.1.7 and B.1.351 viruses and protect in vivo in a mouse model in a neutralization dependent manner	2021-04-06 00:00:00	b.1.351
4	pmid33377359	The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.	2020-12-30 00:00:00	british variant
83	pmid33818474	Phylogenetic classification of the whole-genome sequences of SARS-CoV-2 from India & evolutionary trends.	2021-04-06 00:00:00	b.1.1
91	pmid33623732	Investigation of the dynamics of COVID-19 with a fractional mathematical model: A comparative study with actual data.	2021-02-07 00:00:00	n.3
89	pmid33739254	Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February.	2021-03-24 00:00:00	b.1.1.7
79	pmid33725746	Nursing care and prevalence of adverse events in prone position: Characteristics of mechanically ventilated patients with severe SARS-CoV-2 pulmonary infection.	2021-02-02 00:00:00	v.2
57	pmid33564210	Influence and Analysis of Ambulance on the Containment of COVID-19 in China.	2020-12-24 00:00:00	r.1
57	2021.04.05.438352	A new SARS-CoV-2 lineage that shares mutations with known Variants of Concern is rejected by automated sequence repository quality control	2021-04-06 00:00:00	b.1.1.7
57	2021.04.05.438352	A new SARS-CoV-2 lineage that shares mutations with known Variants of Concern is rejected by automated sequence repository quality control	2021-04-06 00:00:00	b.1
57	2021.04.05.438352	A new SARS-CoV-2 lineage that shares mutations with known Variants of Concern is rejected by automated sequence repository quality control	2021-04-06 00:00:00	b.1.3
38	2021.03.16.21253716	Epitope-resolved serology test differentiates the clinical outcome of COVID-19 and identifies defects in antibody response in SARS-CoV-2 variants	2021-03-20 00:00:00	b.1.1.7
44	2021.02.22.432359	SARS-CoV-2 B.1.1.7 and B.1.351 Spike variants bind human ACE2 with increased affinity	2021-02-22 00:00:00	b.1.1.7
44	2021.02.22.432359	SARS-CoV-2 B.1.1.7 and B.1.351 Spike variants bind human ACE2 with increased affinity	2021-02-22 00:00:00	b.1.351
44	2021.02.22.432359	SARS-CoV-2 B.1.1.7 and B.1.351 Spike variants bind human ACE2 with increased affinity	2021-02-22 00:00:00	b.1.351 variant
72	2021.02.02.21250799	Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant	2021-02-05 00:00:00	uk variant
72	2021.02.02.21250799	Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant	2021-02-05 00:00:00	b.1.1.7
97	2021.01.27.21250048	A Rapid and Low-Cost protocol for the detection of B.1.1.7 lineage of SARS-CoV-2 by using SYBR Green-Based RT-qPCR	2021-01-29 00:00:00	b.1.1.7 lineage
15	2021.02.27.433180	Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees.	2021-03-01 00:00:00	b.1.1.7
15	2021.02.27.433180	Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees.	2021-03-01 00:00:00	b.1.351
15	2021.02.27.433180	Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees.	2021-03-01 00:00:00	p.1
15	2021.02.27.433180	Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees.	2021-03-01 00:00:00	cal.20c
48	pmid32378507	"Letter to the Editor about the Article ""Excess Mortality Estimation During the COVID-19 Pandemic: Preliminary Data from Portugal https://doi.org/10.20344/amp.13928""."	2020-06-10 00:00:00	p.1
75	pmid33117227	Interactions Between Socioeconomic Status and Mental Health Outcomes in the Nigerian Context Amid COVID-19 Pandemic: A Comparative Study.	2020-10-30 00:00:00	v.2
23	2021.04.09.21255131	Early and ongoing importations of SARS-CoV-2 in Canada	2021-04-13 00:00:00	b.1
69	pmid33000129	An ace model for SARS-CoV-2 infection.	2020-12-18 00:00:00	m.2
37	2020.04.04.20053546	Community responses during early phase of the COVID-19 epidemic: a cross-sectional study	2020-04-07 00:00:00	v.2
73	2021.04.10.21255111	Rapid spread and high impact of the Variant of Concern P.1 in the largest city of Brazil	2021-04-14 00:00:00	p.1
2	2020.03.03.20029983	Transmission interval estimates suggest pre-symptomatic spread of COVID-19	2020-03-06 00:00:00	an.1
2	2020.03.03.20029983	Transmission interval estimates suggest pre-symptomatic spread of COVID-19	2020-03-06 00:00:00	b.26
2	2020.03.03.20029983	Transmission interval estimates suggest pre-symptomatic spread of COVID-19	2020-03-06 00:00:00	n.2
2	2020.03.03.20029983	Transmission interval estimates suggest pre-symptomatic spread of COVID-19	2020-03-06 00:00:00	b.27
17	2021.02.25.21252454	RT-qPCR assay for detection of British (B.1.1.7) and South Africa (B.1.351) variants of SARS-CoV-2	2021-03-01 00:00:00	b.1.1.7
17	2021.02.25.21252454	RT-qPCR assay for detection of British (B.1.1.7) and South Africa (B.1.351) variants of SARS-CoV-2	2021-03-01 00:00:00	b.1.35
17	2021.02.25.21252454	RT-qPCR assay for detection of British (B.1.1.7) and South Africa (B.1.351) variants of SARS-CoV-2	2021-03-01 00:00:00	british variant
17	2021.02.25.21252454	RT-qPCR assay for detection of British (B.1.1.7) and South Africa (B.1.351) variants of SARS-CoV-2	2021-03-01 00:00:00	b.1.351
17	2021.02.25.21252454	RT-qPCR assay for detection of British (B.1.1.7) and South Africa (B.1.351) variants of SARS-CoV-2	2021-03-01 00:00:00	b.1.351 variant
70	figshare13235243	COVID-19, seasonal influenza and measles: potential triple burden and the role of flu and MMR vaccines	2020-11-25 00:00:00	c.3
69	2020.12.14.422793	Genomic diversity analysis of SARS-CoV-2 genomes in Rwanda	2020-12-15 00:00:00	b.1
23	2021.02.05.21251230	UK and other SARS-CoV-2-Covariants - Simulation Modeling 70% Increase	2021-02-08 00:00:00	uk variant
21	pmid33099460	Living with covid-19.	2020-10-30 00:00:00	n.5
90	pmid33913179	"Are opioid receptor antagonists adequate for ""Opioid"" overdose in a changing reality?"	2020-11-15 00:00:00	n.1
32	pmid33283842	The Role of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis.	2020-12-07 00:00:00	v.2
72	2021.03.17.21253810	Importation, circulation, and emergence of variants of SARS-CoV-2 in the South Indian State of Karnataka	2021-03-20 00:00:00	lineage b.1.1.7
72	2021.03.17.21253810	Importation, circulation, and emergence of variants of SARS-CoV-2 in the South Indian State of Karnataka	2021-03-20 00:00:00	lineage b.1.351
72	2021.03.17.21253810	Importation, circulation, and emergence of variants of SARS-CoV-2 in the South Indian State of Karnataka	2021-03-20 00:00:00	lineage p.1
72	2021.03.17.21253810	Importation, circulation, and emergence of variants of SARS-CoV-2 in the South Indian State of Karnataka	2021-03-20 00:00:00	b.1.1
72	2021.03.17.21253810	Importation, circulation, and emergence of variants of SARS-CoV-2 in the South Indian State of Karnataka	2021-03-20 00:00:00	uk variant
72	2021.03.17.21253810	Importation, circulation, and emergence of variants of SARS-CoV-2 in the South Indian State of Karnataka	2021-03-20 00:00:00	b.1.36
72	2021.03.17.21253810	Importation, circulation, and emergence of variants of SARS-CoV-2 in the South Indian State of Karnataka	2021-03-20 00:00:00	b.1
72	2021.03.17.21253810	Importation, circulation, and emergence of variants of SARS-CoV-2 in the South Indian State of Karnataka	2021-03-20 00:00:00	b.1.1.7
72	2021.03.17.21253810	Importation, circulation, and emergence of variants of SARS-CoV-2 in the South Indian State of Karnataka	2021-03-20 00:00:00	b.1.468
72	2021.03.17.21253810	Importation, circulation, and emergence of variants of SARS-CoV-2 in the South Indian State of Karnataka	2021-03-20 00:00:00	b.1.351
72	2021.03.17.21253810	Importation, circulation, and emergence of variants of SARS-CoV-2 in the South Indian State of Karnataka	2021-03-20 00:00:00	p.1
59	pmid33916492	Genotyping of the Major SARS-CoV-2 Clade by Short-Amplicon High-Resolution Melting (SA-HRM) Analysis.	2021-03-30 00:00:00	b.1.1.7
59	pmid33916492	Genotyping of the Major SARS-CoV-2 Clade by Short-Amplicon High-Resolution Melting (SA-HRM) Analysis.	2021-03-30 00:00:00	b.1.1
98	2021.02.06.430088	Insights on SARS-CoV-2's Mutations for Evading Human Antibodies: Sacrifice and Survival	2021-02-07 00:00:00	b.1.351
20	pmid32412513	Challenges for medical education in Mexico in the time of COVID-19.	2020-05-15 00:00:00	s.1
12	pmid33730597	Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.	2021-02-16 00:00:00	b.1.351
12	pmid33730597	Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.	2021-02-16 00:00:00	b.1.1.7
12	pmid33730597	Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.	2021-02-16 00:00:00	p.1
90	pmid33890566	Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021.	2021-04-26 00:00:00	b.1.1.7
90	pmid33890566	Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021.	2021-04-26 00:00:00	b.1.351
90	pmid33890566	Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021.	2021-04-26 00:00:00	p.1
16	pmid33743213	Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.	2021-02-26 00:00:00	b.1.351 variant
1	pmid33798499	Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.	2021-03-04 00:00:00	variant of concern 202012/01
1	pmid33798499	Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.	2021-03-04 00:00:00	b.1.1.7
1	pmid33798499	Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.	2021-03-04 00:00:00	b.1.1.7 lineage
54	figshare13117853	Reviewer_2_v.1 – Supplemental material for Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study	2020-10-20 00:00:00	v.1
77	pmid33648934	Covid-19: UK officials try to trace unidentified case of Brazil variant.	2021-03-02 00:00:00	brazil variant
2	pmid33370247	Does Hyperbaric Oxygen Improve Lower Extremity Ulcer Outcomes?	2020-12-28 00:00:00	y.1
2	pmid33370247	Does Hyperbaric Oxygen Improve Lower Extremity Ulcer Outcomes?	2020-12-28 00:00:00	b.4
29	2021.03.25.21253908	A unique SARS-CoV-2 spike protein P681H strain detected in Israel	2021-03-28 00:00:00	b.1.1.7
10	figshare12902092	Reviewer_2_v.1 – Supplemental material for Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia	2020-09-01 00:00:00	v.1
8	pmid33834772	Insights into SARS-CoV-2's Mutations for Evading Human Antibodies: Sacrifice and Survival.	2021-04-09 00:00:00	b.1.351
53	pmid33794345	SARS-CoV-2 escape mutants and protective immunity from natural infections or immunizations.	2021-03-14 00:00:00	b.1.1.7
53	pmid33794345	SARS-CoV-2 escape mutants and protective immunity from natural infections or immunizations.	2021-03-14 00:00:00	b.1.351
53	pmid33794345	SARS-CoV-2 escape mutants and protective immunity from natural infections or immunizations.	2021-03-14 00:00:00	p.1
61	2020.04.20.20072736	Using EpiRank for Analyzing Emerging Coronavirus Epidemic Patterns	2020-04-24 00:00:00	al.1
47	2021.01.30.428921	SARS-CoV-2 binding and neutralizing antibody levels after vaccination with Ad26.COV2.S predict durable protection in rhesus macaques	2021-01-30 00:00:00	n.5
60	2021.04.22.440932	Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India	2021-04-24 00:00:00	lineage b.1.617
51	2021.04.23.441101	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	2021-04-23 00:00:00	b.1.6
51	2021.04.23.441101	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	2021-04-23 00:00:00	lineage b.1.617
60	2021.03.31.21254708	Replication of LZTFL1 gene region as a susceptibility locus for COVID-19 in Latvian population.	2021-04-06 00:00:00	p.2
1	pmid33902527	Excess of all-cause mortality is only partially explained by COVID-19 in Veneto (Italy) during spring outbreak.	2021-04-27 00:00:00	n.3
90	2021.01.29.21250643	Emergence of first strains of Sars-CoV-2 lineage B.1.1.7 in Romania	2021-02-01 00:00:00	lineage b.1.1.7
90	2021.01.29.21250643	Emergence of first strains of Sars-CoV-2 lineage B.1.1.7 in Romania	2021-02-01 00:00:00	b.1.1.7
49	pmid33846689	First detection of the British variant of SARS-CoV-2 in Senegal.	2021-03-18 00:00:00	british variant
63	pmid33026746	Systemic Medications of Dermatological Importance in COVID-19.	2020-10-20 00:00:00	d.2
83	pmid33857895	Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike protein.	2021-03-28 00:00:00	cal.20c
83	pmid33857895	Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike protein.	2021-03-28 00:00:00	b.1.1.29
83	pmid33857895	Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike protein.	2021-03-28 00:00:00	brazilian variant
44	2020.11.25.20233163	Clonal hematopoiesis is associated with risk of severe Covid-19	2020-11-27 00:00:00	al.1
82	pmid33608937	Vaccination Rates and Acceptance of SARS-CoV-2 Vaccination Among US Emergency Department Health Care Personnel.	2021-02-20 00:00:00	s.1
57	2021.04.06.21254923	Co-circulation of SARS-CoV-2 variants B.1.1.7 and P.1	2021-04-07 00:00:00	b.1.1.7
57	2021.04.06.21254923	Co-circulation of SARS-CoV-2 variants B.1.1.7 and P.1	2021-04-07 00:00:00	p.1
57	2021.04.06.21254923	Co-circulation of SARS-CoV-2 variants B.1.1.7 and P.1	2021-04-07 00:00:00	b.1.351
85	2020.09.11.293258	A comparative survey of betacoronavirus strain molecular dynamics identifies key ACE2 binding sites	2020-09-11 00:00:00	b.1.1.7
85	2020.09.11.293258	A comparative survey of betacoronavirus strain molecular dynamics identifies key ACE2 binding sites	2020-09-11 00:00:00	b.1.351
85	2020.09.11.293258	A comparative survey of betacoronavirus strain molecular dynamics identifies key ACE2 binding sites	2020-09-11 00:00:00	p.1
35	2021.01.13.426558	Molecular dynamic simulation reveals E484K mutation enhances spike RBD-ACE2 affinity and the combination of E484K, K417N and N501Y mutations (501Y.V2 variant) induces conformational change greater than N501Y mutant alone, potentially resulting in an escape mutant	2021-01-13 00:00:00	b.1.1.7
35	2021.01.13.426558	Molecular dynamic simulation reveals E484K mutation enhances spike RBD-ACE2 affinity and the combination of E484K, K417N and N501Y mutations (501Y.V2 variant) induces conformational change greater than N501Y mutant alone, potentially resulting in an escape mutant	2021-01-13 00:00:00	uk variant
59	pmid33632858	Genome Sequence of a SARS-CoV-2 Strain from Bangladesh That Is Nearly Identical to United Kingdom SARS-CoV-2 Variant B.1.1.7.	2021-02-26 00:00:00	b.1.1.7
59	pmid33632858	Genome Sequence of a SARS-CoV-2 Strain from Bangladesh That Is Nearly Identical to United Kingdom SARS-CoV-2 Variant B.1.1.7.	2021-02-26 00:00:00	uk variant
26	pmid32342998	American Geriatrics Society (AGS) Policy Brief: COVID-19 and Assisted Living Facilities.	2020-12-18 00:00:00	s.1
64	2021.04.16.21255412	Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination.	2021-04-16 00:00:00	b.1.1.7
64	2021.04.16.21255412	Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination.	2021-04-16 00:00:00	b.1.351
64	2021.04.16.21255412	Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination.	2021-04-16 00:00:00	p.1
64	2021.04.16.21255412	Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination.	2021-04-16 00:00:00	b.1.351 variant
68	2021.04.29.442060	SARS-CoV-2 bearing a mutation at the S1/S2 cleavage site exhibits attenuated virulence and confers protective immunity	2021-04-30 00:00:00	b.1.1.7
68	2021.04.29.442060	SARS-CoV-2 bearing a mutation at the S1/S2 cleavage site exhibits attenuated virulence and confers protective immunity	2021-04-30 00:00:00	p.1
18	2021.03.18.435945	Myocarditis in naturally infected pets with the British variant of COVID-19	2021-03-18 00:00:00	british variant
18	2021.03.18.435945	Myocarditis in naturally infected pets with the British variant of COVID-19	2021-03-18 00:00:00	b.1.1.7
54	2021.04.14.21255429	Emergence of the novel SARS-CoV-2 lineage P.4.1 and massive spread of P.2 in South Brazil	2021-04-20 00:00:00	p.2
54	2021.04.14.21255429	Emergence of the novel SARS-CoV-2 lineage P.4.1 and massive spread of P.2 in South Brazil	2021-04-20 00:00:00	b.1.1
54	2021.04.14.21255429	Emergence of the novel SARS-CoV-2 lineage P.4.1 and massive spread of P.2 in South Brazil	2021-04-20 00:00:00	b.1.9
54	2021.04.14.21255429	Emergence of the novel SARS-CoV-2 lineage P.4.1 and massive spread of P.2 in South Brazil	2021-04-20 00:00:00	b.1.195
54	2021.04.14.21255429	Emergence of the novel SARS-CoV-2 lineage P.4.1 and massive spread of P.2 in South Brazil	2021-04-20 00:00:00	b.1.2
78	2021.02.18.21251809	The unexpected dynamics of COVID-19 in Manaus, Brazil: Herd immunity versus interventions	2021-02-19 00:00:00	p.1
13	2021.01.12.21249613	Genomic surveillance at scale is required to detect newly emerging strains at an early timepoint	2021-01-15 00:00:00	b.1.1.7
13	2021.01.12.21249613	Genomic surveillance at scale is required to detect newly emerging strains at an early timepoint	2021-01-15 00:00:00	s.1
59	2021.04.27.21256222	COVID-19 Outcomes and Sequencing of SARS-CoV-2 isolated from Veterans in New England	2021-04-30 00:00:00	n.1
80	pmid33654292	SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.	2021-03-03 00:00:00	b.1.35
81	pmid33661331	Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study.	2021-03-06 00:00:00	s.1
46	figshare12497219	Reviewer_1_v.1 – Supplemental material for Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications	2020-06-17 00:00:00	v.1
64	pmid33476315	Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021.	2021-01-22 00:00:00	b.1.1.7 lineage
64	pmid33476315	Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021.	2021-01-22 00:00:00	lineage b.1.1.7
64	pmid33476315	Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021.	2021-01-22 00:00:00	b.1.1.7
32	pmid33593840	Anaphylaxis Due to Remdesivir.	2021-02-17 00:00:00	a.1
53	pmid32836768	Impact of COVID-19 on the Perinatal Period Through a Biopsychosocial Systemic Framework.	2020-09-28 00:00:00	p.1
92	2021.03.31.437925	SARS-CoV-2 immune evasion by variant B.1.427/B.1.429	2021-04-01 00:00:00	b.1.427
92	2021.03.31.437925	SARS-CoV-2 immune evasion by variant B.1.427/B.1.429	2021-04-01 00:00:00	b.1.429
92	2021.03.31.437925	SARS-CoV-2 immune evasion by variant B.1.427/B.1.429	2021-04-01 00:00:00	cal.20c
52	2021.02.11.430787	SARS-CoV-2 variants B.1.351 and B.1.1.248: Escape from therapeutic antibodies and antibodies induced by infection and vaccination	2021-02-11 00:00:00	b.1.351
52	2021.02.11.430787	SARS-CoV-2 variants B.1.351 and B.1.1.248: Escape from therapeutic antibodies and antibodies induced by infection and vaccination	2021-02-11 00:00:00	b.1.1.248
52	2021.02.11.430787	SARS-CoV-2 variants B.1.351 and B.1.1.248: Escape from therapeutic antibodies and antibodies induced by infection and vaccination	2021-02-11 00:00:00	b.1.1.7
52	2021.02.11.430787	SARS-CoV-2 variants B.1.351 and B.1.1.248: Escape from therapeutic antibodies and antibodies induced by infection and vaccination	2021-02-11 00:00:00	brazil variant
73	2021.04.25.21256049	Previously infected vaccinees broadly neutralize SARS-CoV-2 variants	2021-04-29 00:00:00	b.1.1.7
73	2021.04.25.21256049	Previously infected vaccinees broadly neutralize SARS-CoV-2 variants	2021-04-29 00:00:00	b.1.351
73	2021.04.25.21256049	Previously infected vaccinees broadly neutralize SARS-CoV-2 variants	2021-04-29 00:00:00	p.1
51	pmid33193281	Corrigendum: Identification of Diverse Bat Alphacoronaviruses and Betacoronaviruses in China Provides New Insights Into the Evolution and Origin of Coronavirus-Related Diseases.	2020-11-16 00:00:00	b.20
63	2021.03.04.433887	SARS-CoV-2 variant with higher affinity to ACE2 shows reduced sera neutralization susceptibility	2021-03-04 00:00:00	brazilian variant
99	figshare12610825	Reviewer_1_v.1 – Supplemental material for C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis	2020-07-04 00:00:00	v.1
96	pmid33250671	An Assessment of Distress Levels of Patients Undergoing Lung Cancer Treatment and Surveillance During the COVID-19 Pandemic.	2020-12-01 00:00:00	s.1
6	pmid33666921	COVID-19 MEDEVAC Best Practices: The Development of a Standardized Medical Operating Guideline.	2021-03-08 00:00:00	s.1
6	pmid33666921	COVID-19 MEDEVAC Best Practices: The Development of a Standardized Medical Operating Guideline.	2021-03-08 00:00:00	n.2
68	pmid33766078	Association of the host genetic factors, hypercholesterolemia and diabetes with mild influenza in an Iranian population.	2021-03-28 00:00:00	v.1
68	pmid33766078	Association of the host genetic factors, hypercholesterolemia and diabetes with mild influenza in an Iranian population.	2021-03-28 00:00:00	c.13
92	pmid33707325	Coding-Complete Genome Sequence and Phylogenetic Relatedness of a SARS-CoV-2 Strain Detected in March 2020 in Cameroon.	2021-03-12 00:00:00	b.1
94	pmid32437870	COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy.	2020-05-05 00:00:00	s.1
94	pmid32437870	COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy.	2020-05-05 00:00:00	d.2
13	pmid33400419	Aesthetic Office Disaster Preparedness and Response Plan.	2021-01-06 00:00:00	d.2
30	pmid32874142	NICU Disaster Preparedness: Were we ready for COVID-19?	2020-09-28 00:00:00	s.1
72	2020.09.01.20186155	SARS-CoV-2 phylogeny during the early outbreak in the Basel area, Switzerland: import and spread dominated by a single B.1 lineage variant (C15324T)	2020-09-05 00:00:00	b.1
72	2020.09.01.20186155	SARS-CoV-2 phylogeny during the early outbreak in the Basel area, Switzerland: import and spread dominated by a single B.1 lineage variant (C15324T)	2020-09-05 00:00:00	b.1.1
55	pmid33179350	Rabbit anti-thymocyte globulin administration to treat rejection in simultaneous pancreas and kidney transplant recipients with recent COVID-19 infection.	2020-11-12 00:00:00	s.1
64	2021.04.17.440288	Emergence of a recurrent insertion in the N-terminal domain of the SARS-CoV-2 spike glycoprotein	2021-04-19 00:00:00	a.2.5
64	2021.04.17.440288	Emergence of a recurrent insertion in the N-terminal domain of the SARS-CoV-2 spike glycoprotein	2021-04-19 00:00:00	b.1.2
21	pmid33679953	Amid COVID-19 pandemic, are non-COVID patients left in the lurch?	2021-03-08 00:00:00	v.1
6	pmid32562553	Challenges in COVID-19 medical response: a nephrology perspective.	2020-06-30 00:00:00	n.1
91	2021.03.16.21253248	Household transmission of SARS-CoV-2 R.1 lineage with spike E484K mutation in Japan	2021-03-20 00:00:00	r.1
36	pmid33176027	Workplace well-being in pediatric anesthesia: How to design and implement a bespoke evidence-based framework in your department.	2020-10-31 00:00:00	s.1
58	2021.01.21.21250228	Simulating the impact of different vaccination policies on the COVID-19 pandemic in New York City	2021-01-22 00:00:00	uk variant
20	pmid33858945	Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination.	2021-04-26 00:00:00	b.1.351 variant
60	2021.03.10.21253311	Bayesian inference across multiple models suggests a strong increase in lethality of COVID-19 in late 2020 in the UK	2021-03-12 00:00:00	b.1.1.7
78	pmid33585374	Patterns of Presentation of SARS-CoV-2 Infection in Children. Experience at the Italian Epicentre of the Pandemic.	2021-02-16 00:00:00	n.7
78	pmid33585374	Patterns of Presentation of SARS-CoV-2 Infection in Children. Experience at the Italian Epicentre of the Pandemic.	2021-02-16 00:00:00	n.5
78	pmid33585374	Patterns of Presentation of SARS-CoV-2 Infection in Children. Experience at the Italian Epicentre of the Pandemic.	2021-02-16 00:00:00	n.2
78	pmid33585374	Patterns of Presentation of SARS-CoV-2 Infection in Children. Experience at the Italian Epicentre of the Pandemic.	2021-02-16 00:00:00	n.1
78	pmid33585374	Patterns of Presentation of SARS-CoV-2 Infection in Children. Experience at the Italian Epicentre of the Pandemic.	2021-02-16 00:00:00	n.3
1	2021.03.24.21254046	Sudden rise in COVID-19 case fatality among young and middle-aged adults in the south of Brazil after identification of the novel B.1.1.28.1 (P.1) SARS-CoV-2 strain: analysis of data from the state of Parana	2021-03-26 00:00:00	b.1.1
1	2021.03.24.21254046	Sudden rise in COVID-19 case fatality among young and middle-aged adults in the south of Brazil after identification of the novel B.1.1.28.1 (P.1) SARS-CoV-2 strain: analysis of data from the state of Parana	2021-03-26 00:00:00	p.1
15	2021.01.28.21250680	The effect of SARS-CoV-2 variant B.1.1.7 on symptomatology, re-infection and transmissibility	2021-01-29 00:00:00	b.1.1.7
87	pmid33914724	Linked Clusters of SARS-CoV-2 Variant B.1.351 - Maryland, January-February 2021.	2021-05-03 00:00:00	b.1.351
87	pmid33914724	Linked Clusters of SARS-CoV-2 Variant B.1.351 - Maryland, January-February 2021.	2021-05-03 00:00:00	b.1.351 lineage
87	pmid33914724	Linked Clusters of SARS-CoV-2 Variant B.1.351 - Maryland, January-February 2021.	2021-05-03 00:00:00	b.1.351 variant
36	pmid32942923	A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19.	2020-09-18 00:00:00	a.1
42	pmid33803400	Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications.	2021-02-28 00:00:00	b.1.1.7
42	pmid33803400	Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications.	2021-02-28 00:00:00	b.1.351
42	pmid33803400	Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications.	2021-02-28 00:00:00	b.1.1
42	pmid33803400	Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications.	2021-02-28 00:00:00	p.1
90	2021.02.22.432189	Acquisition of the L452R mutation in the ACE2-binding interface of Spike protein triggers recent massive expansion of SARS-Cov-2 variants	2021-02-22 00:00:00	cal.20c
90	2021.02.22.432189	Acquisition of the L452R mutation in the ACE2-binding interface of Spike protein triggers recent massive expansion of SARS-Cov-2 variants	2021-02-22 00:00:00	lineage b.1.429
90	2021.02.22.432189	Acquisition of the L452R mutation in the ACE2-binding interface of Spike protein triggers recent massive expansion of SARS-Cov-2 variants	2021-02-22 00:00:00	b.1.2
90	2021.02.22.432189	Acquisition of the L452R mutation in the ACE2-binding interface of Spike protein triggers recent massive expansion of SARS-Cov-2 variants	2021-02-22 00:00:00	l.2
87	2021.03.04.21252550	Estimating the super-spreading rate at workplaces using bluetooth technology	2021-03-08 00:00:00	b.1.1.7
49	pmid33890568	Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021.	2021-04-23 00:00:00	b.1.1.7
49	pmid33890568	Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021.	2021-04-23 00:00:00	b.1.351
97	2021.04.06.437914	Uneven growth of SARS-CoV-2 clones evidenced by more than 500,000 whole-genome sequences	2021-04-06 00:00:00	b.1.1.7
97	2021.04.06.437914	Uneven growth of SARS-CoV-2 clones evidenced by more than 500,000 whole-genome sequences	2021-04-06 00:00:00	b.1.35
97	2021.04.06.437914	Uneven growth of SARS-CoV-2 clones evidenced by more than 500,000 whole-genome sequences	2021-04-06 00:00:00	uk variant
83	2021.01.25.21249974	Emergence and fast spread of B.1.1.7 lineage in Lebanon.	2021-01-26 00:00:00	b.1.1.7 lineage
82	pmid33024848	"Erratum to ""Emergency Medical Services resource capacity and competency amid COVID-19 in the United States: preliminary findings from a national survey"" [Heliyon 6 (5) (May 2020) Article e03900]."	2020-10-12 00:00:00	n.2
82	2021.01.22.21249716	An interactive COVID-19 virus Mutation Tracker (CovMT) with a particular focus on critical mutations in the Receptor Binding Domain (RBD) region of the Spike protein	2021-01-25 00:00:00	s.1
71	pmid33684558	Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs.	2021-02-27 00:00:00	lineage b.1.1.7
71	pmid33684558	Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs.	2021-02-27 00:00:00	b.1.1.7 lineage
87	2021.03.01.433466	Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization	2021-03-02 00:00:00	variant p.1
87	2021.03.01.433466	Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization	2021-03-02 00:00:00	b.1.1.7
87	2021.03.01.433466	Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization	2021-03-02 00:00:00	b.1.351
87	2021.03.01.433466	Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization	2021-03-02 00:00:00	p.1
87	2021.03.01.433466	Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization	2021-03-02 00:00:00	p.1 variant
15	pmid33229168	The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights from 2020.	2020-11-26 00:00:00	y.1
18	pmid33025923	The SARS-CoV-2 Virus may Remain Viable on Oral Appliances for up to 3 Days?	2020-10-08 00:00:00	c.1
18	pmid33025923	The SARS-CoV-2 Virus may Remain Viable on Oral Appliances for up to 3 Days?	2020-10-08 00:00:00	l.3
30	pmid33806013	SARS-CoV-2 N501Y Introductions and Transmissions in Switzerland from Beginning of October 2020 to February 2021-Implementation of Swiss-Wide Diagnostic Screening and Whole Genome Sequencing.	2021-03-10 00:00:00	b.1.1.7
30	pmid33806013	SARS-CoV-2 N501Y Introductions and Transmissions in Switzerland from Beginning of October 2020 to February 2021-Implementation of Swiss-Wide Diagnostic Screening and Whole Genome Sequencing.	2021-03-10 00:00:00	b.1.351
30	pmid33806013	SARS-CoV-2 N501Y Introductions and Transmissions in Switzerland from Beginning of October 2020 to February 2021-Implementation of Swiss-Wide Diagnostic Screening and Whole Genome Sequencing.	2021-03-10 00:00:00	p.1
30	pmid33806013	SARS-CoV-2 N501Y Introductions and Transmissions in Switzerland from Beginning of October 2020 to February 2021-Implementation of Swiss-Wide Diagnostic Screening and Whole Genome Sequencing.	2021-03-10 00:00:00	b.1.1
24	pmid33225317	Repurposing Fostamatinib to Combat SARS-CoV-2-Induced Acute Lung Injury.	2020-11-24 00:00:00	al.1
72	pmid33303095	Fever and Other Clinical Indicators May Fail to Detect COVID-19-Infected Individuals.	2020-12-18 00:00:00	d.2
14	pmid32978111	Defining clinical decision making in the provision of audio-visual outpatient care for acute upper limb trauma services: A review of practice.	2020-10-01 00:00:00	s.1
27	pmid32917283	Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients.	2020-10-01 00:00:00	c.4
27	pmid32917283	Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients.	2020-10-01 00:00:00	c.18
27	pmid32917283	Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients.	2020-10-01 00:00:00	c.21
24	figshare12682129	Reviewer_1_v.2 – Supplemental material for Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study	2020-07-21 00:00:00	v.2
1	pmid33596475	Significant decrease of facial cellulitis admissions during COVID-19 lockdown in France: a multicentric comparative study.	2021-02-17 00:00:00	s.1
28	2020.10.02.20205708	Antigen-based testing but not real-time PCR correlates with SARS-CoV-2 virus culture.	2020-10-05 00:00:00	s.1
18	pmid33789086	The variant gambit: COVID-19's next move.	2021-04-02 00:00:00	b.1.1.7
18	pmid33789086	The variant gambit: COVID-19's next move.	2021-04-02 00:00:00	b.1.351
18	pmid33789086	The variant gambit: COVID-19's next move.	2021-04-02 00:00:00	p.1
18	pmid33789086	The variant gambit: COVID-19's next move.	2021-04-02 00:00:00	b.1.429
75	2021.01.26.21250224	Escape of SARS-CoV-2 501Y.V2 variants from neutralization by convalescent plasma	2021-01-26 00:00:00	lineage b.1.351
75	2021.01.26.21250224	Escape of SARS-CoV-2 501Y.V2 variants from neutralization by convalescent plasma	2021-01-26 00:00:00	b.1.1.117
82	pmid33739364	Lasting memories of SARS-CoV-2 infection.	2021-03-24 00:00:00	m.2
45	pmid33224154	Corrigendum: Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus.	2020-11-23 00:00:00	u.2
49	pmid33893249	Angiotensin-converting Enzyme 2 Specific Cell Subset Identification in Oral Tissues: A Need of the Hour in COVID-19 Research.	2021-04-27 00:00:00	c.2
0	2021.03.23.436684	Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects	2021-03-24 00:00:00	b.1.351
15	pmid33693529	Evaluating the Long-Term Efficacy of COVID-19 Vaccines.	2021-03-11 00:00:00	c.1
59	pmid33538563	Patient Perceptions and Satisfaction With Teledermatology During the COVID-19 Pandemic: A Survey-Based Study.	2021-02-05 00:00:00	d.2
1	2021.04.08.21255150	A multiplexed high-throughput neutralization assay reveals a lack of activity against multiple variants after SARS-CoV-2 infection	2021-04-13 00:00:00	b.1.1.7
1	2021.04.08.21255150	A multiplexed high-throughput neutralization assay reveals a lack of activity against multiple variants after SARS-CoV-2 infection	2021-04-13 00:00:00	b.1.351 variant
7	pmid33496089	Epidemiologic Linkage of COVID-19 Outbreaks at Two University-affiliated Hospitals in the Seoul Metropolitan Area in March 2020.	2021-02-02 00:00:00	b.1
34	2021.03.22.436379	Antidepressant and antipsychotic drugs reduce viral infection by SARS-CoV-2 and fluoxetine show antiviral activity against the novel variants in vitro	2021-03-23 00:00:00	b.1
34	2021.03.22.436379	Antidepressant and antipsychotic drugs reduce viral infection by SARS-CoV-2 and fluoxetine show antiviral activity against the novel variants in vitro	2021-03-23 00:00:00	b.1.1.7
34	2021.03.22.436379	Antidepressant and antipsychotic drugs reduce viral infection by SARS-CoV-2 and fluoxetine show antiviral activity against the novel variants in vitro	2021-03-23 00:00:00	b.1.351
34	2021.03.22.436379	Antidepressant and antipsychotic drugs reduce viral infection by SARS-CoV-2 and fluoxetine show antiviral activity against the novel variants in vitro	2021-03-23 00:00:00	b.1.35
31	pmid33196750	Therapies for Psoriasis: Clinical and Economic Comparisons.	2020-11-23 00:00:00	d.2
48	pmid33506252	Isolation and characterization of VUI-202012/01, a SARS-CoV-2 variant in travellers from the United Kingdom to India.	2021-01-11 00:00:00	vui-202012/01
37	pmid33808687	Phylogenomic Evidence of Reinfection and Persistence of SARS-CoV-2: First Report from Colombia.	2021-03-04 00:00:00	b.1
37	pmid33808687	Phylogenomic Evidence of Reinfection and Persistence of SARS-CoV-2: First Report from Colombia.	2021-03-04 00:00:00	b.1.1.269
82	2021.03.22.435960	CVnCoV protects human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2	2021-03-22 00:00:00	b.1.351
38	pmid33747755	"Corrigendum to ""Joint prevalence of physical activity and sitting time during COVID-19 among US adults in April 2020"" [Prev. Med. Rep. 20 (2020) 101256]."	2021-03-22 00:00:00	r.2
18	2021.03.09.434641	A recombinant ACE2 Triple Decoy that traps and neutralizes SARS-CoV-2 shows enhanced affinity for highly transmissible SARS-CoV-2 variants	2021-03-09 00:00:00	b.1.351 variant
2	2021.02.24.21251892	Discovery of SARS-CoV-2 strain of P.1 lineage harboring K417T/ E484K / N501Y by whole genome sequencing in the city, Japan	2021-02-26 00:00:00	p.1
2	2021.02.24.21251892	Discovery of SARS-CoV-2 strain of P.1 lineage harboring K417T/ E484K / N501Y by whole genome sequencing in the city, Japan	2021-02-26 00:00:00	20j/501y.v3
31	2021.02.18.431897	Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies	2021-02-19 00:00:00	b.1.1.7
31	2021.02.18.431897	Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies	2021-02-19 00:00:00	b.1.351
31	2021.02.18.431897	Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies	2021-02-19 00:00:00	cluster 5
44	2021.01.24.427991	Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant	2021-01-24 00:00:00	b.1.1.7
51	figshare12593941	Reviewer_1_v.1 – Supplemental material for Targeting the gut–lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection	2020-07-01 00:00:00	v.1
83	pmid33163637	"Corrigendum to ""Emergency Medical Services resource capacity and competency amid COVID-19 in the United States: preliminary findings from a national survey""."	2020-11-09 00:00:00	n.2
12	pmid33434709	Wastewater-based epidemiology as a useful tool to track SARS-CoV-2 and support public health policies at municipal level in Brazil.	2020-12-18 00:00:00	b.1.1
60	pmid32359917	"Corrigendum to ""Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and COVID-19 infection during pregnancy"" [Trav Med Infect Dis. (2020) 101641]."	2020-09-13 00:00:00	d.2
68	pmid33059040	Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases.	2020-10-05 00:00:00	n.1
66	pmid32271609	COVID-19 Exposes the Cracks in Our Already Fragile Mental Health System.	2020-07-01 00:00:00	s.1
88	2021.04.28.441474	Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drive rapid and potent immunogenicity capable of single-dose protection	2021-04-28 00:00:00	p.1
15	2021.04.13.21255281	The increase in the risk of severity and fatality rate of covid-19 in southern Brazil after the emergence of the Variant of Concern (VOC) SARS-CoV-2 P.1 was greater among young adults without pre-existing risk conditions	2021-04-19 00:00:00	p.1
15	2021.04.13.21255281	The increase in the risk of severity and fatality rate of covid-19 in southern Brazil after the emergence of the Variant of Concern (VOC) SARS-CoV-2 P.1 was greater among young adults without pre-existing risk conditions	2021-04-19 00:00:00	p.1 variant
15	2021.04.13.21255281	The increase in the risk of severity and fatality rate of covid-19 in southern Brazil after the emergence of the Variant of Concern (VOC) SARS-CoV-2 P.1 was greater among young adults without pre-existing risk conditions	2021-04-19 00:00:00	variant p.1
68	pmid33766902	Genome Sequences of Three SARS-CoV-2 P.1 Strains Identified from Patients Returning from Brazil to Italy.	2021-03-26 00:00:00	p.1
2	2020.02.04.933135	Protein structure and sequence re-analysis of 2019-nCoV genome does not indicate snakes as its intermediate host or the unique similarity between its spike protein insertions and HIV-1	2020-02-08 00:00:00	v.2
9	2021.02.15.431198	Single-Domain SARS-CoV-2 S1 and RBD Antibodies Isolated from Immunized Llama Effectively Bind Targets of the Wuhan, UK, and South African Strains in vitro	2021-02-16 00:00:00	uk variant
9	2021.02.15.431198	Single-Domain SARS-CoV-2 S1 and RBD Antibodies Isolated from Immunized Llama Effectively Bind Targets of the Wuhan, UK, and South African Strains in vitro	2021-02-16 00:00:00	south african variant
80	pmid33042219	Oral Candidiasis in Non-Severe COVID-19 Patients: Call for Antibiotic Stewardship.	2020-10-12 00:00:00	s.1
58	2021.04.08.21254791	Emergence of multiple SARS-CoV-2 antibody escape variants in an immunocompromised host undergoing convalescent plasma treatment	2021-04-11 00:00:00	b.1.351
49	figshare12911767	Reviewer_2_v.1 – Supplemental material for Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease	2020-09-03 00:00:00	v.1
49	2021.02.26.21252227	Sequence Analysis of 20,453 SARS-CoV-2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern	2021-03-02 00:00:00	uk variant
49	2021.02.26.21252227	Sequence Analysis of 20,453 SARS-CoV-2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern	2021-03-02 00:00:00	b.1.1.7
49	2021.02.26.21252227	Sequence Analysis of 20,453 SARS-CoV-2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern	2021-03-02 00:00:00	b.1.35
49	2021.02.26.21252227	Sequence Analysis of 20,453 SARS-CoV-2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern	2021-03-02 00:00:00	brazil variant
49	2021.02.26.21252227	Sequence Analysis of 20,453 SARS-CoV-2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern	2021-03-02 00:00:00	p.1
49	2021.02.26.21252227	Sequence Analysis of 20,453 SARS-CoV-2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern	2021-03-02 00:00:00	p.2
49	2021.02.26.21252227	Sequence Analysis of 20,453 SARS-CoV-2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern	2021-03-02 00:00:00	b.1.429
49	2021.02.26.21252227	Sequence Analysis of 20,453 SARS-CoV-2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern	2021-03-02 00:00:00	b.1.427
61	pmid33663108	Smell disorders in COVID-19 patients: role of olfactory training: A protocol for systematic review and meta-analysis.	2021-03-08 00:00:00	v.1
64	figshare13117850	Reviewer_1_v.1 – Supplemental material for Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study	2020-10-20 00:00:00	v.1
89	pmid33918835	Evaluating the Practice of Preventive Behaviors and the Fear of COVID-19 among Dentists in Oradea Metropolitan Area after the First Wave of Pandemic; a Cross-Sectional Study.	2021-04-01 00:00:00	v.2
2	pmid33493496	Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico.	2021-01-17 00:00:00	uk variant
58	pmid33152198	Isolation and characterization of an early SARS-CoV-2 isolate from the 2020 epidemic in Medellín, Colombia	2020-11-06 00:00:00	b.1
48	2021.03.08.21252586	Categorizing the Status of COVID-19 Outbreaks Around the World	2021-03-09 00:00:00	b.1.351 variant
48	2021.03.08.21252586	Categorizing the Status of COVID-19 Outbreaks Around the World	2021-03-09 00:00:00	b.1.1.7
48	2021.03.08.21252586	Categorizing the Status of COVID-19 Outbreaks Around the World	2021-03-09 00:00:00	p.1 variant
48	2021.03.08.21252586	Categorizing the Status of COVID-19 Outbreaks Around the World	2021-03-09 00:00:00	b.1.1
74	2021.03.05.21252520	Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland	2021-03-09 00:00:00	b.1.1.7
9	pmid33837520	Outcomes of COVID-19 in Patients with Skin Cancer.	2021-04-10 00:00:00	s.1
70	2021.03.31.21254502	Increased household secondary attacks rates with Variant of Concern SARS-CoV-2 index cases	2021-04-05 00:00:00	b.1.1.7
61	pmid33294250	Hospitals' responsibility in response to the threat of infectious disease outbreak in the context of the COVID-19 pandemic: Implications for low- and middle-income countries.	2020-09-07 00:00:00	c.4
79	pmid33830171	S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021.	2021-04-08 00:00:00	b.1.1.7
74	2021.01.11.21249612	The feasibility of targeted test-trace-isolate for the control of B.1.1.7	2021-01-13 00:00:00	b.1.1.7
74	2021.01.11.21249612	The feasibility of targeted test-trace-isolate for the control of B.1.1.7	2021-01-13 00:00:00	p.1
74	2021.01.11.21249612	The feasibility of targeted test-trace-isolate for the control of B.1.1.7	2021-01-13 00:00:00	b.1.351 variant
23	2021.04.13.439482	Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice	2021-04-13 00:00:00	b.1.351 variant
23	2021.04.13.439482	Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice	2021-04-13 00:00:00	b.1.351 lineage
23	2021.04.13.439482	Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice	2021-04-13 00:00:00	b.1.351
87	2020.11.29.20240549	Nationwide SARS-CoV-2 Surveillance Study for Sewage and Sludges of Wastewater Treatment Plants in Turkey	2020-11-30 00:00:00	g.1
9	pmid33053759	A Countrywide Survey in Saudi Arabia Regarding the Knowledge and Attitude of Health Care Professionals about Coronavirus Disease (COVID-19).	2020-10-06 00:00:00	v.2
77	pmid32181873	Tabletop exercise to prepare institutions of higher education for an outbreak of COVID-19.	2020-03-25 00:00:00	y.1
52	pmid33723538	"Erratum to ""Prior cardiovascular risk and screening echocardiograms predict hospitalization and severity of coronavirus infection among elderly Medicare patients"" [American Journal of Preventive Cardiology 3C (2020) 100090]."	2021-03-16 00:00:00	c.2
85	2021.01.15.426849	The impact of Spike mutations on SARS-CoV-2 neutralization	2021-01-19 00:00:00	b.1.1.7
85	2021.01.15.426849	The impact of Spike mutations on SARS-CoV-2 neutralization	2021-01-19 00:00:00	p.1
48	pmid33761326	N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.	2021-02-17 00:00:00	b.1.1.7
48	pmid33761326	N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.	2021-02-17 00:00:00	b.1.351
48	pmid33761326	N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.	2021-02-17 00:00:00	p.1
4	2021.02.19.21251993	Healthcare personnel knowledge, motivations, concerns and intentions regarding COVID-19 vaccines: a cross-sectional survey	2021-02-23 00:00:00	v.1
4	2021.02.19.21251993	Healthcare personnel knowledge, motivations, concerns and intentions regarding COVID-19 vaccines: a cross-sectional survey	2021-02-23 00:00:00	c.8
74	pmid33468702	SARS-CoV-2 Genomic Variation in Space and Time in Hospitalized Patients in Philadelphia.	2021-01-22 00:00:00	b.1
79	2021.04.26.441457	Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the UK B.1.1.7 and SA B.1.351 variant	2021-04-26 00:00:00	b.1.1.7
79	2021.04.26.441457	Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the UK B.1.1.7 and SA B.1.351 variant	2021-04-26 00:00:00	b.1.351 variant
33	2021.03.15.435391	Immunoinformatic Approach for the identification of T Cell and B Cell Epitopes in the Surface Glycoprotein and Designing a Potent Multiepitope Vaccine Construct Against SARS-CoV-2 including the new UK variant	2021-03-16 00:00:00	uk variant
74	figshare12610831	Reviewer_2_v.2 – Supplemental material for C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis	2020-07-04 00:00:00	v.2
51	pmid33570181	Importation of SARS-CoV-2 Variant B.1.1.7 in Pakistan.	2021-02-11 00:00:00	b.1.1.7
51	pmid33570181	Importation of SARS-CoV-2 Variant B.1.1.7 in Pakistan.	2021-02-11 00:00:00	voc-202012/01
51	pmid33570181	Importation of SARS-CoV-2 Variant B.1.1.7 in Pakistan.	2021-02-11 00:00:00	lineage b.1.1.7
52	figshare13252289	The views of ethnic minority and vulnerable communities towards participation in COVID-19 vaccine trials.	2020-11-26 00:00:00	s.1
52	figshare13252289	The views of ethnic minority and vulnerable communities towards participation in COVID-19 vaccine trials.	2020-11-26 00:00:00	a.2
42	2021.02.03.429164	Multi-specific DARPin(R) therapeutics demonstrate very high potency against mutated SARS-CoV-2 variants in vitro	2021-02-03 00:00:00	b.1.1.7
42	2021.02.03.429164	Multi-specific DARPin(R) therapeutics demonstrate very high potency against mutated SARS-CoV-2 variants in vitro	2021-02-03 00:00:00	b.1.351
93	2021.01.19.21249840	Impact of SARS-CoV-2 B.1.1.7 Spike variant on neutralisation potency of sera from individuals vaccinated with Pfizer vaccine BNT162b2	2021-01-20 00:00:00	b.1.1.7
9	pmid33693926	SARS-CoV-2 Variant of Concern 202 012/01 (B.1.1.7) in a Traveler from the United Kingdom to China.	2021-02-17 00:00:00	b.1.1.7
89	2021.03.12.435194	Antibody evasion by the Brazilian P.1 strain of SARS-CoV-2	2021-03-15 00:00:00	p.1
89	2021.03.12.435194	Antibody evasion by the Brazilian P.1 strain of SARS-CoV-2	2021-03-15 00:00:00	b.1.351
89	2021.03.12.435194	Antibody evasion by the Brazilian P.1 strain of SARS-CoV-2	2021-03-15 00:00:00	b.1.1.7
13	pmid32497637	Analysis of Gastrointestinal and Hepatic Manifestations of SARS-CoV-2 Infection in 892 Patients in Queens, NY.	2020-05-26 00:00:00	n.3
52	2020.02.10.20021519	Simulating the infected population and spread trend of 2019-nCov under different policy by EIR model	2020-02-12 00:00:00	n.2
52	2020.02.10.20021519	Simulating the infected population and spread trend of 2019-nCov under different policy by EIR model	2020-02-12 00:00:00	b.1
16	pmid33377244	"Comment on: ""Challenges and solutions for the future of UK dermatology undergraduate curriculum delivery""."	2020-12-30 00:00:00	c.1
19	pmid33583326	Structural genetics of circulating variants affecting the SARS-CoV-2 spike/human ACE2 complex.	2021-02-17 00:00:00	lineage b.1.1.7
3	pmid33713594	The effect of spike mutations on SARS-CoV-2 neutralization.	2021-02-17 00:00:00	b.1.1.7
3	pmid33713594	The effect of spike mutations on SARS-CoV-2 neutralization.	2021-02-17 00:00:00	b.1.351
3	pmid33713594	The effect of spike mutations on SARS-CoV-2 neutralization.	2021-02-17 00:00:00	p.1
22	2020.06.17.158006	Genomic surveillance of SARS-CoV-2 reveals community transmission of a major lineage during the early pandemic phase in Brazil	2020-06-18 00:00:00	b.1.1
84	2021.04.19.440481	Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants	2021-04-20 00:00:00	b.1.351
25	pmid33511657	SARS-CoV-2 Spike Protein Positivity in Pityriasis Rosea-like and Urticaria-like Rashes of COVID-19.	2021-01-29 00:00:00	n.1
99	pmid33612502	The mediating role of religiosity and hope for the effect of self-stigma on psychological well-being among COVID-19 patients.	2021-02-22 00:00:00	v.2
99	2021.01.18.426984	Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera	2021-01-19 00:00:00	lineage b.1.1.7
99	2021.01.18.426984	Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera	2021-01-19 00:00:00	b.1.1.7
99	2021.01.18.426984	Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera	2021-01-19 00:00:00	b.1.1.7 lineage
43	2021.02.25.21252477	Preliminary Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant	2021-03-03 00:00:00	b.1.351 variant
43	2021.02.25.21252477	Preliminary Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant	2021-03-03 00:00:00	b.1.351
19	pmid33237801	Communicating Effectively About Emergency Use Authorization and Vaccines in the COVID-19 Pandemic.	2020-11-25 00:00:00	s.1
8	2021.03.11.21253364	Analysis of severe outcomes associated with the SARS-CoV-2 Variant of Concern 202012/01 in England using ICNARC Case Mix Programme and QResearch databases.	2021-03-12 00:00:00	variant of concern 202012/01
8	2021.03.11.21253364	Analysis of severe outcomes associated with the SARS-CoV-2 Variant of Concern 202012/01 in England using ICNARC Case Mix Programme and QResearch databases.	2021-03-12 00:00:00	lineage b.1.1.7
8	2021.03.11.21253364	Analysis of severe outcomes associated with the SARS-CoV-2 Variant of Concern 202012/01 in England using ICNARC Case Mix Programme and QResearch databases.	2021-03-12 00:00:00	b.1.1.7
3	pmid33781945	The COVID-19 vaccination campaign in Nepal, emerging UK variant and futuristic vaccination strategies to combat the ongoing pandemic.	2021-03-15 00:00:00	uk variant
3	pmid33781945	The COVID-19 vaccination campaign in Nepal, emerging UK variant and futuristic vaccination strategies to combat the ongoing pandemic.	2021-03-15 00:00:00	b.1.1.7
74	pmid32589296	COVID-19: A series of important recent clinical and laboratory reports in immunology and pathogenesis of SARS-CoV-2 infection and care of allergy patients.	2020-07-17 00:00:00	c.1
59	pmid33800281	A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry Data.	2021-02-20 00:00:00	y.1
63	2021.03.10.434447	Naturally-acquired immunity in Syrian Golden Hamsters provides protection from re-exposure to emerging heterosubtypic SARS-CoV-2 variants B.1.1.7 and B.1.351	2021-03-10 00:00:00	b.1.1.7
63	2021.03.10.434447	Naturally-acquired immunity in Syrian Golden Hamsters provides protection from re-exposure to emerging heterosubtypic SARS-CoV-2 variants B.1.1.7 and B.1.351	2021-03-10 00:00:00	b.1.351
12	pmid32871606	[Consequences of the SARS-CoV-2 Pandemia on the Early Childhood Examinations].	2020-09-01 00:00:00	s.1
53	2021.03.22.436468	Characterisation of B.1.1.7 and Pangolin coronavirus spike provides insights on the evolutionary trajectory of SARS-CoV-2	2021-03-22 00:00:00	b.1.1.7
53	2021.03.22.436468	Characterisation of B.1.1.7 and Pangolin coronavirus spike provides insights on the evolutionary trajectory of SARS-CoV-2	2021-03-22 00:00:00	b.1.1.7 lineage
19	pmid32779810	COVID-19 in pregnancy: Placental and neonatal involvement.	2020-10-24 00:00:00	s.1
45	2021.04.26.441517	Relative Mutant N501Y SARS-CoV-2 Spike Protein RBD Inhibition of Anti-Spike Protein IgG and ACE-2 Binding to Spike Protein Species	2021-04-27 00:00:00	b.1.351
7	pmid32899059	Coronavirus disease 2019 (COVID-19) related cytopenia: A protocol for systematic review and meta-analysis.	2020-10-01 00:00:00	v.1
26	2021.03.11.434872	Chimeric spike mRNA vaccines protect against sarbecovirus challenge in mice	2021-03-12 00:00:00	b.1.351 variant
1	2020.07.09.20149856	SARS-CoV-2 spread across the Colombian-Venezuelan border	2020-07-10 00:00:00	b.1.13
7	2020.11.26.20239186	Characteristics of COVID-19 patients admitted to a tertiary care hospital in Pune, India, and cost-effective predictors of intensive care treatment requirement	2020-11-30 00:00:00	c.2
55	2021.02.09.21251411	Estimating the proportion of SARS-CoV-2 infections reported through diagnostic testing	2021-02-10 00:00:00	uk variant
63	2021.03.04.21252528	Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England	2021-03-08 00:00:00	b.1.1.7
18	pmid33555954	Objective and Subjective Clinical Swallowing Outcomes via Telehealth: Reliability in Outpatient Clinical Practice.	2021-02-08 00:00:00	a.1
47	pmid32997001	Genomic and phylogenetic characterisation of an imported case of SARS-CoV-2 in Amazonas State, Brazil.	2020-12-18 00:00:00	a.2
61	2021.03.15.21253549	Impact of Clinical and Genomic Factors on SARS-CoV2 Disease Severity	2021-03-24 00:00:00	b.1.1.7
19	2021.01.25.427948	mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants	2021-01-25 00:00:00	b.1.1.7
19	2021.01.25.427948	mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants	2021-01-25 00:00:00	b.1.35
19	2021.01.25.427948	mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants	2021-01-25 00:00:00	cluster 5
19	2021.01.25.427948	mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants	2021-01-25 00:00:00	b.1.351 variant
19	2021.01.25.427948	mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants	2021-01-25 00:00:00	b.1.351
25	pmid33836142	Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant.	2021-03-05 00:00:00	b.1.1.7
11	2020.03.04.20030965	Comparison of severe and non-severe COVID-19 pneumonia: review and meta-analysis	2020-03-09 00:00:00	s.1
24	2020.06.11.20128330	Genome sequencing of the first SARS-CoV-2 reported from patients with COVID-19 in Ecuador.	2020-06-14 00:00:00	b.1
33	2021.02.05.21251157	How effective was Newfoundland & Labrador's travel ban to prevent the spread of COVID-19? An agent-based analysis	2021-02-08 00:00:00	uk variant
6	2020.05.25.20112656	Association of the Covid-19 lockdown with smoking, drinking, and attempts to quit in England: an analysis of 2019-2020 data	2020-05-27 00:00:00	l.2
37	pmid33866618	Under-representation of people of African ancestry in publications on the cutaneous manifestations of COVID-19: coincidence or physiology?	2021-04-18 00:00:00	s.1
29	pmid32726507	Hypoxia - an overlooked trigger for thrombosis in COVID-19 and other critically ill patients.	2020-07-29 00:00:00	s.1
5	pmid33754328	Can mRNA Vaccines Turn the Tables During the COVID-19 Pandemic? Current Status and Challenges.	2021-03-24 00:00:00	b.1.1
5	pmid33754328	Can mRNA Vaccines Turn the Tables During the COVID-19 Pandemic? Current Status and Challenges.	2021-03-24 00:00:00	b.1.351
99	pmid33743891	Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.	2021-02-06 00:00:00	b.1.1.7
52	2021.03.20.21253956	A Sanger-based approach for scaling up screening of SARS-CoV-2 variants of interest and concern	2021-03-25 00:00:00	p.2
52	2021.03.20.21253956	A Sanger-based approach for scaling up screening of SARS-CoV-2 variants of interest and concern	2021-03-25 00:00:00	p.1
52	2021.03.20.21253956	A Sanger-based approach for scaling up screening of SARS-CoV-2 variants of interest and concern	2021-03-25 00:00:00	b.1.1
82	pmid33842111	A Case of Moderately Severe COVID-19 in a Healthcare Worker in Russia: Virus Isolation and Full Genome Sequencing.	2021-04-13 00:00:00	b.1.1
83	2021.01.27.426895	E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil	2021-01-27 00:00:00	b.1.1
43	pmid33725406	Prompt onset of erythema multiforme following the first BNT162b2 SARS-CoV-2 vaccination.	2021-03-16 00:00:00	y.1
69	pmid33789085	SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera.	2021-03-10 00:00:00	b.1.1.7
69	pmid33789085	SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera.	2021-03-10 00:00:00	b.1.35
45	pmid33741335	Sequence Analysis of 20,453 SARS-CoV-2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern.	2021-03-07 00:00:00	uk variant
45	pmid33741335	Sequence Analysis of 20,453 SARS-CoV-2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern.	2021-03-07 00:00:00	b.1.1.7
45	pmid33741335	Sequence Analysis of 20,453 SARS-CoV-2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern.	2021-03-07 00:00:00	b.1.35
45	pmid33741335	Sequence Analysis of 20,453 SARS-CoV-2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern.	2021-03-07 00:00:00	brazil variant
45	pmid33741335	Sequence Analysis of 20,453 SARS-CoV-2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern.	2021-03-07 00:00:00	p.1
45	pmid33741335	Sequence Analysis of 20,453 SARS-CoV-2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern.	2021-03-07 00:00:00	p.2
45	pmid33741335	Sequence Analysis of 20,453 SARS-CoV-2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern.	2021-03-07 00:00:00	b.1.429
45	pmid33741335	Sequence Analysis of 20,453 SARS-CoV-2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern.	2021-03-07 00:00:00	b.1.427
85	2020.07.06.20147140	Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic	2020-07-07 00:00:00	b.1
19	pmid33909850	SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil.	2021-04-28 00:00:00	p.1
19	pmid33909850	SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil.	2021-04-28 00:00:00	p.1 variant
72	pmid33630825	First Identified Cases of SARS-CoV-2 Variant B.1.1.7 in Minnesota - December 2020-January 2021.	2021-02-26 00:00:00	b.1.1.7
52	2021.02.20.432046	Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variant	2021-02-22 00:00:00	b.1.351
52	2021.02.20.432046	Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variant	2021-02-22 00:00:00	b.1
52	2021.02.20.432046	Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variant	2021-02-22 00:00:00	b.1.351 variant
52	2021.02.26.21251868	The localized rise of a B.1.526 variant containing an E484K mutation in New York State	2021-03-01 00:00:00	b.1.526 variant
52	2021.02.26.21251868	The localized rise of a B.1.526 variant containing an E484K mutation in New York State	2021-03-01 00:00:00	b.1.351
52	2021.02.26.21251868	The localized rise of a B.1.526 variant containing an E484K mutation in New York State	2021-03-01 00:00:00	p.1
52	2021.02.26.21251868	The localized rise of a B.1.526 variant containing an E484K mutation in New York State	2021-03-01 00:00:00	b.1.526
16	2021.03.01.21252652	Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England	2021-03-02 00:00:00	uk variant
34	2021.04.07.438818	Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody	2021-04-08 00:00:00	b.1.1.7
34	2021.04.07.438818	Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody	2021-04-08 00:00:00	b.1.351
34	2021.04.07.438818	Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody	2021-04-08 00:00:00	p.1
34	2021.04.07.438818	Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody	2021-04-08 00:00:00	b.1.427
34	2021.04.07.438818	Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody	2021-04-08 00:00:00	b.1.429
34	2021.04.07.438818	Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody	2021-04-08 00:00:00	b.1.351 variant
47	pmid33900195	Novel SARS-CoV-2 Variant Derived from Clade 19B, France.	2021-04-27 00:00:00	n.1
40	2021.02.16.431437	Phase transitions may explain why SARS-CoV-2 spreads so fast and why new variants are spreading faster	2021-02-17 00:00:00	b.1.1.7
40	2021.02.16.431437	Phase transitions may explain why SARS-CoV-2 spreads so fast and why new variants are spreading faster	2021-02-17 00:00:00	b.1.351
65	2021.04.07.438871	Machine Learning Identifies Ponatinib as a Potent Inhibitor of SARS-CoV2-induced Cytokine Storm	2021-04-09 00:00:00	b.1.351
51	2021.03.22.436481	Neutralization of European, South African, and United States SARS-CoV-2 mutants by a human antibody and antibody domains	2021-03-23 00:00:00	b.1.1.7
32	pmid33894127	A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection.	2021-03-26 00:00:00	b.1.1.7
32	pmid33894127	A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection.	2021-03-26 00:00:00	b.1.351
59	pmid33663644	Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021.	2021-03-08 00:00:00	b.1.1.7
59	pmid33663644	Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021.	2021-03-08 00:00:00	variant of concern 202012/01
29	pmid32837841	Phenomenon of depression and anxiety related to precautions for prevention among population during the outbreak of COVID-19 in Kurdistan Region of Iraq: based on questionnaire survey.	2020-09-28 00:00:00	v.2
38	pmid33072699	Geographical Distribution of Genetic Variants and Lineages of SARS-CoV-2 in Chile.	2020-10-22 00:00:00	b.1
16	2021.02.09.430519	Transformations, Comparisons, and Analysis of Down to Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein Including the UK Variant B.1.1.7	2021-02-09 00:00:00	uk variant
16	2021.02.09.430519	Transformations, Comparisons, and Analysis of Down to Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein Including the UK Variant B.1.1.7	2021-02-09 00:00:00	b.1.1.7
16	2021.02.09.430519	Transformations, Comparisons, and Analysis of Down to Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein Including the UK Variant B.1.1.7	2021-02-09 00:00:00	b.1.351
51	pmid32393088	Response to Wang et al., Virtual Reality as a Bridge in Palliative Care during COVID-19 (DOI: 10.1089/jpm.2020.0212).	2020-07-07 00:00:00	m.2
26	2021.03.22.436427	Replicative fitness SARS-CoV-2 20I/501Y.V1 variant in a human reconstituted bronchial epithelium	2021-03-22 00:00:00	lineage b.1.1.7
26	2021.03.22.436427	Replicative fitness SARS-CoV-2 20I/501Y.V1 variant in a human reconstituted bronchial epithelium	2021-03-22 00:00:00	b.1.1.7 lineage
38	2020.08.25.20182105	DNA Methylation Architecture of the ACE2 gene in Nasal Cells	2020-08-31 00:00:00	y.1
32	pmid33614100	Analysing the impact of global demographic characteristics over the COVID-19 spread using class rule mining and pattern matching.	2021-02-23 00:00:00	variant of concern 202012/01
77	2021.03.03.21252706	Model-based evaluation of transmissibility and reinfection for the P.1 variant of the SARS-CoV-2	2021-03-05 00:00:00	p.1 variant
77	2021.03.03.21252706	Model-based evaluation of transmissibility and reinfection for the P.1 variant of the SARS-CoV-2	2021-03-05 00:00:00	p.1
77	2021.03.03.21252706	Model-based evaluation of transmissibility and reinfection for the P.1 variant of the SARS-CoV-2	2021-03-05 00:00:00	variant p.1
51	pmid33680474	Severe acute respiratory syndrome coronavirus 2 may exploit human transcription factors involved in retinoic acid and interferon-mediated response: a hypothesis supported by an in-silico analysis.	2021-02-22 00:00:00	p.1 variant
43	2021.04.27.21254849	Local emergence and decline of a SARS-CoV-2 variant with mutations L452R and N501Y in the spike protein	2021-04-29 00:00:00	a.27
43	2021.04.27.21254849	Local emergence and decline of a SARS-CoV-2 variant with mutations L452R and N501Y in the spike protein	2021-04-29 00:00:00	b.1.1.7
72	pmid33778795	Phylogenomic analysis of COVID-19 summer and winter outbreaks in Hong Kong: An observational study.	2021-03-01 00:00:00	b.1.1.63
72	pmid33778795	Phylogenomic analysis of COVID-19 summer and winter outbreaks in Hong Kong: An observational study.	2021-03-01 00:00:00	b.1.36.2
51	2021.02.20.21251598	A statewide analysis of SARS-CoV-2 transmission in New York	2021-02-27 00:00:00	b.1
79	2021.03.16.21253377	First and second SARS-CoV-2 waves in inner London: A comparison of admission characteristics and the effects of the B.1.1.7 variant	2021-03-24 00:00:00	b.1.1.7
93	2020.12.22.423920	Evolutionary tracking of SARS-CoV-2 genetic variants highlights intricate balance of stabilizing and destabilizing mutations	2020-12-22 00:00:00	b.1
93	2020.12.22.423920	Evolutionary tracking of SARS-CoV-2 genetic variants highlights intricate balance of stabilizing and destabilizing mutations	2020-12-22 00:00:00	b.1.1
93	2020.12.22.423920	Evolutionary tracking of SARS-CoV-2 genetic variants highlights intricate balance of stabilizing and destabilizing mutations	2020-12-22 00:00:00	b.1.2
93	2020.12.22.423920	Evolutionary tracking of SARS-CoV-2 genetic variants highlights intricate balance of stabilizing and destabilizing mutations	2020-12-22 00:00:00	b.1.3
22	pmid33835617	Ribonucleic acid (RNA) COVID-19 vaccine associated cutaneous adverse drug events: a case series of two patients.	2021-04-09 00:00:00	r.1
49	2021.01.13.426571	Using image-based haplotype alignments to map global adaptation of SARS-CoV-2	2021-01-13 00:00:00	b.1.177
49	2021.01.13.426571	Using image-based haplotype alignments to map global adaptation of SARS-CoV-2	2021-01-13 00:00:00	b.1.1.7
54	pmid33507805	The Pandemic and the Supply Chain: Gaps in Pharmaceutical Production and Distribution.	2021-01-28 00:00:00	s.1
44	pmid33868743	COVID-19 and mutations a threat level assessment.	2021-03-25 00:00:00	b.1.1.7
44	pmid33868743	COVID-19 and mutations a threat level assessment.	2021-03-25 00:00:00	south african variant
44	pmid33868743	COVID-19 and mutations a threat level assessment.	2021-03-25 00:00:00	b.1.35
44	pmid33868743	COVID-19 and mutations a threat level assessment.	2021-03-25 00:00:00	brazilian variant
44	pmid33868743	COVID-19 and mutations a threat level assessment.	2021-03-25 00:00:00	p.1
44	pmid33868743	COVID-19 and mutations a threat level assessment.	2021-03-25 00:00:00	b.1.526
44	pmid33868743	COVID-19 and mutations a threat level assessment.	2021-03-25 00:00:00	b.1.351
2	pmid33723411	Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.	2021-03-16 00:00:00	lineage b.1.1.7
2	pmid33723411	Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.	2021-03-16 00:00:00	b.1.1.7
8	2020.09.04.20184523	MOLECULAR EPIDEMIOLOGY TO UNDERSTAND THE SARS-CoV-2 EMERGENCE IN THE BRAZILIAN AMAZON REGION	2020-09-07 00:00:00	b.1
8	2020.09.04.20184523	MOLECULAR EPIDEMIOLOGY TO UNDERSTAND THE SARS-CoV-2 EMERGENCE IN THE BRAZILIAN AMAZON REGION	2020-09-07 00:00:00	b.1.1
37	pmid33664494	Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies.	2021-03-09 00:00:00	b.1.1.7
74	pmid32950703	"Answer to Vieira et al. ""Cytokine profile as a prognostic tool in coronavirus disease 2019"". Joint Bone Spine 2020. Doi:10.1016/j.jbspin.2020.09.006."	2020-10-10 00:00:00	n.2
8	2020.09.09.289074	Structural Genetics of circulating variants affecting the SARS CoV-2 Spike / human ACE2 complex	2020-09-09 00:00:00	lineage b.1.1.7
38	2021.03.04.21252928	Rapid detection of SARS-CoV-2 variants of concern identifying a cluster of B.1.1.28/P.1 variant in British Columbia, Canada	2021-03-12 00:00:00	b.1.1
38	2021.03.04.21252928	Rapid detection of SARS-CoV-2 variants of concern identifying a cluster of B.1.1.28/P.1 variant in British Columbia, Canada	2021-03-12 00:00:00	p.1
38	2021.03.04.21252928	Rapid detection of SARS-CoV-2 variants of concern identifying a cluster of B.1.1.28/P.1 variant in British Columbia, Canada	2021-03-12 00:00:00	b.1.1.7
38	2021.03.04.21252928	Rapid detection of SARS-CoV-2 variants of concern identifying a cluster of B.1.1.28/P.1 variant in British Columbia, Canada	2021-03-12 00:00:00	b.1.35
24	2021.04.01.21254484	A Rapid SARS-CoV-2 Variant Detection by Molecular-Clamping Based RT-qPCR	2021-04-05 00:00:00	uk variant
24	2021.04.01.21254484	A Rapid SARS-CoV-2 Variant Detection by Molecular-Clamping Based RT-qPCR	2021-04-05 00:00:00	b.1.1.7
42	2021.02.14.21251708	Impact of January 2021 social distancing measures on SARS-CoV-2 B.1.1.7 circulation in France	2021-02-16 00:00:00	b.1.1.7
49	figshare12610828	Reviewer_2_v.1 – Supplemental material for C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis	2020-07-04 00:00:00	v.1
75	pmid32931711	Reply to: Anti-FXa Activity with Intermediate Dose Thromboprophylaxis in COVID-19.	2020-09-15 00:00:00	m.2
63	2021.03.20.436243	A bispecific monomeric nanobody induces SARS-COV-2 spike trimer dimers	2021-03-21 00:00:00	b.1.351 variant
70	pmid33767447	Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.	2021-03-26 00:00:00	lineage b.1.1.7
70	pmid33767447	Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.	2021-03-26 00:00:00	variant of concern 202012/01
70	pmid33767447	Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.	2021-03-26 00:00:00	b.1.1.7 lineage
0	2021.02.03.429522	Knowledge and Awareness of coronavirus disease 2019 (COVID-19) among Chinese dental students----a comparison study.	2021-02-03 00:00:00	s.1
24	2021.01.12.20249080	Early Analysis of a potential link between viral load and the N501Y mutation in the SARS-COV-2 spike protein	2021-01-15 00:00:00	lineage b.1.1.7
24	2021.01.12.20249080	Early Analysis of a potential link between viral load and the N501Y mutation in the SARS-COV-2 spike protein	2021-01-15 00:00:00	vui-202012/01
33	pmid32449668	"[Letter to the Editor about the Article: ""Excess Mortality Estimation During the COVID-19 Pandemic: Preliminary Data from Portugal https://doi.org/10.20344/amp.13928""]."	2020-11-18 00:00:00	p.1
24	2021.03.25.21254289	On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe	2021-03-28 00:00:00	b.1.1.7
13	2021.04.04.21254881	Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serum	2021-04-09 00:00:00	b.1.1.7
13	2021.04.04.21254881	Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serum	2021-04-09 00:00:00	b.1.351
70	pmid33199402	Venous thromboembolism in patients with COVID-19 and correlation with D-dimers: a single-centre experience.	2020-10-23 00:00:00	v.1
76	2021.03.11.21253409	Metagenomic sequencing of municipal wastewater provides a near-complete SARS-CoV-2 genome sequence identified as the B.1.1.7 variant of concern from a Canadian municipality concurrent with an outbreak	2021-03-17 00:00:00	b.1.1.7
36	2021.03.16.435594	Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants	2021-03-16 00:00:00	b.1.1.7
36	2021.03.16.435594	Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants	2021-03-16 00:00:00	b.1.351
36	2021.03.16.435594	Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants	2021-03-16 00:00:00	p.1
36	2021.03.16.435594	Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants	2021-03-16 00:00:00	b.1.351 variant
84	pmid33728228	Stay-At-Home Orders Are Associated With Emergence of Novel SARS-CoV-2 Variants.	2021-03-18 00:00:00	p.1
86	pmid32396400	RETRACTED: No deleterious effect of lockdown due to COVID-19 pandemic on glycaemic control, measured by glucose monitoring, in adults with type 1 diabetes.	2020-08-12 00:00:00	a.2
54	2021.03.26.437274	Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants	2021-03-27 00:00:00	b.1.1.7
54	2021.03.26.437274	Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants	2021-03-27 00:00:00	b.1.351
54	2021.03.26.437274	Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants	2021-03-27 00:00:00	p.1 variant
90	pmid33252670	SARS-CoV-2 Among Military and Civilian Patients, Metro Manila, Philippines.	2020-10-30 00:00:00	b.6
92	2021.04.21.21255889	Evaluation of Different Types of Face Masks to Limit the Spread of SARS CoV 2, A Modeling Study	2021-04-27 00:00:00	b.1.1.7
74	2020.03.12.989186	Nucleotide Analogues as Inhibitors of SARS-CoV Polymerase	2020-03-14 00:00:00	y.1
89	pmid33835709	SARS-CoV-2 outbreak in Iran; the dynamics of the epidemic and evidence on two independent introductions.	2021-04-09 00:00:00	b.4
89	pmid33835709	SARS-CoV-2 outbreak in Iran; the dynamics of the epidemic and evidence on two independent introductions.	2021-04-09 00:00:00	b.1
1	zenodo.4624269	Oxadiazoles for Covid-19?	2021-03-19 00:00:00	b.20
55	2021.04.02.21254818	Covid-19 does not look like what you are looking for: clustering symptoms by nation and multi- morbidities reveal substantial differences to the classical symptom triad	2021-04-07 00:00:00	s.1
98	pmid33514629	Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.	2021-01-30 00:00:00	lineage b.1.1.7
98	pmid33514629	Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.	2021-01-30 00:00:00	b.1.1.7
98	pmid33514629	Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.	2021-01-30 00:00:00	b.1.1.7 lineage
10	pmid33542443	Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection.	2021-02-16 00:00:00	b.6
93	pmid33853975	Identification of B.1.346 Lineage of SARS-CoV-2 in Japan: Genomic Evidence of Re-entry of Clade 20C.	2021-04-15 00:00:00	b.1.346
93	pmid33853975	Identification of B.1.346 Lineage of SARS-CoV-2 in Japan: Genomic Evidence of Re-entry of Clade 20C.	2021-04-15 00:00:00	b.1.1.284
93	pmid33853975	Identification of B.1.346 Lineage of SARS-CoV-2 in Japan: Genomic Evidence of Re-entry of Clade 20C.	2021-04-15 00:00:00	b.1.1
22	2021.02.17.431683	Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016	2021-02-22 00:00:00	b.1.351
22	2021.02.17.431683	Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016	2021-02-22 00:00:00	p.1
22	2021.02.17.431683	Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016	2021-02-22 00:00:00	b.1.429
44	2020.06.17.20134098	SEROPREVALENCE AND CLINICAL SPECTRUM OF SARS-CoV-2 INFECTION IN THE FIRST VERSUS THIRD TRIMESTER OF PREGNANCY	2020-06-19 00:00:00	a.5
44	2020.06.17.20134098	SEROPREVALENCE AND CLINICAL SPECTRUM OF SARS-CoV-2 INFECTION IN THE FIRST VERSUS THIRD TRIMESTER OF PREGNANCY	2020-06-19 00:00:00	r.1
44	2020.06.17.20134098	SEROPREVALENCE AND CLINICAL SPECTRUM OF SARS-CoV-2 INFECTION IN THE FIRST VERSUS THIRD TRIMESTER OF PREGNANCY	2020-06-19 00:00:00	m.1
38	2021.02.16.21251535	Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2	2021-02-19 00:00:00	b.1.1.7
38	pmid33049069	Analysis of SARS-CoV-2 mutations in Mexico, Belize, and isolated regions of Guatemala and its implication in the diagnosis.	2020-09-15 00:00:00	v.1
5	2020.11.16.20229047	Two independent introductions of SARS-CoV-2 into the Iranian outbreak	2020-11-20 00:00:00	b.4
5	2020.11.16.20229047	Two independent introductions of SARS-CoV-2 into the Iranian outbreak	2020-11-20 00:00:00	b.1
25	pmid33716085	Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants.	2021-02-23 00:00:00	south african variant
2	2021.04.27.21255706	Surging COVID-19 in Bangladesh driven by B.1.351 variant	2021-04-29 00:00:00	b.1.351 variant
2	2021.04.27.21255706	Surging COVID-19 in Bangladesh driven by B.1.351 variant	2021-04-29 00:00:00	b.1.351
9	2021.02.13.21251678	Characterization of SARS-CoV-2 genetic structure and infection clusters in a large German city based on integrated genomic surveillance, outbreak analysis, and contact tracing	2021-02-18 00:00:00	b.1.1.7
9	2021.02.13.21251678	Characterization of SARS-CoV-2 genetic structure and infection clusters in a large German city based on integrated genomic surveillance, outbreak analysis, and contact tracing	2021-02-18 00:00:00	b.1.351
51	2021.02.12.431018	HaVoC, a bioinformatic pipeline for reference-based consensus assembly and lineage assignment for SARS-CoV-2 sequences	2021-02-15 00:00:00	uk variant
51	2021.02.12.431018	HaVoC, a bioinformatic pipeline for reference-based consensus assembly and lineage assignment for SARS-CoV-2 sequences	2021-02-15 00:00:00	b.1.1.7
51	2021.02.12.431018	HaVoC, a bioinformatic pipeline for reference-based consensus assembly and lineage assignment for SARS-CoV-2 sequences	2021-02-15 00:00:00	south african variant
51	2021.02.12.431018	HaVoC, a bioinformatic pipeline for reference-based consensus assembly and lineage assignment for SARS-CoV-2 sequences	2021-02-15 00:00:00	brazilian variant
51	2021.02.12.431018	HaVoC, a bioinformatic pipeline for reference-based consensus assembly and lineage assignment for SARS-CoV-2 sequences	2021-02-15 00:00:00	p.1
75	2020.06.10.20127423	Serology-informed estimates of SARS-COV-2 infection fatality risk in Geneva, Switzerland	2020-06-12 00:00:00	s.1
27	2020.02.27.967760	The ACE2 expression of maternal-fetal interface and fetal organs indicates potential risk of vertical transmission of SARS-COV-2	2020-02-27 00:00:00	l.2
63	2021.02.22.432357	Experimental evidence for enhanced receptor binding by rapidly spreading SARS-CoV-2 variants	2021-02-22 00:00:00	lineage b.1.1.7
63	2021.02.22.432357	Experimental evidence for enhanced receptor binding by rapidly spreading SARS-CoV-2 variants	2021-02-22 00:00:00	b.1.35
63	2021.02.22.432357	Experimental evidence for enhanced receptor binding by rapidly spreading SARS-CoV-2 variants	2021-02-22 00:00:00	b.1.351
84	2021.01.12.426365	The lethal triad: SARS-CoV-2 Spike, ACE2 and TMPRSS2. Mutations in host and pathogen may affect the course of pandemic.	2021-01-14 00:00:00	b.1.1.7
5	2021.04.09.439166	Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques	2021-04-10 00:00:00	b.1.351
15	2021.03.04.21252557	Genome sequencing and detection of Philippine SARS-CoV-2 infections with viruses classified under the B.1.1.7 lineage	2021-03-08 00:00:00	b.1.1.7 lineage
23	pmid32798760	Management of urology during COVID-19 pandemic: A perspective from Sichuan Province, China.	2020-08-04 00:00:00	c.2
23	pmid32798760	Management of urology during COVID-19 pandemic: A perspective from Sichuan Province, China.	2020-08-04 00:00:00	b.1.2
51	2021.01.27.428478	Early therapy with remdesivir and antibody combinations improves COVID-19 disease in mice	2021-01-28 00:00:00	b.1.351 variant
18	2021.02.17.431492	SARS-CoV-2 vaccination induces neutralizing antibodies against pandemic and pre-emergent SARS-related coronaviruses in monkeys	2021-02-17 00:00:00	b.1.1.7
17	2021.03.05.21252709	A Simple RT-PCR Melting temperature Assay to Rapidly Screen for Widely Circulating SARS-CoV-2 Variants.	2021-03-08 00:00:00	b.1.1.7
17	2021.03.05.21252709	A Simple RT-PCR Melting temperature Assay to Rapidly Screen for Widely Circulating SARS-CoV-2 Variants.	2021-03-08 00:00:00	p.1
17	2021.03.05.21252709	A Simple RT-PCR Melting temperature Assay to Rapidly Screen for Widely Circulating SARS-CoV-2 Variants.	2021-03-08 00:00:00	b.1.427
17	2021.03.05.21252709	A Simple RT-PCR Melting temperature Assay to Rapidly Screen for Widely Circulating SARS-CoV-2 Variants.	2021-03-08 00:00:00	b.1.1
17	2021.03.05.21252709	A Simple RT-PCR Melting temperature Assay to Rapidly Screen for Widely Circulating SARS-CoV-2 Variants.	2021-03-08 00:00:00	b.1.351 variant
40	2021.03.30.437622	Rapid characterization of spike variants via mammalian cell surface display	2021-03-30 00:00:00	b.1.1.7
40	2021.03.30.437622	Rapid characterization of spike variants via mammalian cell surface display	2021-03-30 00:00:00	b.1.351
40	2021.03.30.437622	Rapid characterization of spike variants via mammalian cell surface display	2021-03-30 00:00:00	b.1.1.248
40	2021.03.30.437622	Rapid characterization of spike variants via mammalian cell surface display	2021-03-30 00:00:00	b.1.427
40	2021.03.30.437622	Rapid characterization of spike variants via mammalian cell surface display	2021-03-30 00:00:00	b.1.429
34	2021.03.25.21254324	Droplet Digital RT-PCR to detect SARS-CoV-2 variants of concern in wastewater.	2021-03-26 00:00:00	lineage b.1.351
34	2021.03.25.21254324	Droplet Digital RT-PCR to detect SARS-CoV-2 variants of concern in wastewater.	2021-03-26 00:00:00	b.1.1.7
66	2021.01.28.21250577	Effect of RBD (Y453F) mutation in spike glycoprotein of SARS-CoV-2 on neutralizing IgG affinity.	2021-02-01 00:00:00	b.1.1.7
66	2021.01.28.21250577	Effect of RBD (Y453F) mutation in spike glycoprotein of SARS-CoV-2 on neutralizing IgG affinity.	2021-02-01 00:00:00	b.1.351
66	2021.01.28.21250577	Effect of RBD (Y453F) mutation in spike glycoprotein of SARS-CoV-2 on neutralizing IgG affinity.	2021-02-01 00:00:00	b.1.1.248
6	pmid32761908	The arrival and spread of SARS-CoV-2 in Colombia.	2020-07-31 00:00:00	b.1
15	2021.05.03.441080	Human organoid systems reveal in vitro correlates of fitness for SARS-CoV-2 B.1.1.7	2021-05-03 00:00:00	b.1.1.7
15	2021.05.03.441080	Human organoid systems reveal in vitro correlates of fitness for SARS-CoV-2 B.1.1.7	2021-05-03 00:00:00	british variant
60	pmid33815186	Mood Disorder in Cancer Patients Undergoing Radiotherapy During the COVID-19 Outbreak.	2021-04-06 00:00:00	v.2
93	pmid33126993	Protecting Youth Mental Health During the COVID-19 Pandemic: A Challenging Engagement and Learning Process.	2020-08-10 00:00:00	n.1
97	pmid32937868	Spatio-Temporal Mutational Profile Appearances of Swedish SARS-CoV-2 during the Early Pandemic.	2020-09-11 00:00:00	b.1.1
97	pmid32937868	Spatio-Temporal Mutational Profile Appearances of Swedish SARS-CoV-2 during the Early Pandemic.	2020-09-11 00:00:00	b.1
72	pmid33690207	A straightforward molecular strategy to retrospectively investigate the spread of SARS-CoV-2 VOC202012/01 B.1.1.7 variant.	2021-03-12 00:00:00	b.1.1.7
72	pmid33690207	A straightforward molecular strategy to retrospectively investigate the spread of SARS-CoV-2 VOC202012/01 B.1.1.7 variant.	2021-03-12 00:00:00	lineage b.1.1.7
22	2021.03.19.21253620	SARS-CoV-2 genome sequencing from COVID-19 in Ecuadorian patients: a whole country analysis.	2021-03-24 00:00:00	b.1.1.119
22	2021.03.19.21253620	SARS-CoV-2 genome sequencing from COVID-19 in Ecuadorian patients: a whole country analysis.	2021-03-24 00:00:00	b.1.1.7 lineage
22	2021.03.19.21253620	SARS-CoV-2 genome sequencing from COVID-19 in Ecuadorian patients: a whole country analysis.	2021-03-24 00:00:00	b.1.1.7
47	2021.04.06.438540	TMPRSS2 and RNA-dependent RNA polymerase are effective targets of therapeutic intervention for treatment of COVID-19 caused by SARS-CoV-2 variants (B.1.1.7 and B.1.351)	2021-04-08 00:00:00	b.1.1.7
47	2021.04.06.438540	TMPRSS2 and RNA-dependent RNA polymerase are effective targets of therapeutic intervention for treatment of COVID-19 caused by SARS-CoV-2 variants (B.1.1.7 and B.1.351)	2021-04-08 00:00:00	b.1.351
47	2021.04.06.438540	TMPRSS2 and RNA-dependent RNA polymerase are effective targets of therapeutic intervention for treatment of COVID-19 caused by SARS-CoV-2 variants (B.1.1.7 and B.1.351)	2021-04-08 00:00:00	lineage b.1.1.7
47	2021.04.06.438540	TMPRSS2 and RNA-dependent RNA polymerase are effective targets of therapeutic intervention for treatment of COVID-19 caused by SARS-CoV-2 variants (B.1.1.7 and B.1.351)	2021-04-08 00:00:00	lineage b.1.351
23	2021.03.26.21253712	A Novel Diagnostic Test to Screen SARS-CoV-2 Variants Containing E484K and N501Y Mutations	2021-03-29 00:00:00	b.1.351
23	2021.03.26.21253712	A Novel Diagnostic Test to Screen SARS-CoV-2 Variants Containing E484K and N501Y Mutations	2021-03-29 00:00:00	p.1 variant
12	2021.01.18.427166	SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma	2021-01-19 00:00:00	b.1.35
28	pmid33639175	SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: prospective, national observational cohort surveillance, July-December 2020, England.	2021-03-04 00:00:00	b.1.1.7
24	pmid33784237	Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, in British Columbia, Canada.	2021-03-30 00:00:00	b.1.1
24	pmid33784237	Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, in British Columbia, Canada.	2021-03-30 00:00:00	p.1
24	pmid33784237	Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, in British Columbia, Canada.	2021-03-30 00:00:00	b.1.1.7
24	pmid33784237	Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, in British Columbia, Canada.	2021-03-30 00:00:00	b.1.351
45	2021.04.19.21255673	Modelling to inform the COVID-19 response in Bangladesh	2021-04-22 00:00:00	b.1.351 variant
63	pmid33861846	Down but far from out: The durability of SARS-CoV-2 immunity after asymptomatic infection.	2021-04-26 00:00:00	m.2
8	pmid33888533	Modelling the impact of the tier system on SARS-CoV-2 transmission in the UK between the first and second national lockdowns.	2021-04-23 00:00:00	b.1.1.7
56	pmid33519315	Corrigendum to Postgraduate Inpatient Training in the Time COVID-19.	2021-02-01 00:00:00	a.2
8	2021.03.25.437035	Computational assessment of the spike protein antigenicity reveals diversity in B cell epitopes but stability in T cell epitopes across SARS-CoV-2 variants	2021-03-25 00:00:00	b.1.1.7
8	2021.03.25.437035	Computational assessment of the spike protein antigenicity reveals diversity in B cell epitopes but stability in T cell epitopes across SARS-CoV-2 variants	2021-03-25 00:00:00	b.1.351
8	2021.03.25.437035	Computational assessment of the spike protein antigenicity reveals diversity in B cell epitopes but stability in T cell epitopes across SARS-CoV-2 variants	2021-03-25 00:00:00	p.1
8	2021.03.25.437035	Computational assessment of the spike protein antigenicity reveals diversity in B cell epitopes but stability in T cell epitopes across SARS-CoV-2 variants	2021-03-25 00:00:00	b.1.429
8	2021.03.25.437035	Computational assessment of the spike protein antigenicity reveals diversity in B cell epitopes but stability in T cell epitopes across SARS-CoV-2 variants	2021-03-25 00:00:00	b.1.351 lineage
8	2021.03.25.437035	Computational assessment of the spike protein antigenicity reveals diversity in B cell epitopes but stability in T cell epitopes across SARS-CoV-2 variants	2021-03-25 00:00:00	p.1 variant
41	2021.03.27.21253966	Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR	2021-03-29 00:00:00	b.1.1.7
41	2021.03.27.21253966	Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR	2021-03-29 00:00:00	s.1
72	pmid33478625	Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020.	2021-02-01 00:00:00	variant of concern 202012/01
16	2021.02.25.432969	Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants	2021-02-26 00:00:00	b.1.1.7
16	2021.02.25.432969	Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants	2021-02-26 00:00:00	b.1.351
27	2020.12.14.422555	Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/V70	2020-12-14 00:00:00	b.1.1.7
20	2021.02.10.21251540	Early introductions and community transmission of SARS-CoV-2 variant B.1.1.7 in the United States	2021-02-15 00:00:00	b.1.1.7
20	2021.02.10.21251540	Early introductions and community transmission of SARS-CoV-2 variant B.1.1.7 in the United States	2021-02-15 00:00:00	lineage b.1.1.7
84	2021.03.12.434969	A potential SARS-CoV-2 variant of interest (VOI) harboring mutation E484K in the Spike protein was identified within lineage B.1.1.33 circulating in Brazil	2021-03-13 00:00:00	b.1.1
84	2021.03.12.434969	A potential SARS-CoV-2 variant of interest (VOI) harboring mutation E484K in the Spike protein was identified within lineage B.1.1.33 circulating in Brazil	2021-03-13 00:00:00	p.1
84	2021.03.12.434969	A potential SARS-CoV-2 variant of interest (VOI) harboring mutation E484K in the Spike protein was identified within lineage B.1.1.33 circulating in Brazil	2021-03-13 00:00:00	p.2
84	2021.03.12.434969	A potential SARS-CoV-2 variant of interest (VOI) harboring mutation E484K in the Spike protein was identified within lineage B.1.1.33 circulating in Brazil	2021-03-13 00:00:00	lineage b.1.1.28
84	2021.03.12.434969	A potential SARS-CoV-2 variant of interest (VOI) harboring mutation E484K in the Spike protein was identified within lineage B.1.1.33 circulating in Brazil	2021-03-13 00:00:00	lineage p.1
84	2021.03.12.434969	A potential SARS-CoV-2 variant of interest (VOI) harboring mutation E484K in the Spike protein was identified within lineage B.1.1.33 circulating in Brazil	2021-03-13 00:00:00	n.9
39	2021.03.16.21253753	Rapid, widespread, and preferential increase of SARS-CoV-2 B.1.1.7 variant in Houston, TX, revealed by 8,857 genome sequences	2021-03-24 00:00:00	b.1.1.7
47	2021.01.25.21250447	Molecular epidemiology of SARS-CoV-2 - a regional to global perspective	2021-01-26 00:00:00	b.1.1.7
47	2021.01.25.21250447	Molecular epidemiology of SARS-CoV-2 - a regional to global perspective	2021-01-26 00:00:00	b.1.351
73	zenodo.4579857	Increased mortality in community-tested cases of  SARS-CoV-2 lineage B.1.1.7	2021-03-04 00:00:00	lineage b.1.1.7
73	zenodo.4579857	Increased mortality in community-tested cases of  SARS-CoV-2 lineage B.1.1.7	2021-03-04 00:00:00	b.1.1.7
81	pmid33193462	Corrigendum: Interferon-α2b Treatment for COVID-19.	2020-11-16 00:00:00	u.2
29	pmid33581746	Public health actions to control new SARS-CoV-2 variants.	2021-02-18 00:00:00	b.1.1.7
0	pmid33834573	Anesthesia and surgery for positive COVID-19 asymptomatic pediatric patients: how long should we wait?	2021-04-09 00:00:00	g.1
95	2021.01.23.427885	Variation analysis of SARS-CoV-2 complete sequences from Iran	2021-01-24 00:00:00	b.4
95	2021.01.23.427885	Variation analysis of SARS-CoV-2 complete sequences from Iran	2021-01-24 00:00:00	b.1
95	2021.01.23.427885	Variation analysis of SARS-CoV-2 complete sequences from Iran	2021-01-24 00:00:00	b.1.36
35	pmid33585890	A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in COVID-19 patients with Regular Intravenous Immunoglobulin Therapy.	2021-02-15 00:00:00	s.1
45	pmid33191269	Knowledge level and factors influencing prevention of COVID-19 pandemic among residents of Dessie and Kombolcha City administrations, North-East Ethiopia: a population-based cross-sectional study.	2020-11-19 00:00:00	v.2
26	pmid33520657	"Corrigendum to ""A fatal case of COVID-19 due to metabolic acidosis following dysregulate inflammatory response (cytokine storm)"" [ID Cases 21 (2020) e00829]."	2021-02-01 00:00:00	r.2
27	pmid32673759	The American College of Surgeons Responds to COVID-19.	2020-06-19 00:00:00	s.1
37	pmid33693754	First Report of SARS-CoV-2 B.1.1.251 Lineage in Brazil.	2021-02-23 00:00:00	b.1.1.251
68	pmid33519033	"Corrigendum to ""Learning from past pandemic governance: Early response and public-private partnerships in testing of COVID-19 in South Korea"" [World Development 137 (2021) 105198]."	2021-02-01 00:00:00	v.2
75	2021.02.07.429299	A human antibody with blocking activity to RBD proteins of multiple SARS-CoV-2 variants including B.1.351 showed potent prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus macaques	2021-02-07 00:00:00	b.1.351
41	2021.04.15.21255510	More than a year after the onset of the CoVid-19 pandemic in the UK: lessons learned from a minimalistic model capturing essential features including social awareness and policy making	2021-04-16 00:00:00	uk variant
43	pmid32315725	Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.	2021-02-23 00:00:00	r.2
54	2021.02.22.21252235	Estimating the spreading and dominance of SARS-CoV-2 VOC 202012/01 (lineage B.1.1.7) across Europe	2021-02-23 00:00:00	lineage b.1.1.7
54	2021.02.22.21252235	Estimating the spreading and dominance of SARS-CoV-2 VOC 202012/01 (lineage B.1.1.7) across Europe	2021-02-23 00:00:00	b.1.1.7
97	2021.03.17.21253775	Estimating the increased transmissibility of the B.1.1.7 strain over previously circulating strains in England using fractions of GISAID sequences and the distribution of serial intervals	2021-03-17 00:00:00	b.1.1.7
7	pmid33772259	Phylogenetic analyses of SARS-CoV-2 B.1.1.7 lineage suggest a single origin followed by multiple exportation events versus convergent evolution.	2021-03-27 00:00:00	b.1.1.7 lineage
7	pmid33772259	Phylogenetic analyses of SARS-CoV-2 B.1.1.7 lineage suggest a single origin followed by multiple exportation events versus convergent evolution.	2021-03-27 00:00:00	b.1.1.7
67	pmid33807556	Molecular Analysis of SARS-CoV-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level.	2021-03-03 00:00:00	uk variant
67	pmid33807556	Molecular Analysis of SARS-CoV-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level.	2021-03-03 00:00:00	b.1.1.31
67	pmid33807556	Molecular Analysis of SARS-CoV-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level.	2021-03-03 00:00:00	b.1.36
67	pmid33807556	Molecular Analysis of SARS-CoV-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level.	2021-03-03 00:00:00	b.1.1.7
67	pmid33807556	Molecular Analysis of SARS-CoV-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level.	2021-03-03 00:00:00	b.1.1.7 lineage
81	pmid33841880	Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2.	2021-03-04 00:00:00	c.1
59	pmid33035675	First COVID-19 Case in Zambia - Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries.	2020-09-29 00:00:00	b.1.1
59	pmid33035675	First COVID-19 Case in Zambia - Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries.	2020-09-29 00:00:00	b.1
34	pmid32837147	Performing an urgent neonatal cardiac intervention safely during the COVID-19 pandemic.	2020-06-18 00:00:00	n.2
19	2021.04.12.21255084	Reliability of Spike Gene Target Failure for ascertaining SARS-CoV-2 lineage B.1.1.7 prevalence in a hospital setting	2021-04-14 00:00:00	lineage b.1.1.7
45	pmid33332472	Genomic epidemiology reveals multiple introductions and spread of SARS-CoV-2 in the Indian state of Karnataka.	2020-12-21 00:00:00	b.1
45	pmid33332472	Genomic epidemiology reveals multiple introductions and spread of SARS-CoV-2 in the Indian state of Karnataka.	2020-12-21 00:00:00	b.1.8
45	pmid33332472	Genomic epidemiology reveals multiple introductions and spread of SARS-CoV-2 in the Indian state of Karnataka.	2020-12-21 00:00:00	b.1.1
45	pmid33332472	Genomic epidemiology reveals multiple introductions and spread of SARS-CoV-2 in the Indian state of Karnataka.	2020-12-21 00:00:00	b.4
45	pmid33332472	Genomic epidemiology reveals multiple introductions and spread of SARS-CoV-2 in the Indian state of Karnataka.	2020-12-21 00:00:00	b.6
65	2021.03.09.21253242	Environmental drivers of SARS-CoV-2 lineage B.1.1.7 transmission in England, October to December 2020	2021-03-12 00:00:00	lineage b.1.1.7
65	2021.03.09.21253242	Environmental drivers of SARS-CoV-2 lineage B.1.1.7 transmission in England, October to December 2020	2021-03-12 00:00:00	b.1.1.7
8	2020.12.24.20248814	S gene dropout patterns in SARS-CoV-2 tests suggest spread of the H69del/V70del mutation in the US.	2020-12-30 00:00:00	b.1.1.7
12	pmid33507802	Improving the Fate of Nursing Homes During the COVID-19 Pandemic: The Need for Policy.	2021-01-28 00:00:00	s.1
29	pmid33638924	Herpes Zoster Following Inactivated COVID-19 Vaccine: a Coexistence or Coincidence?	2021-02-27 00:00:00	s.1
51	pmid33706364	Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.	2021-03-11 00:00:00	b.1.1.7
96	pmid33475211	Parent-Reported Hesitancy to seek emergency Care for Children at the Crest of the first Wave of COVID-19 in chicago.	2021-01-21 00:00:00	s.1
53	2020.07.22.20160341	Effects of non-pharmaceutical interventions on COVID-19: A Tale of Two Models	2020-07-27 00:00:00	al.1
89	2021.03.17.21253131	Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines	2021-03-17 00:00:00	b.1.1.7
16	2021.04.19.440435	SARS-CoV-2 20I/501Y.V1 variant in the hamster model	2021-04-19 00:00:00	lineage b.1.1.7
42	pmid33853970	Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.	2021-04-21 00:00:00	p.1
42	pmid33853970	Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.	2021-04-21 00:00:00	lineage p.1
64	2020.12.30.20249034	Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data	2021-01-04 00:00:00	lineage b.1.1.7
64	2020.12.30.20249034	Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data	2021-01-04 00:00:00	variant of concern 202012/01
63	pmid33872395	Non-surgical Cosmetic Practice and COVID.	2021-04-19 00:00:00	m.1
96	2021.03.02.21252290	HiSpike: A high-throughput cost effective sequencing method for the SARS-CoV-2 spike gene	2021-03-05 00:00:00	south african variant
96	pmid32572377	Corrigendum to 'An Overview of Coronaviruses including the SARS-2 Coronavirus - Molecular Biology, Epidemiology and Clinical Implications' [Cur Med Res Pract. (2019) Vol. 10, pages 54-64].	2020-09-28 00:00:00	p.2
66	pmid33860748	Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France.	2021-04-19 00:00:00	b.1.1.7
28	2021.04.09.439181	Theoretical causes of the Brazilian P.1 and P.2 lineages of the SARS-CoV-2 virus through molecular dynamics	2021-04-10 00:00:00	p.1
28	2021.04.09.439181	Theoretical causes of the Brazilian P.1 and P.2 lineages of the SARS-CoV-2 virus through molecular dynamics	2021-04-10 00:00:00	p.2
28	2021.04.09.439181	Theoretical causes of the Brazilian P.1 and P.2 lineages of the SARS-CoV-2 virus through molecular dynamics	2021-04-10 00:00:00	lineage b.1.1.28
4	2020.02.28.20028068	Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China	2020-03-03 00:00:00	s.1
2	pmid33178980	Impact of the COVID-19 pandemic on radiography practice: findings from a UK radiography workforce survey.	2020-08-17 00:00:00	v.2
17	pmid33782449	DNA methylation architecture of the ACE2 gene in nasal cells of children.	2021-03-31 00:00:00	y.1
59	pmid33861950	Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States.	2021-02-25 00:00:00	b.1.1.7
11	2021.03.06.434059	Structural Analysis of Spike Protein Mutations in an Emergent SARS-CoV-2 Variant from the Philippines	2021-03-08 00:00:00	p.3
11	2021.03.06.434059	Structural Analysis of Spike Protein Mutations in an Emergent SARS-CoV-2 Variant from the Philippines	2021-03-08 00:00:00	b.1.351
11	2021.03.06.434059	Structural Analysis of Spike Protein Mutations in an Emergent SARS-CoV-2 Variant from the Philippines	2021-03-08 00:00:00	p.1
11	2021.03.06.434059	Structural Analysis of Spike Protein Mutations in an Emergent SARS-CoV-2 Variant from the Philippines	2021-03-08 00:00:00	b.1.1.7
65	pmid33893169	Correlates of Neutralization Against SARS-CoV-2 Variants of Concern by Early Pandemic Sera.	2021-04-24 00:00:00	b.1.1.7
65	pmid33893169	Correlates of Neutralization Against SARS-CoV-2 Variants of Concern by Early Pandemic Sera.	2021-04-24 00:00:00	b.1.351
65	pmid33893169	Correlates of Neutralization Against SARS-CoV-2 Variants of Concern by Early Pandemic Sera.	2021-04-24 00:00:00	b.1.351 variant
22	2021.01.08.425825	Artemisia annua L. extracts prevent in vitro replication of SARS-CoV-2	2021-01-08 00:00:00	south african variant
69	pmid33441410	An Observational Laboratory-Based Assessment of SARS-CoV-2 Molecular Diagnostics in Benin, Western Africa.	2021-01-15 00:00:00	a.4
69	pmid33441410	An Observational Laboratory-Based Assessment of SARS-CoV-2 Molecular Diagnostics in Benin, Western Africa.	2021-01-15 00:00:00	b.1
87	2021.01.08.21249379	Detection of SARS-CoV-2 variants in Switzerland by genomic analysis of wastewater samples	2021-01-09 00:00:00	b.1.1.7
87	2021.01.08.21249379	Detection of SARS-CoV-2 variants in Switzerland by genomic analysis of wastewater samples	2021-01-09 00:00:00	501.v2
60	2021.04.21.440801	Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 isolates from Pennsylvania	2021-04-21 00:00:00	b.1.1.7
60	2021.04.21.440801	Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 isolates from Pennsylvania	2021-04-21 00:00:00	lineage b.1.1.7
51	pmid33682241	"""Delayed hypersensitivity reaction to hyaluronic acid dermal filler post COVID-19 viral infection""."	2021-03-08 00:00:00	n.1
60	pmid33028563	Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis.	2020-12-18 00:00:00	v.1
96	2021.03.24.436620	B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies	2021-03-24 00:00:00	b.1.526
96	2021.03.24.436620	B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies	2021-03-24 00:00:00	b.1.526 variant
21	pmid33476236	COVID-19 Surveillance Data: A Primer for Epidemiology and Data Science.	2021-01-21 00:00:00	a.1
1	2021.03.16.21252974	Molecular Epidemiology of SARS-CoV-2 in Cyprus	2021-03-24 00:00:00	b.1.2
1	2021.03.16.21252974	Molecular Epidemiology of SARS-CoV-2 in Cyprus	2021-03-24 00:00:00	b.1.1.7
1	2021.03.16.21252974	Molecular Epidemiology of SARS-CoV-2 in Cyprus	2021-03-24 00:00:00	uk variant
